id	sid	tid	token	lemma	pos
dpc-3332	1	1	dermatology	dermatology	NOUN
dpc-3332	1	2	:	:	PUNCT
dpc-3332	1	3	practical	practical	ADJ
dpc-3332	1	4	and	and	CCONJ
dpc-3332	1	5	conceptual	conceptual	ADJ
dpc-3332	1	6	original	original	ADJ
dpc-3332	1	7	article	article	NOUN
dpc-3332	1	8	|	|	ADV
dpc-3332	1	9	dermatol	dermatol	ADJ
dpc-3332	1	10	pract	pract	NOUN
dpc-3332	1	11	concept	concept	NOUN
dpc-3332	1	12	.	.	PUNCT
dpc-3332	2	1	2024;14(2):e2024097	2024;14(2):e2024097	NUM
dpc-3332	2	2	1	1	NUM
dpc-3332	2	3	importance	importance	NOUN
dpc-3332	2	4	of	of	ADP
dpc-3332	2	5	the	the	DET
dpc-3332	2	6	c	c	NOUN
dpc-3332	2	7	-	-	PUNCT
dpc-3332	2	8	reactive	reactive	ADJ
dpc-3332	2	9	protein	protein	NOUN
dpc-3332	2	10	to	to	ADP
dpc-3332	2	11	albumin	albumin	ADJ
dpc-3332	2	12	ratio	ratio	NOUN
dpc-3332	2	13	in	in	ADP
dpc-3332	2	14	the	the	DET
dpc-3332	2	15	diagnosis	diagnosis	NOUN
dpc-3332	2	16	and	and	CCONJ
dpc-3332	2	17	prognosis	prognosis	NOUN
dpc-3332	2	18	of	of	ADP
dpc-3332	2	19	mycosis	mycosis	NOUN
dpc-3332	2	20	fungoides	fungoide	NOUN
dpc-3332	2	21	gamze	gamze	VERB
dpc-3332	2	22	taş	taş	NOUN
dpc-3332	2	23	-	-	PUNCT
dpc-3332	2	24	aygar1	aygar1	PROPN
dpc-3332	2	25	,	,	PUNCT
dpc-3332	2	26	hatice	hatice	PROPN
dpc-3332	2	27	ataş1	ataş1	PROPN
dpc-3332	2	28	,	,	PUNCT
dpc-3332	2	29	müzeyyen	müzeyyen	NOUN
dpc-3332	2	30	gönül1	gönül1	PROPN
dpc-3332	2	31	,	,	PUNCT
dpc-3332	2	32	selda	selda	PROPN
dpc-3332	2	33	pelin	pelin	PROPN
dpc-3332	2	34	kartal1	kartal1	PROPN
dpc-3332	2	35	1	1	NUM
dpc-3332	2	36	university	university	PROPN
dpc-3332	2	37	of	of	ADP
dpc-3332	2	38	health	health	PROPN
dpc-3332	2	39	sciences	sciences	PROPN
dpc-3332	2	40	,	,	PUNCT
dpc-3332	2	41	etlik	etlik	ADJ
dpc-3332	2	42	city	city	NOUN
dpc-3332	2	43	hospital	hospital	NOUN
dpc-3332	2	44	,	,	PUNCT
dpc-3332	2	45	dermatology	dermatology	NOUN
dpc-3332	2	46	clinic	clinic	NOUN
dpc-3332	2	47	,	,	PUNCT
dpc-3332	2	48	ankara	ankara	PROPN
dpc-3332	2	49	,	,	PUNCT
dpc-3332	2	50	turkey	turkey	PROPN
dpc-3332	2	51	key	key	ADJ
dpc-3332	2	52	words	word	NOUN
dpc-3332	2	53	:	:	PUNCT
dpc-3332	2	54	mycosis	mycosis	NOUN
dpc-3332	2	55	fungoides	fungoide	NOUN
dpc-3332	2	56	,	,	PUNCT
dpc-3332	2	57	diagnosis	diagnosis	NOUN
dpc-3332	2	58	,	,	PUNCT
dpc-3332	2	59	crp	crp	PROPN
dpc-3332	2	60	,	,	PUNCT
dpc-3332	2	61	albumin	albumin	ADJ
dpc-3332	2	62	citation	citation	NOUN
dpc-3332	2	63	:	:	PUNCT
dpc-3332	2	64	taş	taş	NOUN
dpc-3332	2	65	-	-	PUNCT
dpc-3332	2	66	aygar	aygar	NOUN
dpc-3332	2	67	g	g	NOUN
dpc-3332	2	68	,	,	PUNCT
dpc-3332	2	69	ataş	ataş	ADJ
dpc-3332	2	70	h	h	NOUN
dpc-3332	2	71	,	,	PUNCT
dpc-3332	2	72	gönül	gönül	PROPN
dpc-3332	2	73	m	m	NOUN
dpc-3332	2	74	,	,	PUNCT
dpc-3332	2	75	kartal	kartal	ADJ
dpc-3332	2	76	sp	sp	NOUN
dpc-3332	2	77	.	.	NOUN
dpc-3332	2	78	importance	importance	NOUN
dpc-3332	2	79	of	of	ADP
dpc-3332	2	80	the	the	DET
dpc-3332	2	81	c	c	NOUN
dpc-3332	2	82	-	-	PUNCT
dpc-3332	2	83	reactive	reactive	ADJ
dpc-3332	2	84	protein	protein	NOUN
dpc-3332	2	85	to	to	ADP
dpc-3332	2	86	albumin	albumin	ADJ
dpc-3332	2	87	ratio	ratio	NOUN
dpc-3332	2	88	in	in	ADP
dpc-3332	2	89	the	the	DET
dpc-3332	2	90	diagnosis	diagnosis	NOUN
dpc-3332	2	91	and	and	CCONJ
dpc-3332	2	92	prognosis	prognosis	NOUN
dpc-3332	2	93	of	of	ADP
dpc-3332	2	94	mycosis	mycosis	NOUN
dpc-3332	2	95	fungoides	fungoide	NOUN
dpc-3332	2	96	.	.	PUNCT
dpc-3332	3	1	dermatol	dermatol	NOUN
dpc-3332	3	2	pract	pract	PROPN
dpc-3332	3	3	concept	concept	NOUN
dpc-3332	3	4	.	.	PUNCT
dpc-3332	4	1	2024;14(2):e2024097	2024;14(2):e2024097	NUM
dpc-3332	4	2	.	.	X
dpc-3332	5	1	doi	doi	NOUN
dpc-3332	5	2	:	:	PUNCT
dpc-3332	5	3	https://doi.org/10.5826/dpc.1402a97	https://doi.org/10.5826/dpc.1402a97	NOUN
dpc-3332	5	4	accepted	accept	VERB
dpc-3332	5	5	:	:	PUNCT
dpc-3332	5	6	november	november	PROPN
dpc-3332	5	7	18	18	NUM
dpc-3332	5	8	,	,	PUNCT
dpc-3332	5	9	2023	2023	NUM
dpc-3332	5	10	;	;	PUNCT
dpc-3332	5	11	published	publish	VERB
dpc-3332	5	12	:	:	PUNCT
dpc-3332	6	1	april	april	PROPN
dpc-3332	6	2	2024	2024	NUM
dpc-3332	6	3	copyright	copyright	NOUN
dpc-3332	6	4	:	:	PUNCT
dpc-3332	6	5	©	©	PROPN
dpc-3332	6	6	2024	2024	NUM
dpc-3332	6	7	taş	taş	NOUN
dpc-3332	6	8	-	-	PUNCT
dpc-3332	6	9	aygar	aygar	NOUN
dpc-3332	6	10	et	et	PROPN
dpc-3332	6	11	al	al	PROPN
dpc-3332	6	12	.	.	PUNCT
dpc-3332	7	1	this	this	PRON
dpc-3332	7	2	is	be	AUX
dpc-3332	7	3	an	an	DET
dpc-3332	7	4	open	open	ADJ
dpc-3332	7	5	-	-	PUNCT
dpc-3332	7	6	access	access	NOUN
dpc-3332	7	7	article	article	NOUN
dpc-3332	7	8	distributed	distribute	VERB
dpc-3332	7	9	under	under	ADP
dpc-3332	7	10	the	the	DET
dpc-3332	7	11	terms	term	NOUN
dpc-3332	7	12	of	of	ADP
dpc-3332	7	13	the	the	DET
dpc-3332	7	14	creative	creative	ADJ
dpc-3332	7	15	commons	common	NOUN
dpc-3332	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-3332	7	17	license	license	NOUN
dpc-3332	7	18	(	(	PUNCT
dpc-3332	7	19	by	by	ADP
dpc-3332	7	20	-	-	PUNCT
dpc-3332	7	21	nc-4.0	nc-4.0	NOUN
dpc-3332	7	22	)	)	PUNCT
dpc-3332	7	23	,	,	PUNCT
dpc-3332	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-3332	7	25	,	,	PUNCT
dpc-3332	7	26	which	which	PRON
dpc-3332	7	27	permits	permit	VERB
dpc-3332	7	28	unrestricted	unrestricted	ADJ
dpc-3332	7	29	noncommercial	noncommercial	ADJ
dpc-3332	7	30	use	use	NOUN
dpc-3332	7	31	,	,	PUNCT
dpc-3332	7	32	distribution	distribution	NOUN
dpc-3332	7	33	,	,	PUNCT
dpc-3332	7	34	and	and	CCONJ
dpc-3332	7	35	reproduction	reproduction	NOUN
dpc-3332	7	36	in	in	ADP
dpc-3332	7	37	any	any	DET
dpc-3332	7	38	medium	medium	NOUN
dpc-3332	7	39	,	,	PUNCT
dpc-3332	7	40	provided	provide	VERB
dpc-3332	7	41	the	the	DET
dpc-3332	7	42	original	original	ADJ
dpc-3332	7	43	authors	author	NOUN
dpc-3332	7	44	and	and	CCONJ
dpc-3332	7	45	source	source	NOUN
dpc-3332	7	46	are	be	AUX
dpc-3332	7	47	credited	credit	VERB
dpc-3332	7	48	.	.	PUNCT
dpc-3332	8	1	funding	funding	NOUN
dpc-3332	8	2	:	:	PUNCT
dpc-3332	8	3	none	none	NOUN
dpc-3332	8	4	.	.	PUNCT
dpc-3332	9	1	competing	compete	VERB
dpc-3332	9	2	interests	interest	NOUN
dpc-3332	9	3	:	:	PUNCT
dpc-3332	9	4	none	none	NOUN
dpc-3332	9	5	.	.	PUNCT
dpc-3332	10	1	authorship	authorship	NOUN
dpc-3332	10	2	:	:	PUNCT
dpc-3332	10	3	all	all	DET
dpc-3332	10	4	authors	author	NOUN
dpc-3332	10	5	have	have	AUX
dpc-3332	10	6	contributed	contribute	VERB
dpc-3332	10	7	significantly	significantly	ADV
dpc-3332	10	8	to	to	ADP
dpc-3332	10	9	this	this	DET
dpc-3332	10	10	publication	publication	NOUN
dpc-3332	10	11	.	.	PUNCT
dpc-3332	11	1	corresponding	correspond	VERB
dpc-3332	11	2	author	author	NOUN
dpc-3332	11	3	:	:	PUNCT
dpc-3332	11	4	taş	taş	NOUN
dpc-3332	11	5	-	-	PUNCT
dpc-3332	11	6	aygar	aygar	NOUN
dpc-3332	11	7	gamze	gamze	NOUN
dpc-3332	11	8	,	,	PUNCT
dpc-3332	11	9	university	university	NOUN
dpc-3332	11	10	of	of	ADP
dpc-3332	11	11	health	health	PROPN
dpc-3332	11	12	sciences	sciences	PROPN
dpc-3332	11	13	,	,	PUNCT
dpc-3332	11	14	etlik	etlik	ADJ
dpc-3332	11	15	city	city	NOUN
dpc-3332	11	16	hospital	hospital	NOUN
dpc-3332	11	17	,	,	PUNCT
dpc-3332	11	18	dermatology	dermatology	NOUN
dpc-3332	11	19	clinic	clinic	NOUN
dpc-3332	11	20	,	,	PUNCT
dpc-3332	11	21	ankara	ankara	PROPN
dpc-3332	11	22	,	,	PUNCT
dpc-3332	11	23	turkey	turkey	PROPN
dpc-3332	11	24	,	,	PUNCT
dpc-3332	11	25	e	e	NOUN
dpc-3332	11	26	-	-	NOUN
dpc-3332	11	27	mail	mail	NOUN
dpc-3332	11	28	:	:	PUNCT
dpc-3332	11	29	gamze_0890@hotmail.com	gamze_0890@hotmail.com	X
dpc-3332	11	30	.	.	PUNCT
dpc-3332	11	31	introduction	introduction	NOUN
dpc-3332	11	32	:	:	PUNCT
dpc-3332	11	33	the	the	DET
dpc-3332	11	34	c	c	NOUN
dpc-3332	11	35	-	-	PUNCT
dpc-3332	11	36	reactive	reactive	ADJ
dpc-3332	11	37	protein	protein	NOUN
dpc-3332	11	38	to	to	ADP
dpc-3332	11	39	albumin	albumin	ADJ
dpc-3332	11	40	ratio	ratio	NOUN
dpc-3332	11	41	(	(	PUNCT
dpc-3332	11	42	car	car	NOUN
dpc-3332	11	43	)	)	PUNCT
dpc-3332	11	44	lately	lately	ADV
dpc-3332	11	45	has	have	AUX
dpc-3332	11	46	demonstrated	demonstrate	VERB
dpc-3332	11	47	as	as	ADP
dpc-3332	11	48	a	a	DET
dpc-3332	11	49	prognostic	prognostic	ADJ
dpc-3332	11	50	factor	factor	NOUN
dpc-3332	11	51	and	and	CCONJ
dpc-3332	11	52	an	an	DET
dpc-3332	11	53	indicator	indicator	NOUN
dpc-3332	11	54	of	of	ADP
dpc-3332	11	55	disease	disease	NOUN
dpc-3332	11	56	activity	activity	NOUN
dpc-3332	11	57	,	,	PUNCT
dpc-3332	11	58	severity	severity	NOUN
dpc-3332	11	59	and	and	CCONJ
dpc-3332	11	60	prognosis	prognosis	NOUN
dpc-3332	11	61	in	in	ADP
dpc-3332	11	62	solid	solid	ADJ
dpc-3332	11	63	organ	organ	NOUN
dpc-3332	11	64	malignancies	malignancy	NOUN
dpc-3332	11	65	and	and	CCONJ
dpc-3332	11	66	inflammatory	inflammatory	ADJ
dpc-3332	11	67	diseases	disease	NOUN
dpc-3332	11	68	.	.	PUNCT
dpc-3332	12	1	however	however	ADV
dpc-3332	12	2	,	,	PUNCT
dpc-3332	12	3	the	the	DET
dpc-3332	12	4	effects	effect	NOUN
dpc-3332	12	5	of	of	ADP
dpc-3332	12	6	car	car	NOUN
dpc-3332	12	7	have	have	AUX
dpc-3332	12	8	not	not	PART
dpc-3332	12	9	been	be	AUX
dpc-3332	12	10	investigated	investigate	VERB
dpc-3332	12	11	in	in	ADP
dpc-3332	12	12	mycosis	mycosis	NOUN
dpc-3332	12	13	fungoides	fungoide	NOUN
dpc-3332	12	14	(	(	PUNCT
dpc-3332	12	15	mf	mf	NOUN
dpc-3332	12	16	)	)	PUNCT
dpc-3332	12	17	patients	patient	NOUN
dpc-3332	12	18	yet	yet	ADV
dpc-3332	12	19	.	.	PUNCT
dpc-3332	13	1	objectives	objective	NOUN
dpc-3332	13	2	:	:	PUNCT
dpc-3332	14	1	this	this	DET
dpc-3332	14	2	study	study	NOUN
dpc-3332	14	3	aimed	aim	VERB
dpc-3332	14	4	to	to	PART
dpc-3332	14	5	determine	determine	VERB
dpc-3332	14	6	the	the	DET
dpc-3332	14	7	potential	potential	ADJ
dpc-3332	14	8	role	role	NOUN
dpc-3332	14	9	of	of	ADP
dpc-3332	14	10	car	car	NOUN
dpc-3332	14	11	as	as	ADP
dpc-3332	14	12	a	a	DET
dpc-3332	14	13	diagnostic	diagnostic	ADJ
dpc-3332	14	14	and	and	CCONJ
dpc-3332	14	15	a	a	DET
dpc-3332	14	16	prognostic	prognostic	ADJ
dpc-3332	14	17	indicator	indicator	NOUN
dpc-3332	14	18	in	in	ADP
dpc-3332	14	19	mf	mf	PROPN
dpc-3332	14	20	.	.	PROPN
dpc-3332	14	21	methods	method	NOUN
dpc-3332	14	22	:	:	PUNCT
dpc-3332	14	23	we	we	PRON
dpc-3332	14	24	retrospectively	retrospectively	ADV
dpc-3332	14	25	investigated	investigate	VERB
dpc-3332	14	26	the	the	DET
dpc-3332	14	27	electronic	electronic	ADJ
dpc-3332	14	28	medical	medical	ADJ
dpc-3332	14	29	records	record	NOUN
dpc-3332	14	30	of	of	ADP
dpc-3332	14	31	97	97	NUM
dpc-3332	14	32	patients	patient	NOUN
dpc-3332	14	33	with	with	ADP
dpc-3332	14	34	mf	mf	PRON
dpc-3332	14	35	admitted	admit	VERB
dpc-3332	14	36	to	to	ADP
dpc-3332	14	37	the	the	DET
dpc-3332	14	38	dermatology	dermatology	NOUN
dpc-3332	14	39	clinic	clinic	NOUN
dpc-3332	14	40	of	of	ADP
dpc-3332	14	41	health	health	PROPN
dpc-3332	14	42	sciences	sciences	PROPN
dpc-3332	14	43	university	university	PROPN
dpc-3332	14	44	,	,	PUNCT
dpc-3332	14	45	diskapi	diskapi	PROPN
dpc-3332	14	46	yildirim	yildirim	NOUN
dpc-3332	14	47	beyazit	beyazit	NOUN
dpc-3332	14	48	training	training	NOUN
dpc-3332	14	49	and	and	CCONJ
dpc-3332	14	50	research	research	NOUN
dpc-3332	14	51	hospital	hospital	NOUN
dpc-3332	14	52	between	between	ADP
dpc-3332	14	53	january	january	PROPN
dpc-3332	14	54	2014	2014	NUM
dpc-3332	14	55	and	and	CCONJ
dpc-3332	14	56	december	december	PROPN
dpc-3332	14	57	2020	2020	NUM
dpc-3332	14	58	.	.	PUNCT
dpc-3332	15	1	in	in	ADP
dpc-3332	15	2	total	total	ADJ
dpc-3332	15	3	,	,	PUNCT
dpc-3332	15	4	60	60	NUM
dpc-3332	15	5	patients	patient	NOUN
dpc-3332	15	6	with	with	ADP
dpc-3332	15	7	mf	mf	NOUN
dpc-3332	15	8	were	be	AUX
dpc-3332	15	9	enrolled	enrol	VERB
dpc-3332	15	10	in	in	ADP
dpc-3332	15	11	the	the	DET
dpc-3332	15	12	study	study	NOUN
dpc-3332	15	13	.	.	PUNCT
dpc-3332	16	1	car	car	NOUN
dpc-3332	16	2	was	be	AUX
dpc-3332	16	3	evaluated	evaluate	VERB
dpc-3332	16	4	,	,	PUNCT
dpc-3332	16	5	patient	patient	ADJ
dpc-3332	16	6	and	and	CCONJ
dpc-3332	16	7	control	control	NOUN
dpc-3332	16	8	group	group	NOUN
dpc-3332	16	9	.	.	PUNCT
dpc-3332	17	1	also	also	ADV
dpc-3332	17	2	,	,	PUNCT
dpc-3332	17	3	the	the	DET
dpc-3332	17	4	other	other	ADJ
dpc-3332	17	5	clinicopathological	clinicopathological	ADJ
dpc-3332	17	6	factors	factor	NOUN
dpc-3332	17	7	including	include	VERB
dpc-3332	17	8	age	age	NOUN
dpc-3332	17	9	,	,	PUNCT
dpc-3332	17	10	lactate	lactate	NOUN
dpc-3332	17	11	dehydrogenase	dehydrogenase	NOUN
dpc-3332	17	12	,	,	PUNCT
dpc-3332	17	13	stage	stage	NOUN
dpc-3332	17	14	of	of	ADP
dpc-3332	17	15	disease	disease	NOUN
dpc-3332	17	16	,	,	PUNCT
dpc-3332	17	17	beta-2	beta-2	PROPN
dpc-3332	17	18	-	-	PUNCT
dpc-3332	17	19	microglobulin	microglobulin	PROPN
dpc-3332	17	20	levels	level	NOUN
dpc-3332	17	21	,	,	PUNCT
dpc-3332	17	22	and	and	CCONJ
dpc-3332	17	23	sedimentation	sedimentation	NOUN
dpc-3332	17	24	levels	level	NOUN
dpc-3332	17	25	were	be	AUX
dpc-3332	17	26	evaluated	evaluate	VERB
dpc-3332	17	27	.	.	PUNCT
dpc-3332	18	1	results	result	NOUN
dpc-3332	18	2	:	:	PUNCT
dpc-3332	18	3	the	the	DET
dpc-3332	18	4	median	median	ADJ
dpc-3332	18	5	value	value	NOUN
dpc-3332	18	6	of	of	ADP
dpc-3332	18	7	car	car	NOUN
dpc-3332	18	8	was	be	AUX
dpc-3332	18	9	0.85	0.85	NUM
dpc-3332	18	10	(	(	PUNCT
dpc-3332	18	11	0.10	0.10	NUM
dpc-3332	18	12	-	-	SYM
dpc-3332	18	13	7.51	7.51	NUM
dpc-3332	18	14	)	)	PUNCT
dpc-3332	18	15	in	in	ADP
dpc-3332	18	16	the	the	DET
dpc-3332	18	17	patient	patient	NOUN
dpc-3332	18	18	group	group	NOUN
dpc-3332	18	19	,	,	PUNCT
dpc-3332	18	20	whereas	whereas	SCONJ
dpc-3332	18	21	it	it	PRON
dpc-3332	18	22	was	be	AUX
dpc-3332	18	23	0.39	0.39	NUM
dpc-3332	18	24	(	(	PUNCT
dpc-3332	18	25	0.0	0.0	NUM
dpc-3332	18	26	-	-	SYM
dpc-3332	18	27	1.11	1.11	NUM
dpc-3332	18	28	)	)	PUNCT
dpc-3332	18	29	in	in	ADP
dpc-3332	18	30	the	the	DET
dpc-3332	18	31	control	control	NOUN
dpc-3332	18	32	group	group	NOUN
dpc-3332	18	33	(	(	PUNCT
dpc-3332	18	34	p	p	X
dpc-3332	18	35	<	<	X
dpc-3332	18	36	0.001	0.001	NUM
dpc-3332	18	37	)	)	PUNCT
dpc-3332	18	38	.	.	PUNCT
dpc-3332	19	1	patients	patient	NOUN
dpc-3332	19	2	with	with	ADP
dpc-3332	19	3	disease	disease	NOUN
dpc-3332	19	4	progression	progression	NOUN
dpc-3332	19	5	(	(	PUNCT
dpc-3332	19	6	n	n	NOUN
dpc-3332	19	7	=	=	SYM
dpc-3332	19	8	16	16	NUM
dpc-3332	19	9	,	,	PUNCT
dpc-3332	19	10	13	13	NUM
dpc-3332	19	11	m	m	NOUN
dpc-3332	19	12	,	,	PUNCT
dpc-3332	19	13	3	3	NUM
dpc-3332	19	14	f	f	NOUN
dpc-3332	19	15	)	)	PUNCT
dpc-3332	19	16	had	have	VERB
dpc-3332	19	17	a	a	DET
dpc-3332	19	18	median	median	ADJ
dpc-3332	19	19	value	value	NOUN
dpc-3332	19	20	of	of	ADP
dpc-3332	19	21	car	car	NOUN
dpc-3332	19	22	0.84	0.84	NUM
dpc-3332	19	23	(	(	PUNCT
dpc-3332	19	24	0.10	0.10	NUM
dpc-3332	19	25	-	-	SYM
dpc-3332	19	26	7.51	7.51	NUM
dpc-3332	19	27	)	)	PUNCT
dpc-3332	19	28	and	and	CCONJ
dpc-3332	19	29	the	the	DET
dpc-3332	19	30	median	median	ADJ
dpc-3332	19	31	value	value	NOUN
dpc-3332	19	32	of	of	ADP
dpc-3332	19	33	car	car	NOUN
dpc-3332	19	34	(	(	PUNCT
dpc-3332	19	35	n	n	NOUN
dpc-3332	19	36	=	=	SYM
dpc-3332	19	37	44	44	NUM
dpc-3332	19	38	)	)	PUNCT
dpc-3332	19	39	was	be	AUX
dpc-3332	19	40	0.86	0.86	NUM
dpc-3332	19	41	(	(	PUNCT
dpc-3332	19	42	0.12	0.12	NUM
dpc-3332	19	43	-	-	SYM
dpc-3332	19	44	4.57	4.57	NUM
dpc-3332	19	45	)	)	PUNCT
dpc-3332	19	46	in	in	ADP
dpc-3332	19	47	the	the	DET
dpc-3332	19	48	group	group	NOUN
dpc-3332	19	49	of	of	ADP
dpc-3332	19	50	patients	patient	NOUN
dpc-3332	19	51	with	with	ADP
dpc-3332	19	52	stable	stable	ADJ
dpc-3332	19	53	disease	disease	NOUN
dpc-3332	19	54	.	.	PUNCT
dpc-3332	20	1	the	the	DET
dpc-3332	20	2	car	car	NOUN
dpc-3332	20	3	value	value	NOUN
dpc-3332	20	4	had	have	VERB
dpc-3332	20	5	no	no	DET
dpc-3332	20	6	prognostic	prognostic	ADJ
dpc-3332	20	7	significance	significance	NOUN
dpc-3332	20	8	(	(	PUNCT
dpc-3332	20	9	p	p	X
dpc-3332	20	10	>	>	X
dpc-3332	20	11	0.05	0.05	NUM
dpc-3332	20	12	)	)	PUNCT
dpc-3332	20	13	.	.	PUNCT
dpc-3332	21	1	conclusions	conclusion	NOUN
dpc-3332	21	2	:	:	PUNCT
dpc-3332	21	3	there	there	PRON
dpc-3332	21	4	is	be	VERB
dpc-3332	21	5	no	no	DET
dpc-3332	21	6	association	association	NOUN
dpc-3332	21	7	between	between	ADP
dpc-3332	21	8	the	the	DET
dpc-3332	21	9	car	car	NOUN
dpc-3332	21	10	and	and	CCONJ
dpc-3332	21	11	progression	progression	NOUN
dpc-3332	21	12	in	in	ADP
dpc-3332	21	13	the	the	DET
dpc-3332	21	14	stage	stage	NOUN
dpc-3332	21	15	in	in	ADP
dpc-3332	21	16	mf	mf	NOUN
dpc-3332	21	17	patients	patient	NOUN
dpc-3332	21	18	.	.	PUNCT
dpc-3332	22	1	but	but	CCONJ
dpc-3332	22	2	the	the	DET
dpc-3332	22	3	car	car	NOUN
dpc-3332	22	4	is	be	AUX
dpc-3332	22	5	significantly	significantly	ADV
dpc-3332	22	6	higher	high	ADJ
dpc-3332	22	7	in	in	ADP
dpc-3332	22	8	patients	patient	NOUN
dpc-3332	22	9	with	with	ADP
dpc-3332	22	10	mf	mf	NOUN
dpc-3332	22	11	than	than	ADP
dpc-3332	22	12	in	in	ADP
dpc-3332	22	13	the	the	DET
dpc-3332	22	14	control	control	NOUN
dpc-3332	22	15	group	group	NOUN
dpc-3332	22	16	.	.	PUNCT
dpc-3332	23	1	the	the	DET
dpc-3332	23	2	car	car	NOUN
dpc-3332	23	3	can	can	AUX
dpc-3332	23	4	be	be	AUX
dpc-3332	23	5	a	a	DET
dpc-3332	23	6	guide	guide	NOUN
dpc-3332	23	7	for	for	ADP
dpc-3332	23	8	us	we	PRON
dpc-3332	23	9	in	in	ADP
dpc-3332	23	10	cases	case	NOUN
dpc-3332	23	11	where	where	SCONJ
dpc-3332	23	12	we	we	PRON
dpc-3332	23	13	have	have	VERB
dpc-3332	23	14	difficulty	difficulty	NOUN
dpc-3332	23	15	in	in	ADP
dpc-3332	23	16	diagnosing	diagnose	VERB
dpc-3332	23	17	.	.	PUNCT
dpc-3332	24	1	abstract	abstract	ADJ
dpc-3332	24	2	2	2	NUM
dpc-3332	24	3	original	original	ADJ
dpc-3332	24	4	article	article	NOUN
dpc-3332	24	5	|	|	ADV
dpc-3332	24	6	dermatol	dermatol	ADJ
dpc-3332	24	7	pract	pract	NOUN
dpc-3332	24	8	concept	concept	NOUN
dpc-3332	24	9	.	.	PUNCT
dpc-3332	25	1	2024;14(2):e2024097	2024;14(2):e2024097	NUM
dpc-3332	25	2	introduction	introduction	NOUN
dpc-3332	25	3	primary	primary	ADJ
dpc-3332	25	4	cutaneous	cutaneous	ADJ
dpc-3332	25	5	lymphomas	lymphoma	NOUN
dpc-3332	25	6	are	be	AUX
dpc-3332	25	7	a	a	DET
dpc-3332	25	8	heterogeneous	heterogeneous	ADJ
dpc-3332	25	9	group	group	NOUN
dpc-3332	25	10	of	of	ADP
dpc-3332	25	11	extranodal	extranodal	ADJ
dpc-3332	25	12	non	non	ADJ
dpc-3332	25	13	-	-	ADJ
dpc-3332	25	14	hodgkin	hodgkin	ADJ
dpc-3332	25	15	lymphomas	lymphoma	NOUN
dpc-3332	25	16	.	.	PUNCT
dpc-3332	26	1	mycosis	mycosis	NOUN
dpc-3332	26	2	fungoides	fungoide	NOUN
dpc-3332	26	3	(	(	PUNCT
dpc-3332	26	4	mf	mf	X
dpc-3332	26	5	)	)	PUNCT
dpc-3332	26	6	is	be	AUX
dpc-3332	26	7	the	the	DET
dpc-3332	26	8	most	most	ADV
dpc-3332	26	9	common	common	ADJ
dpc-3332	26	10	type	type	NOUN
dpc-3332	26	11	of	of	ADP
dpc-3332	26	12	primary	primary	ADJ
dpc-3332	26	13	cutaneous	cutaneous	ADJ
dpc-3332	26	14	t	t	PROPN
dpc-3332	26	15	-	-	PUNCT
dpc-3332	26	16	cell	cell	NOUN
dpc-3332	26	17	lymphomas	lymphoma	NOUN
dpc-3332	26	18	(	(	PUNCT
dpc-3332	26	19	ctcl	ctcl	NOUN
dpc-3332	26	20	)	)	PUNCT
dpc-3332	26	21	caused	cause	VERB
dpc-3332	26	22	by	by	ADP
dpc-3332	26	23	malignant	malignant	ADJ
dpc-3332	26	24	proliferation	proliferation	NOUN
dpc-3332	26	25	of	of	ADP
dpc-3332	26	26	clonal	clonal	ADJ
dpc-3332	26	27	t	t	PROPN
dpc-3332	26	28	lymphocytes	lymphocyte	NOUN
dpc-3332	26	29	in	in	ADP
dpc-3332	26	30	the	the	DET
dpc-3332	26	31	skin	skin	NOUN
dpc-3332	26	32	.	.	PUNCT
dpc-3332	27	1	mf	mf	NOUN
dpc-3332	27	2	was	be	AUX
dpc-3332	27	3	generally	generally	ADV
dpc-3332	27	4	affecting	affect	VERB
dpc-3332	27	5	older	old	ADJ
dpc-3332	27	6	patients	patient	NOUN
dpc-3332	27	7	with	with	ADP
dpc-3332	27	8	the	the	DET
dpc-3332	27	9	median	median	ADJ
dpc-3332	27	10	age	age	NOUN
dpc-3332	27	11	at	at	ADP
dpc-3332	27	12	diagnosis	diagnosis	NOUN
dpc-3332	27	13	between	between	ADP
dpc-3332	27	14	55	55	NUM
dpc-3332	27	15	and	and	CCONJ
dpc-3332	27	16	60	60	NUM
dpc-3332	27	17	years	year	NOUN
dpc-3332	27	18	old	old	ADJ
dpc-3332	27	19	and	and	CCONJ
dpc-3332	27	20	affecting	affect	VERB
dpc-3332	27	21	more	more	ADJ
dpc-3332	27	22	men	man	NOUN
dpc-3332	27	23	than	than	ADP
dpc-3332	27	24	women	woman	NOUN
dpc-3332	27	25	.	.	PUNCT
dpc-3332	28	1	the	the	DET
dpc-3332	28	2	children	child	NOUN
dpc-3332	28	3	can	can	AUX
dpc-3332	28	4	also	also	ADV
dpc-3332	28	5	be	be	AUX
dpc-3332	28	6	affected	affect	VERB
dpc-3332	28	7	by	by	ADP
dpc-3332	28	8	this	this	DET
dpc-3332	28	9	lymphoma	lymphoma	NOUN
dpc-3332	28	10	.	.	PUNCT
dpc-3332	29	1	the	the	DET
dpc-3332	29	2	disease	disease	NOUN
dpc-3332	29	3	usually	usually	ADV
dpc-3332	29	4	begins	begin	VERB
dpc-3332	29	5	as	as	ADP
dpc-3332	29	6	brownish	brownish	ADJ
dpc-3332	29	7	erythematous	erythematous	ADJ
dpc-3332	29	8	patches	patch	NOUN
dpc-3332	29	9	in	in	ADP
dpc-3332	29	10	sun	sun	NOUN
dpc-3332	29	11	-	-	PUNCT
dpc-3332	29	12	protected	protect	VERB
dpc-3332	29	13	areas	area	NOUN
dpc-3332	29	14	and	and	CCONJ
dpc-3332	29	15	progresses	progress	NOUN
dpc-3332	29	16	slowly	slowly	ADV
dpc-3332	29	17	over	over	ADP
dpc-3332	29	18	the	the	DET
dpc-3332	29	19	years	year	NOUN
dpc-3332	29	20	,	,	PUNCT
dpc-3332	29	21	and	and	CCONJ
dpc-3332	29	22	in	in	ADP
dpc-3332	29	23	some	some	DET
dpc-3332	29	24	patients	patient	NOUN
dpc-3332	29	25	may	may	AUX
dpc-3332	29	26	remain	remain	VERB
dpc-3332	29	27	in	in	ADP
dpc-3332	29	28	the	the	DET
dpc-3332	29	29	same	same	ADJ
dpc-3332	29	30	stage	stage	NOUN
dpc-3332	29	31	for	for	ADP
dpc-3332	29	32	years	year	NOUN
dpc-3332	29	33	without	without	ADP
dpc-3332	29	34	progress	progress	NOUN
dpc-3332	29	35	.	.	PUNCT
dpc-3332	30	1	currently	currently	ADV
dpc-3332	30	2	,	,	PUNCT
dpc-3332	30	3	there	there	PRON
dpc-3332	30	4	is	be	VERB
dpc-3332	30	5	no	no	DET
dpc-3332	30	6	cure	cure	NOUN
dpc-3332	30	7	for	for	ADP
dpc-3332	30	8	mf	mf	NOUN
dpc-3332	30	9	and	and	CCONJ
dpc-3332	30	10	symptomatic	symptomatic	ADJ
dpc-3332	30	11	treatment	treatment	NOUN
dpc-3332	30	12	is	be	AUX
dpc-3332	30	13	given	give	VERB
dpc-3332	30	14	especially	especially	ADV
dpc-3332	30	15	in	in	ADP
dpc-3332	30	16	early	early	ADJ
dpc-3332	30	17	-	-	PUNCT
dpc-3332	30	18	stage	stage	NOUN
dpc-3332	30	19	disease	disease	NOUN
dpc-3332	30	20	.	.	PUNCT
dpc-3332	31	1	while	while	SCONJ
dpc-3332	31	2	it	it	PRON
dpc-3332	31	3	is	be	AUX
dpc-3332	31	4	aimed	aim	VERB
dpc-3332	31	5	to	to	PART
dpc-3332	31	6	increase	increase	VERB
dpc-3332	31	7	the	the	DET
dpc-3332	31	8	quality	quality	NOUN
dpc-3332	31	9	of	of	ADP
dpc-3332	31	10	life	life	NOUN
dpc-3332	31	11	in	in	ADP
dpc-3332	31	12	early	early	ADJ
dpc-3332	31	13	-	-	PUNCT
dpc-3332	31	14	stage	stage	NOUN
dpc-3332	31	15	patients	patient	NOUN
dpc-3332	31	16	,	,	PUNCT
dpc-3332	31	17	it	it	PRON
dpc-3332	31	18	is	be	AUX
dpc-3332	31	19	aimed	aim	VERB
dpc-3332	31	20	to	to	PART
dpc-3332	31	21	increase	increase	VERB
dpc-3332	31	22	life	life	NOUN
dpc-3332	31	23	expectancy	expectancy	NOUN
dpc-3332	31	24	in	in	ADP
dpc-3332	31	25	advanced	advanced	ADJ
dpc-3332	31	26	stage	stage	NOUN
dpc-3332	31	27	patients	patient	NOUN
dpc-3332	31	28	.	.	PUNCT
dpc-3332	32	1	the	the	DET
dpc-3332	32	2	main	main	ADJ
dpc-3332	32	3	treatment	treatment	NOUN
dpc-3332	32	4	of	of	ADP
dpc-3332	32	5	early	early	ADJ
dpc-3332	32	6	-	-	PUNCT
dpc-3332	32	7	stage	stage	NOUN
dpc-3332	32	8	disease	disease	NOUN
dpc-3332	32	9	is	be	AUX
dpc-3332	32	10	skin	skin	NOUN
dpc-3332	32	11	-	-	PUNCT
dpc-3332	32	12	directed	direct	VERB
dpc-3332	32	13	treatments	treatment	NOUN
dpc-3332	32	14	(	(	PUNCT
dpc-3332	32	15	topical	topical	ADJ
dpc-3332	32	16	corticosteroids	corticosteroid	NOUN
dpc-3332	32	17	and	and	CCONJ
dpc-3332	32	18	phototherapy	phototherapy	NOUN
dpc-3332	32	19	)	)	PUNCT
dpc-3332	32	20	.	.	PUNCT
dpc-3332	33	1	when	when	SCONJ
dpc-3332	33	2	the	the	DET
dpc-3332	33	3	disease	disease	NOUN
dpc-3332	33	4	progresses	progress	VERB
dpc-3332	33	5	to	to	ADP
dpc-3332	33	6	advanced	advanced	ADJ
dpc-3332	33	7	stages	stage	NOUN
dpc-3332	33	8	,	,	PUNCT
dpc-3332	33	9	systemic	systemic	ADJ
dpc-3332	33	10	therapy	therapy	NOUN
dpc-3332	33	11	including	include	VERB
dpc-3332	33	12	systemic	systemic	ADJ
dpc-3332	33	13	chemotherapy	chemotherapy	NOUN
dpc-3332	33	14	is	be	AUX
dpc-3332	33	15	applied	apply	VERB
dpc-3332	33	16	and	and	CCONJ
dpc-3332	33	17	the	the	DET
dpc-3332	33	18	disease	disease	NOUN
dpc-3332	33	19	can	can	AUX
dpc-3332	33	20	be	be	AUX
dpc-3332	33	21	fatal	fatal	ADJ
dpc-3332	33	22	[	[	X
dpc-3332	33	23	1	1	NUM
dpc-3332	33	24	-	-	SYM
dpc-3332	33	25	4	4	NUM
dpc-3332	33	26	]	]	PUNCT
dpc-3332	33	27	.	.	PUNCT
dpc-3332	34	1	therefore	therefore	ADV
dpc-3332	34	2	,	,	PUNCT
dpc-3332	34	3	to	to	PART
dpc-3332	34	4	diagnose	diagnose	VERB
dpc-3332	34	5	the	the	DET
dpc-3332	34	6	disease	disease	NOUN
dpc-3332	34	7	and	and	CCONJ
dpc-3332	34	8	anticipating	anticipate	VERB
dpc-3332	34	9	the	the	DET
dpc-3332	34	10	prognosis	prognosis	NOUN
dpc-3332	34	11	is	be	AUX
dpc-3332	34	12	an	an	DET
dpc-3332	34	13	important	important	ADJ
dpc-3332	34	14	need	need	NOUN
dpc-3332	34	15	.	.	PUNCT
dpc-3332	35	1	an	an	DET
dpc-3332	35	2	indicator	indicator	NOUN
dpc-3332	35	3	that	that	PRON
dpc-3332	35	4	informs	inform	VERB
dpc-3332	35	5	the	the	DET
dpc-3332	35	6	prognosis	prognosis	NOUN
dpc-3332	35	7	of	of	ADP
dpc-3332	35	8	the	the	DET
dpc-3332	35	9	disease	disease	NOUN
dpc-3332	35	10	and	and	CCONJ
dpc-3332	35	11	provides	provide	VERB
dpc-3332	35	12	information	information	NOUN
dpc-3332	35	13	about	about	ADP
dpc-3332	35	14	the	the	DET
dpc-3332	35	15	severity	severity	NOUN
dpc-3332	35	16	of	of	ADP
dpc-3332	35	17	the	the	DET
dpc-3332	35	18	disease	disease	NOUN
dpc-3332	35	19	can	can	AUX
dpc-3332	35	20	be	be	AUX
dpc-3332	35	21	useful	useful	ADJ
dpc-3332	35	22	in	in	ADP
dpc-3332	35	23	making	make	VERB
dpc-3332	35	24	treatment	treatment	NOUN
dpc-3332	35	25	decisions	decision	NOUN
dpc-3332	35	26	in	in	ADP
dpc-3332	35	27	complex	complex	ADJ
dpc-3332	35	28	cases	case	NOUN
dpc-3332	35	29	.	.	PUNCT
dpc-3332	36	1	c	c	X
dpc-3332	36	2	-	-	PUNCT
dpc-3332	36	3	reactive	reactive	ADJ
dpc-3332	36	4	protein	protein	NOUN
dpc-3332	36	5	(	(	PUNCT
dpc-3332	36	6	crp	crp	NOUN
dpc-3332	36	7	)	)	PUNCT
dpc-3332	36	8	to	to	ADP
dpc-3332	36	9	albumin	albumin	ADJ
dpc-3332	36	10	ratio	ratio	NOUN
dpc-3332	36	11	(	(	PUNCT
dpc-3332	36	12	car	car	NOUN
dpc-3332	36	13	)	)	PUNCT
dpc-3332	36	14	was	be	AUX
dpc-3332	36	15	calculated	calculate	VERB
dpc-3332	36	16	as	as	ADP
dpc-3332	36	17	the	the	DET
dpc-3332	36	18	ratio	ratio	NOUN
dpc-3332	36	19	of	of	ADP
dpc-3332	36	20	serum	serum	NOUN
dpc-3332	36	21	crp	crp	PROPN
dpc-3332	36	22	level	level	NOUN
dpc-3332	36	23	(	(	PUNCT
dpc-3332	36	24	mg	mg	PROPN
dpc-3332	36	25	/	/	SYM
dpc-3332	36	26	l	l	NOUN
dpc-3332	36	27	)	)	PUNCT
dpc-3332	36	28	to	to	PART
dpc-3332	36	29	serum	serum	VERB
dpc-3332	36	30	albumin	albumin	ADJ
dpc-3332	36	31	level	level	NOUN
dpc-3332	36	32	(	(	PUNCT
dpc-3332	36	33	g	g	NOUN
dpc-3332	36	34	/	/	SYM
dpc-3332	36	35	dl	dl	PROPN
dpc-3332	36	36	)	)	PUNCT
dpc-3332	36	37	,	,	PUNCT
dpc-3332	36	38	which	which	PRON
dpc-3332	36	39	were	be	AUX
dpc-3332	36	40	obtained	obtain	VERB
dpc-3332	36	41	from	from	ADP
dpc-3332	36	42	the	the	DET
dpc-3332	36	43	biochemistry	biochemistry	NOUN
dpc-3332	36	44	profile	profile	NOUN
dpc-3332	36	45	.	.	PUNCT
dpc-3332	37	1	car	car	NOUN
dpc-3332	37	2	is	be	AUX
dpc-3332	37	3	a	a	DET
dpc-3332	37	4	novel	novel	ADJ
dpc-3332	37	5	inflammation	inflammation	NOUN
dpc-3332	37	6	-	-	PUNCT
dpc-3332	37	7	based	base	VERB
dpc-3332	37	8	prognostic	prognostic	ADJ
dpc-3332	37	9	score	score	NOUN
dpc-3332	37	10	and	and	CCONJ
dpc-3332	37	11	an	an	DET
dpc-3332	37	12	inflammation	inflammation	NOUN
dpc-3332	37	13	biomarker	biomarker	NOUN
dpc-3332	37	14	in	in	ADP
dpc-3332	37	15	inflammatory	inflammatory	ADJ
dpc-3332	37	16	processes	process	NOUN
dpc-3332	37	17	.	.	PUNCT
dpc-3332	38	1	car	car	NOUN
dpc-3332	38	2	is	be	AUX
dpc-3332	38	3	associated	associate	VERB
dpc-3332	38	4	with	with	ADP
dpc-3332	38	5	poor	poor	ADJ
dpc-3332	38	6	outcomes	outcome	NOUN
dpc-3332	38	7	and	and	CCONJ
dpc-3332	38	8	severity	severity	NOUN
dpc-3332	38	9	of	of	ADP
dpc-3332	38	10	inflammation	inflammation	NOUN
dpc-3332	38	11	in	in	ADP
dpc-3332	38	12	various	various	ADJ
dpc-3332	38	13	diseases	disease	NOUN
dpc-3332	38	14	,	,	PUNCT
dpc-3332	38	15	such	such	ADJ
dpc-3332	38	16	as	as	ADP
dpc-3332	38	17	psoriasis	psoriasis	NOUN
dpc-3332	38	18	,	,	PUNCT
dpc-3332	38	19	cardiovascular	cardiovascular	ADJ
dpc-3332	38	20	diseases	disease	NOUN
dpc-3332	38	21	,	,	PUNCT
dpc-3332	38	22	ischemic	ischemic	ADJ
dpc-3332	38	23	stroke	stroke	NOUN
dpc-3332	38	24	,	,	PUNCT
dpc-3332	38	25	sepsis	sepsis	NOUN
dpc-3332	38	26	,	,	PUNCT
dpc-3332	38	27	acute	acute	PROPN
dpc-3332	38	28	pancreatitis	pancreatitis	PROPN
dpc-3332	38	29	,	,	PUNCT
dpc-3332	38	30	uveitis	uveitis	NOUN
dpc-3332	38	31	,	,	PUNCT
dpc-3332	38	32	takayasu	takayasu	NOUN
dpc-3332	38	33	arteritis	arteritis	NOUN
dpc-3332	38	34	,	,	PUNCT
dpc-3332	38	35	and	and	CCONJ
dpc-3332	38	36	cancers	cancer	NOUN
dpc-3332	38	37	.	.	PUNCT
dpc-3332	39	1	car	car	NOUN
dpc-3332	39	2	has	have	VERB
dpc-3332	39	3	higher	high	ADJ
dpc-3332	39	4	diagnostic	diagnostic	ADJ
dpc-3332	39	5	accuracy	accuracy	NOUN
dpc-3332	39	6	than	than	ADP
dpc-3332	39	7	c	c	NOUN
dpc-3332	39	8	-	-	PUNCT
dpc-3332	39	9	reactive	reactive	ADJ
dpc-3332	39	10	protein	protein	NOUN
dpc-3332	39	11	alone	alone	ADJ
dpc-3332	39	12	[	[	X
dpc-3332	39	13	5	5	NUM
dpc-3332	39	14	-	-	SYM
dpc-3332	39	15	13	13	NUM
dpc-3332	39	16	]	]	PUNCT
dpc-3332	39	17	.	.	PUNCT
dpc-3332	40	1	car	car	NOUN
dpc-3332	40	2	has	have	AUX
dpc-3332	40	3	been	be	AUX
dpc-3332	40	4	considered	consider	VERB
dpc-3332	40	5	as	as	ADP
dpc-3332	40	6	a	a	DET
dpc-3332	40	7	valuable	valuable	ADJ
dpc-3332	40	8	indicator	indicator	NOUN
dpc-3332	40	9	of	of	ADP
dpc-3332	40	10	inflammatory	inflammatory	ADJ
dpc-3332	40	11	status	status	NOUN
dpc-3332	40	12	and	and	CCONJ
dpc-3332	40	13	prognosis	prognosis	NOUN
dpc-3332	40	14	in	in	ADP
dpc-3332	40	15	cancers	cancer	NOUN
dpc-3332	40	16	,	,	PUNCT
dpc-3332	40	17	it	it	PRON
dpc-3332	40	18	has	have	AUX
dpc-3332	40	19	not	not	PART
dpc-3332	40	20	been	be	AUX
dpc-3332	40	21	evaluated	evaluate	VERB
dpc-3332	40	22	in	in	ADP
dpc-3332	40	23	patients	patient	NOUN
dpc-3332	40	24	with	with	ADP
dpc-3332	40	25	mf	mf	PROPN
dpc-3332	40	26	.	.	PROPN
dpc-3332	40	27	objectives	objective	NOUN
dpc-3332	40	28	in	in	ADP
dpc-3332	40	29	this	this	DET
dpc-3332	40	30	investigation	investigation	NOUN
dpc-3332	40	31	,	,	PUNCT
dpc-3332	40	32	our	our	PRON
dpc-3332	40	33	aim	aim	NOUN
dpc-3332	40	34	was	be	AUX
dpc-3332	40	35	to	to	PART
dpc-3332	40	36	assess	assess	VERB
dpc-3332	40	37	the	the	DET
dpc-3332	40	38	applicability	applicability	NOUN
dpc-3332	40	39	of	of	ADP
dpc-3332	40	40	the	the	DET
dpc-3332	40	41	car	car	NOUN
dpc-3332	40	42	value	value	NOUN
dpc-3332	40	43	,	,	PUNCT
dpc-3332	40	44	readily	readily	ADV
dpc-3332	40	45	and	and	CCONJ
dpc-3332	40	46	inexpensively	inexpensively	ADV
dpc-3332	40	47	derived	derive	VERB
dpc-3332	40	48	from	from	ADP
dpc-3332	40	49	blood	blood	NOUN
dpc-3332	40	50	parameters	parameter	NOUN
dpc-3332	40	51	,	,	PUNCT
dpc-3332	40	52	in	in	ADP
dpc-3332	40	53	both	both	DET
dpc-3332	40	54	diagnosing	diagnose	VERB
dpc-3332	40	55	and	and	CCONJ
dpc-3332	40	56	prognosticating	prognosticate	VERB
dpc-3332	40	57	mf	mf	NOUN
dpc-3332	40	58	disease	disease	NOUN
dpc-3332	40	59	.	.	PUNCT
dpc-3332	41	1	methods	method	NOUN
dpc-3332	41	2	we	we	PRON
dpc-3332	41	3	reviewed	review	VERB
dpc-3332	41	4	the	the	DET
dpc-3332	41	5	files	file	NOUN
dpc-3332	41	6	of	of	ADP
dpc-3332	41	7	mf	mf	NOUN
dpc-3332	41	8	patients	patient	NOUN
dpc-3332	41	9	in	in	ADP
dpc-3332	41	10	the	the	DET
dpc-3332	41	11	dermatology	dermatology	NOUN
dpc-3332	41	12	clinic	clinic	NOUN
dpc-3332	41	13	of	of	ADP
dpc-3332	41	14	health	health	PROPN
dpc-3332	41	15	sciences	sciences	PROPN
dpc-3332	41	16	university	university	PROPN
dpc-3332	41	17	,	,	PUNCT
dpc-3332	41	18	diskapi	diskapi	PROPN
dpc-3332	41	19	yildirim	yildirim	NOUN
dpc-3332	41	20	beyazit	beyazit	NOUN
dpc-3332	41	21	training	training	NOUN
dpc-3332	41	22	and	and	CCONJ
dpc-3332	41	23	research	research	NOUN
dpc-3332	41	24	hospital	hospital	NOUN
dpc-3332	41	25	between	between	ADP
dpc-3332	41	26	january	january	PROPN
dpc-3332	41	27	2014	2014	NUM
dpc-3332	41	28	and	and	CCONJ
dpc-3332	41	29	december	december	PROPN
dpc-3332	41	30	2020	2020	NUM
dpc-3332	41	31	.	.	PUNCT
dpc-3332	42	1	a	a	DET
dpc-3332	42	2	total	total	NOUN
dpc-3332	42	3	of	of	ADP
dpc-3332	42	4	97	97	NUM
dpc-3332	42	5	patients	patient	NOUN
dpc-3332	42	6	were	be	AUX
dpc-3332	42	7	retrieved	retrieve	VERB
dpc-3332	42	8	initially	initially	ADV
dpc-3332	42	9	,	,	PUNCT
dpc-3332	42	10	37	37	NUM
dpc-3332	42	11	were	be	AUX
dpc-3332	42	12	excluded	exclude	VERB
dpc-3332	42	13	from	from	ADP
dpc-3332	42	14	the	the	DET
dpc-3332	42	15	study	study	NOUN
dpc-3332	42	16	due	due	ADP
dpc-3332	42	17	to	to	ADP
dpc-3332	42	18	lack	lack	NOUN
dpc-3332	42	19	of	of	ADP
dpc-3332	42	20	follow	follow	NOUN
dpc-3332	42	21	-	-	PUNCT
dpc-3332	42	22	up	up	NOUN
dpc-3332	42	23	and	and	CCONJ
dpc-3332	42	24	insufficient	insufficient	ADJ
dpc-3332	42	25	laboratory	laboratory	NOUN
dpc-3332	42	26	values	value	NOUN
dpc-3332	42	27	.	.	PUNCT
dpc-3332	43	1	the	the	DET
dpc-3332	43	2	study	study	NOUN
dpc-3332	43	3	enrolled	enrol	VERB
dpc-3332	43	4	all	all	DET
dpc-3332	43	5	patients	patient	NOUN
dpc-3332	43	6	aged	age	VERB
dpc-3332	43	7	18	18	NUM
dpc-3332	43	8	and	and	CCONJ
dpc-3332	43	9	over	over	ADP
dpc-3332	43	10	who	who	PRON
dpc-3332	43	11	had	have	AUX
dpc-3332	43	12	available	available	ADJ
dpc-3332	43	13	data	datum	NOUN
dpc-3332	43	14	.	.	PUNCT
dpc-3332	44	1	inclusion	inclusion	NOUN
dpc-3332	44	2	criteria	criterion	NOUN
dpc-3332	44	3	include	include	VERB
dpc-3332	44	4	being	be	AUX
dpc-3332	44	5	diagnosed	diagnose	VERB
dpc-3332	44	6	with	with	ADP
dpc-3332	44	7	mf	mf	PRON
dpc-3332	44	8	clinically	clinically	ADV
dpc-3332	44	9	and	and	CCONJ
dpc-3332	44	10	histopathologically	histopathologically	ADV
dpc-3332	44	11	,	,	PUNCT
dpc-3332	44	12	and	and	CCONJ
dpc-3332	44	13	no	no	DET
dpc-3332	44	14	history	history	NOUN
dpc-3332	44	15	of	of	ADP
dpc-3332	44	16	inflammatory	inflammatory	ADJ
dpc-3332	44	17	disease	disease	NOUN
dpc-3332	44	18	and	and	CCONJ
dpc-3332	44	19	malignancy	malignancy	NOUN
dpc-3332	44	20	(	(	PUNCT
dpc-3332	44	21	non	non	ADJ
dpc-3332	44	22	-	-	ADJ
dpc-3332	44	23	mf	mf	NOUN
dpc-3332	44	24	)	)	PUNCT
dpc-3332	44	25	.	.	PUNCT
dpc-3332	45	1	all	all	DET
dpc-3332	45	2	our	our	PRON
dpc-3332	45	3	patients	patient	NOUN
dpc-3332	45	4	had	have	AUX
dpc-3332	45	5	not	not	PART
dpc-3332	45	6	yet	yet	ADV
dpc-3332	45	7	received	receive	VERB
dpc-3332	45	8	treatment	treatment	NOUN
dpc-3332	45	9	when	when	SCONJ
dpc-3332	45	10	they	they	PRON
dpc-3332	45	11	were	be	AUX
dpc-3332	45	12	included	include	VERB
dpc-3332	45	13	in	in	ADP
dpc-3332	45	14	the	the	DET
dpc-3332	45	15	study	study	NOUN
dpc-3332	45	16	.	.	PUNCT
dpc-3332	46	1	data	datum	NOUN
dpc-3332	46	2	on	on	ADP
dpc-3332	46	3	age	age	NOUN
dpc-3332	46	4	,	,	PUNCT
dpc-3332	46	5	sex	sex	NOUN
dpc-3332	46	6	,	,	PUNCT
dpc-3332	46	7	duration	duration	NOUN
dpc-3332	46	8	,	,	PUNCT
dpc-3332	46	9	onset	onset	VERB
dpc-3332	46	10	age	age	NOUN
dpc-3332	46	11	and	and	CCONJ
dpc-3332	46	12	stage	stage	NOUN
dpc-3332	46	13	of	of	ADP
dpc-3332	46	14	disease	disease	NOUN
dpc-3332	46	15	,	,	PUNCT
dpc-3332	46	16	serum	serum	PROPN
dpc-3332	46	17	biochemistry	biochemistry	PROPN
dpc-3332	46	18	profile	profile	NOUN
dpc-3332	46	19	,	,	PUNCT
dpc-3332	46	20	including	include	VERB
dpc-3332	46	21	serum	serum	PROPN
dpc-3332	46	22	crp	crp	PROPN
dpc-3332	46	23	,	,	PUNCT
dpc-3332	46	24	albumin	albumin	NOUN
dpc-3332	46	25	,	,	PUNCT
dpc-3332	46	26	lactate	lactate	NOUN
dpc-3332	46	27	dehydrogenase	dehydrogenase	NOUN
dpc-3332	46	28	(	(	PUNCT
dpc-3332	46	29	ldh	ldh	NOUN
dpc-3332	46	30	)	)	PUNCT
dpc-3332	46	31	and	and	CCONJ
dpc-3332	46	32	beta2	beta2	PROPN
dpc-3332	46	33	microglobulin	microglobulin	PROPN
dpc-3332	46	34	levels	level	NOUN
dpc-3332	46	35	and	and	CCONJ
dpc-3332	46	36	complete	complete	ADJ
dpc-3332	46	37	blood	blood	NOUN
dpc-3332	46	38	count	count	NOUN
dpc-3332	46	39	,	,	PUNCT
dpc-3332	46	40	were	be	AUX
dpc-3332	46	41	collected	collect	VERB
dpc-3332	46	42	.	.	PUNCT
dpc-3332	47	1	blood	blood	NOUN
dpc-3332	47	2	samples	sample	NOUN
dpc-3332	47	3	were	be	AUX
dpc-3332	47	4	taken	take	VERB
dpc-3332	47	5	from	from	ADP
dpc-3332	47	6	all	all	DET
dpc-3332	47	7	patients	patient	NOUN
dpc-3332	47	8	under	under	ADP
dpc-3332	47	9	the	the	DET
dpc-3332	47	10	same	same	ADJ
dpc-3332	47	11	conditions	condition	NOUN
dpc-3332	47	12	in	in	ADP
dpc-3332	47	13	our	our	PRON
dpc-3332	47	14	hospital	hospital	NOUN
dpc-3332	47	15	laboratory	laboratory	NOUN
dpc-3332	47	16	.	.	PUNCT
dpc-3332	48	1	tnmb	tnmb	PROPN
dpc-3332	48	2	and	and	CCONJ
dpc-3332	48	3	histopathological	histopathological	ADJ
dpc-3332	48	4	staging	staging	NOUN
dpc-3332	48	5	of	of	ADP
dpc-3332	48	6	the	the	DET
dpc-3332	48	7	cases	case	NOUN
dpc-3332	48	8	were	be	AUX
dpc-3332	48	9	performed	perform	VERB
dpc-3332	48	10	in	in	ADP
dpc-3332	48	11	accordance	accordance	NOUN
dpc-3332	48	12	with	with	ADP
dpc-3332	48	13	international	international	ADJ
dpc-3332	48	14	society	society	NOUN
dpc-3332	48	15	for	for	ADP
dpc-3332	48	16	cutaneous	cutaneous	ADJ
dpc-3332	48	17	lymphomas	lymphoma	NOUN
dpc-3332	48	18	/	/	SYM
dpc-3332	48	19	european	european	ADJ
dpc-3332	48	20	organization	organization	NOUN
dpc-3332	48	21	of	of	ADP
dpc-3332	48	22	research	research	NOUN
dpc-3332	48	23	and	and	CCONJ
dpc-3332	48	24	treatment	treatment	NOUN
dpc-3332	48	25	of	of	ADP
dpc-3332	48	26	cancer	cancer	NOUN
dpc-3332	48	27	(	(	PUNCT
dpc-3332	48	28	iscl	iscl	PROPN
dpc-3332	48	29	/	/	SYM
dpc-3332	48	30	eortc	eortc	ADJ
dpc-3332	48	31	)	)	PUNCT
dpc-3332	48	32	criteria	criterion	NOUN
dpc-3332	48	33	at	at	ADP
dpc-3332	48	34	the	the	DET
dpc-3332	48	35	time	time	NOUN
dpc-3332	48	36	of	of	ADP
dpc-3332	48	37	peripheral	peripheral	ADJ
dpc-3332	48	38	blood	blood	NOUN
dpc-3332	48	39	sampling	sampling	NOUN
dpc-3332	48	40	,	,	PUNCT
dpc-3332	48	41	retrospectively	retrospectively	ADV
dpc-3332	48	42	.	.	PUNCT
dpc-3332	49	1	healthy	healthy	ADJ
dpc-3332	49	2	volunteers	volunteer	NOUN
dpc-3332	49	3	who	who	PRON
dpc-3332	49	4	underwent	undergo	VERB
dpc-3332	49	5	routine	routine	ADJ
dpc-3332	49	6	physical	physical	ADJ
dpc-3332	49	7	examination	examination	NOUN
dpc-3332	49	8	in	in	ADP
dpc-3332	49	9	our	our	PRON
dpc-3332	49	10	hospital	hospital	NOUN
dpc-3332	49	11	were	be	AUX
dpc-3332	49	12	taken	take	VERB
dpc-3332	49	13	as	as	ADP
dpc-3332	49	14	the	the	DET
dpc-3332	49	15	control	control	NOUN
dpc-3332	49	16	group	group	NOUN
dpc-3332	49	17	.	.	PUNCT
dpc-3332	50	1	the	the	DET
dpc-3332	50	2	patient	patient	ADJ
dpc-3332	50	3	and	and	CCONJ
dpc-3332	50	4	control	control	NOUN
dpc-3332	50	5	groups	group	NOUN
dpc-3332	50	6	were	be	AUX
dpc-3332	50	7	matched	match	VERB
dpc-3332	50	8	in	in	ADP
dpc-3332	50	9	terms	term	NOUN
dpc-3332	50	10	of	of	ADP
dpc-3332	50	11	age	age	NOUN
dpc-3332	50	12	and	and	CCONJ
dpc-3332	50	13	gender	gender	NOUN
dpc-3332	50	14	.	.	PUNCT
dpc-3332	51	1	persons	person	NOUN
dpc-3332	51	2	who	who	PRON
dpc-3332	51	3	had	have	VERB
dpc-3332	51	4	other	other	ADJ
dpc-3332	51	5	autoimmune	autoimmune	ADJ
dpc-3332	51	6	diseases	disease	NOUN
dpc-3332	51	7	,	,	PUNCT
dpc-3332	51	8	liver	liver	NOUN
dpc-3332	51	9	or	or	CCONJ
dpc-3332	51	10	kidney	kidney	NOUN
dpc-3332	51	11	disease	disease	NOUN
dpc-3332	51	12	,	,	PUNCT
dpc-3332	51	13	hematologic	hematologic	NOUN
dpc-3332	51	14	disease	disease	NOUN
dpc-3332	51	15	,	,	PUNCT
dpc-3332	51	16	diabetes	diabetes	NOUN
dpc-3332	51	17	,	,	PUNCT
dpc-3332	51	18	cancer	cancer	NOUN
dpc-3332	51	19	,	,	PUNCT
dpc-3332	51	20	acute	acute	ADJ
dpc-3332	51	21	or	or	CCONJ
dpc-3332	51	22	chronic	chronic	ADJ
dpc-3332	51	23	infections	infection	NOUN
dpc-3332	51	24	were	be	AUX
dpc-3332	51	25	excluded	exclude	VERB
dpc-3332	51	26	from	from	ADP
dpc-3332	51	27	the	the	DET
dpc-3332	51	28	study	study	NOUN
dpc-3332	51	29	.	.	PUNCT
dpc-3332	52	1	disease	disease	NOUN
dpc-3332	52	2	progression	progression	NOUN
dpc-3332	52	3	was	be	AUX
dpc-3332	52	4	considered	consider	VERB
dpc-3332	52	5	as	as	ADP
dpc-3332	52	6	tumor	tumor	NOUN
dpc-3332	52	7	development	development	NOUN
dpc-3332	52	8	and	and	CCONJ
dpc-3332	52	9	transition	transition	NOUN
dpc-3332	52	10	to	to	ADP
dpc-3332	52	11	advanced	advanced	ADJ
dpc-3332	52	12	stages	stage	NOUN
dpc-3332	52	13	(	(	PUNCT
dpc-3332	52	14	stage	stage	NOUN
dpc-3332	52	15	iib	iib	NOUN
dpc-3332	52	16	and	and	CCONJ
dpc-3332	52	17	above	above	ADV
dpc-3332	52	18	)	)	PUNCT
dpc-3332	52	19	.	.	PUNCT
dpc-3332	53	1	because	because	SCONJ
dpc-3332	53	2	with	with	ADP
dpc-3332	53	3	tumor	tumor	NOUN
dpc-3332	53	4	development	development	NOUN
dpc-3332	53	5	,	,	PUNCT
dpc-3332	53	6	the	the	DET
dpc-3332	53	7	disease	disease	NOUN
dpc-3332	53	8	transforms	transform	VERB
dpc-3332	53	9	from	from	ADP
dpc-3332	53	10	early	early	ADJ
dpc-3332	53	11	stage	stage	NOUN
dpc-3332	53	12	to	to	ADP
dpc-3332	53	13	advanced	advanced	ADJ
dpc-3332	53	14	stage	stage	NOUN
dpc-3332	53	15	disease	disease	NOUN
dpc-3332	53	16	.	.	PUNCT
dpc-3332	54	1	tumor	tumor	NOUN
dpc-3332	54	2	stage	stage	NOUN
dpc-3332	54	3	and	and	CCONJ
dpc-3332	54	4	above	above	ADP
dpc-3332	54	5	stages	stage	NOUN
dpc-3332	54	6	are	be	AUX
dpc-3332	54	7	considered	consider	VERB
dpc-3332	54	8	advanced	advanced	ADJ
dpc-3332	54	9	stage	stage	NOUN
dpc-3332	54	10	disease	disease	NOUN
dpc-3332	54	11	in	in	ADP
dpc-3332	54	12	mf(2	mf(2	PROPN
dpc-3332	54	13	)	)	PUNCT
dpc-3332	54	14	.	.	PUNCT
dpc-3332	55	1	in	in	ADP
dpc-3332	55	2	this	this	DET
dpc-3332	55	3	study	study	NOUN
dpc-3332	55	4	,	,	PUNCT
dpc-3332	55	5	3	3	NUM
dpc-3332	55	6	of	of	ADP
dpc-3332	55	7	our	our	PRON
dpc-3332	55	8	patients	patient	NOUN
dpc-3332	55	9	were	be	AUX
dpc-3332	55	10	in	in	ADP
dpc-3332	55	11	stage	stage	NOUN
dpc-3332	55	12	iia	iia	NOUN
dpc-3332	55	13	at	at	ADP
dpc-3332	55	14	the	the	DET
dpc-3332	55	15	time	time	NOUN
dpc-3332	55	16	of	of	ADP
dpc-3332	55	17	diagnosis	diagnosis	NOUN
dpc-3332	55	18	,	,	PUNCT
dpc-3332	55	19	but	but	CCONJ
dpc-3332	55	20	subsequently	subsequently	ADV
dpc-3332	55	21	showed	show	VERB
dpc-3332	55	22	tumor	tumor	NOUN
dpc-3332	55	23	formation	formation	NOUN
dpc-3332	55	24	through	through	ADP
dpc-3332	55	25	their	their	PRON
dpc-3332	55	26	plaques	plaque	NOUN
dpc-3332	55	27	and	and	CCONJ
dpc-3332	55	28	progressed	progress	VERB
dpc-3332	55	29	to	to	ADP
dpc-3332	55	30	stage	stage	NOUN
dpc-3332	55	31	iib	iib	PROPN
dpc-3332	55	32	.	.	PUNCT
dpc-3332	56	1	at	at	ADP
dpc-3332	56	2	the	the	DET
dpc-3332	56	3	same	same	ADJ
dpc-3332	56	4	time	time	NOUN
dpc-3332	56	5	,	,	PUNCT
dpc-3332	56	6	those	those	PRON
dpc-3332	56	7	who	who	PRON
dpc-3332	56	8	were	be	AUX
dpc-3332	56	9	initially	initially	ADV
dpc-3332	56	10	in	in	ADP
dpc-3332	56	11	the	the	DET
dpc-3332	56	12	advanced	advanced	ADJ
dpc-3332	56	13	stage	stage	NOUN
dpc-3332	56	14	group	group	NOUN
dpc-3332	56	15	but	but	CCONJ
dpc-3332	56	16	showed	show	VERB
dpc-3332	56	17	improvement	improvement	NOUN
dpc-3332	56	18	and	and	CCONJ
dpc-3332	56	19	moved	move	VERB
dpc-3332	56	20	to	to	ADP
dpc-3332	56	21	the	the	DET
dpc-3332	56	22	early	early	ADJ
dpc-3332	56	23	-	-	PUNCT
dpc-3332	56	24	stage	stage	NOUN
dpc-3332	56	25	group	group	NOUN
dpc-3332	56	26	were	be	AUX
dpc-3332	56	27	included	include	VERB
dpc-3332	56	28	in	in	ADP
dpc-3332	56	29	the	the	DET
dpc-3332	56	30	"	"	PUNCT
dpc-3332	56	31	good	good	ADJ
dpc-3332	56	32	prognosis	prognosis	NOUN
dpc-3332	56	33	"	"	PUNCT
dpc-3332	56	34	group	group	NOUN
dpc-3332	56	35	.	.	PUNCT
dpc-3332	57	1	we	we	PRON
dpc-3332	57	2	have	have	VERB
dpc-3332	57	3	2	2	NUM
dpc-3332	57	4	patients	patient	NOUN
dpc-3332	57	5	with	with	ADP
dpc-3332	57	6	this	this	DET
dpc-3332	57	7	situation	situation	NOUN
dpc-3332	57	8	.	.	PUNCT
dpc-3332	58	1	the	the	DET
dpc-3332	58	2	tumors	tumor	NOUN
dpc-3332	58	3	of	of	ADP
dpc-3332	58	4	patients	patient	NOUN
dpc-3332	58	5	who	who	PRON
dpc-3332	58	6	were	be	AUX
dpc-3332	58	7	initially	initially	ADV
dpc-3332	58	8	stage	stage	NOUN
dpc-3332	58	9	iib	iib	PROPN
dpc-3332	58	10	regressed	regress	VERB
dpc-3332	58	11	clinically	clinically	ADV
dpc-3332	58	12	and	and	CCONJ
dpc-3332	58	13	pathologically	pathologically	ADV
dpc-3332	58	14	and	and	CCONJ
dpc-3332	58	15	progressed	progress	VERB
dpc-3332	58	16	to	to	ADP
dpc-3332	58	17	the	the	DET
dpc-3332	58	18	plaque	plaque	NOUN
dpc-3332	58	19	stage	stage	NOUN
dpc-3332	58	20	.	.	PUNCT
dpc-3332	59	1	one	one	NUM
dpc-3332	59	2	of	of	ADP
dpc-3332	59	3	these	these	DET
dpc-3332	59	4	patients	patient	NOUN
dpc-3332	59	5	is	be	AUX
dpc-3332	59	6	directly	directly	ADV
dpc-3332	59	7	followed	follow	VERB
dpc-3332	59	8	as	as	ADP
dpc-3332	59	9	stage	stage	NOUN
dpc-3332	59	10	ib	ib	NOUN
dpc-3332	59	11	because	because	SCONJ
dpc-3332	59	12	there	there	PRON
dpc-3332	59	13	is	be	VERB
dpc-3332	59	14	no	no	DET
dpc-3332	59	15	lymph	lymph	NOUN
dpc-3332	59	16	node	node	NOUN
dpc-3332	59	17	involvement	involvement	NOUN
dpc-3332	59	18	.	.	PUNCT
dpc-3332	60	1	the	the	DET
dpc-3332	60	2	other	other	ADJ
dpc-3332	60	3	patient	patient	NOUN
dpc-3332	60	4	is	be	AUX
dpc-3332	60	5	followed	follow	VERB
dpc-3332	60	6	as	as	ADP
dpc-3332	60	7	stage	stage	NOUN
dpc-3332	60	8	iia	iia	NOUN
dpc-3332	60	9	.	.	PUNCT
dpc-3332	61	1	in	in	ADP
dpc-3332	61	2	our	our	PRON
dpc-3332	61	3	clinic	clinic	NOUN
dpc-3332	61	4	,	,	PUNCT
dpc-3332	61	5	file	file	NOUN
dpc-3332	61	6	records	record	NOUN
dpc-3332	61	7	of	of	ADP
dpc-3332	61	8	all	all	DET
dpc-3332	61	9	our	our	PRON
dpc-3332	61	10	patients	patient	NOUN
dpc-3332	61	11	are	be	AUX
dpc-3332	61	12	kept	keep	VERB
dpc-3332	61	13	meticulously	meticulously	ADV
dpc-3332	61	14	.	.	PUNCT
dpc-3332	62	1	the	the	DET
dpc-3332	62	2	disease	disease	NOUN
dpc-3332	62	3	prognoses	prognosis	NOUN
dpc-3332	62	4	of	of	ADP
dpc-3332	62	5	all	all	DET
dpc-3332	62	6	patients	patient	NOUN
dpc-3332	62	7	included	include	VERB
dpc-3332	62	8	in	in	ADP
dpc-3332	62	9	the	the	DET
dpc-3332	62	10	study	study	NOUN
dpc-3332	62	11	were	be	AUX
dpc-3332	62	12	examined	examine	VERB
dpc-3332	62	13	one	one	NUM
dpc-3332	62	14	by	by	ADP
dpc-3332	62	15	one	one	NUM
dpc-3332	62	16	and	and	CCONJ
dpc-3332	62	17	recorded	recorded	ADJ
dpc-3332	62	18	.	.	PUNCT
dpc-3332	63	1	patients	patient	NOUN
dpc-3332	63	2	who	who	PRON
dpc-3332	63	3	are	be	AUX
dpc-3332	63	4	at	at	ADP
dpc-3332	63	5	an	an	DET
dpc-3332	63	6	advanced	advanced	ADJ
dpc-3332	63	7	stage	stage	NOUN
dpc-3332	63	8	and	and	CCONJ
dpc-3332	63	9	whose	whose	DET
dpc-3332	63	10	disease	disease	NOUN
dpc-3332	63	11	does	do	AUX
dpc-3332	63	12	not	not	PART
dpc-3332	63	13	regress	regress	ADV
dpc-3332	63	14	are	be	AUX
dpc-3332	63	15	not	not	PART
dpc-3332	63	16	included	include	VERB
dpc-3332	63	17	in	in	ADP
dpc-3332	63	18	the	the	DET
dpc-3332	63	19	"	"	PUNCT
dpc-3332	63	20	good	good	ADJ
dpc-3332	63	21	prognosis	prognosis	NOUN
dpc-3332	63	22	"	"	PUNCT
dpc-3332	63	23	group	group	NOUN
dpc-3332	63	24	.	.	PUNCT
dpc-3332	64	1	the	the	DET
dpc-3332	64	2	data	datum	NOUN
dpc-3332	64	3	obtained	obtain	VERB
dpc-3332	64	4	were	be	AUX
dpc-3332	64	5	transferred	transfer	VERB
dpc-3332	64	6	to	to	ADP
dpc-3332	64	7	the	the	DET
dpc-3332	64	8	computer	computer	NOUN
dpc-3332	64	9	environment	environment	NOUN
dpc-3332	64	10	and	and	CCONJ
dpc-3332	64	11	evaluated	evaluate	VERB
dpc-3332	64	12	with	with	ADP
dpc-3332	64	13	the	the	DET
dpc-3332	64	14	spss	spss	PROPN
dpc-3332	64	15	(	(	PUNCT
dpc-3332	64	16	v.15.0	v.15.0	X
dpc-3332	64	17	)	)	PUNCT
dpc-3332	64	18	statistics	statistic	NOUN
dpc-3332	64	19	package	package	NOUN
dpc-3332	64	20	program	program	NOUN
dpc-3332	64	21	.	.	PUNCT
dpc-3332	65	1	the	the	DET
dpc-3332	65	2	compliance	compliance	NOUN
dpc-3332	65	3	of	of	ADP
dpc-3332	65	4	the	the	DET
dpc-3332	65	5	data	datum	NOUN
dpc-3332	65	6	to	to	ADP
dpc-3332	65	7	normal	normal	ADJ
dpc-3332	65	8	distribution	distribution	NOUN
dpc-3332	65	9	was	be	AUX
dpc-3332	65	10	evaluated	evaluate	VERB
dpc-3332	65	11	with	with	ADP
dpc-3332	65	12	the	the	DET
dpc-3332	65	13	kolmogrov	kolmogrov	ADJ
dpc-3332	65	14	smirnov	smirnov	PROPN
dpc-3332	65	15	test	test	NOUN
dpc-3332	65	16	.	.	PUNCT
dpc-3332	66	1	this	this	DET
dpc-3332	66	2	study	study	NOUN
dpc-3332	66	3	was	be	AUX
dpc-3332	66	4	approved	approve	VERB
dpc-3332	66	5	by	by	ADP
dpc-3332	66	6	the	the	DET
dpc-3332	66	7	tertiary	tertiary	ADJ
dpc-3332	66	8	hospital	hospital	NOUN
dpc-3332	66	9	ethics	ethic	NOUN
dpc-3332	66	10	committee	committee	PROPN
dpc-3332	66	11	.	.	PUNCT
dpc-3332	67	1	written	write	VERB
dpc-3332	67	2	informed	informed	ADJ
dpc-3332	67	3	consent	consent	NOUN
dpc-3332	67	4	was	be	AUX
dpc-3332	67	5	obtained	obtain	VERB
dpc-3332	67	6	from	from	ADP
dpc-3332	67	7	all	all	DET
dpc-3332	67	8	participants	participant	NOUN
dpc-3332	67	9	original	original	ADJ
dpc-3332	67	10	article	article	NOUN
dpc-3332	67	11	|	|	ADV
dpc-3332	67	12	dermatol	dermatol	ADJ
dpc-3332	67	13	pract	pract	NOUN
dpc-3332	67	14	concept	concept	NOUN
dpc-3332	67	15	.	.	PUNCT
dpc-3332	68	1	2024;14(2):e2024097	2024;14(2):e2024097	NUM
dpc-3332	68	2	3	3	NUM
dpc-3332	68	3	results	result	VERB
dpc-3332	68	4	the	the	DET
dpc-3332	68	5	study	study	NOUN
dpc-3332	68	6	group	group	NOUN
dpc-3332	68	7	consisted	consist	VERB
dpc-3332	68	8	of	of	ADP
dpc-3332	68	9	a	a	DET
dpc-3332	68	10	total	total	NOUN
dpc-3332	68	11	of	of	ADP
dpc-3332	68	12	120	120	NUM
dpc-3332	68	13	people	people	NOUN
dpc-3332	68	14	,	,	PUNCT
dpc-3332	68	15	including	include	VERB
dpc-3332	68	16	60	60	NUM
dpc-3332	68	17	mf	mf	NOUN
dpc-3332	68	18	(	(	PUNCT
dpc-3332	68	19	28	28	NUM
dpc-3332	68	20	female	female	NOUN
dpc-3332	68	21	,	,	PUNCT
dpc-3332	68	22	32	32	NUM
dpc-3332	68	23	male	male	NOUN
dpc-3332	68	24	)	)	PUNCT
dpc-3332	68	25	patients	patient	NOUN
dpc-3332	68	26	and	and	CCONJ
dpc-3332	68	27	60	60	NUM
dpc-3332	68	28	(	(	PUNCT
dpc-3332	68	29	28	28	NUM
dpc-3332	68	30	female	female	NOUN
dpc-3332	68	31	,	,	PUNCT
dpc-3332	68	32	32	32	NUM
dpc-3332	68	33	  	  	SPACE
dpc-3332	68	34	male	male	NOUN
dpc-3332	68	35	)	)	PUNCT
dpc-3332	68	36	control	control	NOUN
dpc-3332	68	37	group	group	NOUN
dpc-3332	68	38	.	.	PUNCT
dpc-3332	69	1	patient	patient	ADJ
dpc-3332	69	2	age	age	NOUN
dpc-3332	69	3	ranged	range	VERB
dpc-3332	69	4	from	from	ADP
dpc-3332	69	5	20	20	NUM
dpc-3332	69	6	to	to	PART
dpc-3332	69	7	83	83	NUM
dpc-3332	69	8	 	 	SPACE
dpc-3332	69	9	years	year	NOUN
dpc-3332	69	10	(	(	PUNCT
dpc-3332	69	11	51.95±13,64	51.95±13,64	NUM
dpc-3332	69	12	)	)	PUNCT
dpc-3332	69	13	.	.	PUNCT
dpc-3332	70	1	there	there	PRON
dpc-3332	70	2	was	be	VERB
dpc-3332	70	3	no	no	DET
dpc-3332	70	4	difference	difference	NOUN
dpc-3332	70	5	in	in	ADP
dpc-3332	70	6	age	age	NOUN
dpc-3332	70	7	and	and	CCONJ
dpc-3332	70	8	gender	gender	NOUN
dpc-3332	70	9	between	between	ADP
dpc-3332	70	10	control	control	NOUN
dpc-3332	70	11	and	and	CCONJ
dpc-3332	70	12	patient	patient	ADJ
dpc-3332	70	13	groups	group	NOUN
dpc-3332	70	14	in	in	ADP
dpc-3332	70	15	the	the	DET
dpc-3332	70	16	study	study	NOUN
dpc-3332	70	17	(	(	PUNCT
dpc-3332	70	18	p	p	X
dpc-3332	70	19	 	 	SPACE
dpc-3332	70	20	>	>	X
dpc-3332	70	21	0.05	0.05	NUM
dpc-3332	70	22	for	for	ADP
dpc-3332	70	23	each	each	PRON
dpc-3332	70	24	)	)	PUNCT
dpc-3332	70	25	.	.	PUNCT
dpc-3332	71	1	based	base	VERB
dpc-3332	71	2	on	on	ADP
dpc-3332	71	3	iscl	iscl	PROPN
dpc-3332	71	4	/	/	SYM
dpc-3332	71	5	eortc	eortc	VERB
dpc-3332	71	6	staging	staging	NOUN
dpc-3332	71	7	,	,	PUNCT
dpc-3332	71	8	9	9	NUM
dpc-3332	71	9	patients	patient	NOUN
dpc-3332	71	10	(	(	PUNCT
dpc-3332	71	11	15	15	NUM
dpc-3332	71	12	%	%	NOUN
dpc-3332	71	13	)	)	PUNCT
dpc-3332	71	14	were	be	AUX
dpc-3332	71	15	stage	stage	NOUN
dpc-3332	71	16	ia	ia	PROPN
dpc-3332	71	17	,	,	PUNCT
dpc-3332	71	18	2	2	NUM
dpc-3332	71	19	(	(	PUNCT
dpc-3332	71	20	3.3	3.3	NUM
dpc-3332	71	21	%	%	NOUN
dpc-3332	71	22	)	)	PUNCT
dpc-3332	71	23	were	be	AUX
dpc-3332	71	24	stage	stage	NOUN
dpc-3332	71	25	ib	ib	NOUN
dpc-3332	71	26	,	,	PUNCT
dpc-3332	71	27	34	34	NUM
dpc-3332	71	28	(	(	PUNCT
dpc-3332	71	29	56.7	56.7	NUM
dpc-3332	71	30	%	%	NOUN
dpc-3332	71	31	)	)	PUNCT
dpc-3332	71	32	were	be	AUX
dpc-3332	71	33	stage	stage	NOUN
dpc-3332	71	34	iia	iia	NOUN
dpc-3332	71	35	,	,	PUNCT
dpc-3332	71	36	6	6	NUM
dpc-3332	71	37	(	(	PUNCT
dpc-3332	71	38	10.0	10.0	NUM
dpc-3332	71	39	%	%	NOUN
dpc-3332	71	40	)	)	PUNCT
dpc-3332	72	1	were	be	AUX
dpc-3332	72	2	stage	stage	NOUN
dpc-3332	72	3	iib	iib	NOUN
dpc-3332	72	4	,	,	PUNCT
dpc-3332	72	5	7	7	NUM
dpc-3332	72	6	(	(	PUNCT
dpc-3332	72	7	11.7	11.7	NUM
dpc-3332	72	8	%	%	NOUN
dpc-3332	72	9	)	)	PUNCT
dpc-3332	72	10	were	be	AUX
dpc-3332	72	11	stage	stage	NOUN
dpc-3332	72	12	iiib	iiib	NOUN
dpc-3332	72	13	,	,	PUNCT
dpc-3332	72	14	1	1	NUM
dpc-3332	72	15	(	(	PUNCT
dpc-3332	72	16	1.65	1.65	NUM
dpc-3332	72	17	%	%	NOUN
dpc-3332	72	18	)	)	PUNCT
dpc-3332	73	1	was	be	AUX
dpc-3332	73	2	stage	stage	NOUN
dpc-3332	73	3	iva1	iva1	NOUN
dpc-3332	73	4	and	and	CCONJ
dpc-3332	73	5	1(1.65	1(1.65	NUM
dpc-3332	73	6	%	%	NOUN
dpc-3332	73	7	)	)	PUNCT
dpc-3332	73	8	was	be	AUX
dpc-3332	73	9	stage	stage	NOUN
dpc-3332	73	10	iva2	iva2	PROPN
dpc-3332	73	11	.	.	PUNCT
dpc-3332	74	1	the	the	DET
dpc-3332	74	2	median	median	ADJ
dpc-3332	74	3	value	value	NOUN
dpc-3332	74	4	of	of	ADP
dpc-3332	74	5	car	car	NOUN
dpc-3332	74	6	was	be	AUX
dpc-3332	74	7	0.91	0.91	NUM
dpc-3332	74	8	(	(	PUNCT
dpc-3332	74	9	0.12	0.12	NUM
dpc-3332	74	10	-	-	NUM
dpc-3332	74	11	7.51	7.51	NUM
dpc-3332	74	12	)	)	PUNCT
dpc-3332	74	13	in	in	ADP
dpc-3332	74	14	the	the	DET
dpc-3332	74	15	patient	patient	NOUN
dpc-3332	74	16	group	group	NOUN
dpc-3332	74	17	,	,	PUNCT
dpc-3332	74	18	whereas	whereas	SCONJ
dpc-3332	74	19	it	it	PRON
dpc-3332	74	20	was	be	AUX
dpc-3332	74	21	0.39	0.39	NUM
dpc-3332	74	22	(	(	PUNCT
dpc-3332	74	23	0.0	0.0	NUM
dpc-3332	74	24	-	-	SYM
dpc-3332	74	25	1.11	1.11	NUM
dpc-3332	74	26	)	)	PUNCT
dpc-3332	74	27	in	in	ADP
dpc-3332	74	28	the	the	DET
dpc-3332	74	29	control	control	NOUN
dpc-3332	74	30	group	group	NOUN
dpc-3332	74	31	.	.	PUNCT
dpc-3332	75	1	there	there	PRON
dpc-3332	75	2	was	be	VERB
dpc-3332	75	3	a	a	DET
dpc-3332	75	4	statistically	statistically	ADV
dpc-3332	75	5	significant	significant	ADJ
dpc-3332	75	6	difference	difference	NOUN
dpc-3332	75	7	between	between	ADP
dpc-3332	75	8	groups	group	NOUN
dpc-3332	75	9	(	(	PUNCT
dpc-3332	75	10	p	p	X
dpc-3332	75	11	<	<	X
dpc-3332	75	12	0.001	0.001	NUM
dpc-3332	75	13	)	)	PUNCT
dpc-3332	75	14	.	.	PUNCT
dpc-3332	76	1	there	there	PRON
dpc-3332	76	2	was	be	VERB
dpc-3332	76	3	a	a	DET
dpc-3332	76	4	statistically	statistically	ADV
dpc-3332	76	5	significant	significant	ADJ
dpc-3332	76	6	difference	difference	NOUN
dpc-3332	76	7	in	in	ADP
dpc-3332	76	8	sedimentation	sedimentation	NOUN
dpc-3332	76	9	,	,	PUNCT
dpc-3332	76	10	crp	crp	PROPN
dpc-3332	76	11	,	,	PUNCT
dpc-3332	76	12	albumin	albumin	ADJ
dpc-3332	76	13	and	and	CCONJ
dpc-3332	76	14	eosinophil	eosinophil	ADJ
dpc-3332	76	15	levels	level	NOUN
dpc-3332	76	16	between	between	ADP
dpc-3332	76	17	patient	patient	NOUN
dpc-3332	76	18	and	and	CCONJ
dpc-3332	76	19	control	control	NOUN
dpc-3332	76	20	groups	group	NOUN
dpc-3332	76	21	(	(	PUNCT
dpc-3332	76	22	table	table	NOUN
dpc-3332	76	23	1	1	NUM
dpc-3332	76	24	)	)	PUNCT
dpc-3332	76	25	.	.	PUNCT
dpc-3332	77	1	patients	patient	NOUN
dpc-3332	77	2	were	be	AUX
dpc-3332	77	3	first	first	ADV
dpc-3332	77	4	evaluated	evaluate	VERB
dpc-3332	77	5	according	accord	VERB
dpc-3332	77	6	to	to	ADP
dpc-3332	77	7	stages	stage	NOUN
dpc-3332	77	8	.	.	PUNCT
dpc-3332	78	1	in	in	ADP
dpc-3332	78	2	stage	stage	NOUN
dpc-3332	78	3	i	i	PRON
dpc-3332	78	4	(	(	PUNCT
dpc-3332	78	5	t1	t1	NOUN
dpc-3332	78	6	,	,	PUNCT
dpc-3332	78	7	t2	t2	NOUN
dpc-3332	78	8	)	)	PUNCT
dpc-3332	78	9	,	,	PUNCT
dpc-3332	78	10	there	there	PRON
dpc-3332	78	11	are	be	VERB
dpc-3332	78	12	patients	patient	NOUN
dpc-3332	78	13	with	with	ADP
dpc-3332	78	14	only	only	ADJ
dpc-3332	78	15	skin	skin	NOUN
dpc-3332	78	16	findings	finding	NOUN
dpc-3332	78	17	without	without	ADP
dpc-3332	78	18	involvement	involvement	NOUN
dpc-3332	78	19	of	of	ADP
dpc-3332	78	20	any	any	DET
dpc-3332	78	21	other	other	ADJ
dpc-3332	78	22	area	area	NOUN
dpc-3332	78	23	.	.	PUNCT
dpc-3332	79	1	stage	stage	NOUN
dpc-3332	79	2	i	i	PRON
dpc-3332	79	3	is	be	AUX
dpc-3332	79	4	divided	divide	VERB
dpc-3332	79	5	into	into	ADP
dpc-3332	79	6	two	two	NUM
dpc-3332	79	7	:	:	PUNCT
dpc-3332	79	8	stage	stage	NOUN
dpc-3332	79	9	ia	ia	PROPN
dpc-3332	79	10	and	and	CCONJ
dpc-3332	79	11	stage	stage	NOUN
dpc-3332	79	12	ib	ib	PROPN
dpc-3332	79	13	.	.	PUNCT
dpc-3332	80	1	t1	t1	PROPN
dpc-3332	80	2	represents	represent	VERB
dpc-3332	80	3	patients	patient	NOUN
dpc-3332	80	4	with	with	ADP
dpc-3332	80	5	patches	patch	NOUN
dpc-3332	80	6	and/or	and/or	CCONJ
dpc-3332	80	7	plaques	plaque	NOUN
dpc-3332	80	8	covering	cover	VERB
dpc-3332	80	9	<	<	X
dpc-3332	80	10	10	10	NUM
dpc-3332	80	11	%	%	NOUN
dpc-3332	80	12	of	of	ADP
dpc-3332	80	13	the	the	DET
dpc-3332	80	14	body	body	NOUN
dpc-3332	80	15	.	.	PUNCT
dpc-3332	81	1	however	however	ADV
dpc-3332	81	2	,	,	PUNCT
dpc-3332	81	3	since	since	SCONJ
dpc-3332	81	4	the	the	DET
dpc-3332	81	5	tumor	tumor	NOUN
dpc-3332	81	6	burden	burden	NOUN
dpc-3332	81	7	of	of	ADP
dpc-3332	81	8	patches	patch	NOUN
dpc-3332	81	9	and	and	CCONJ
dpc-3332	81	10	plaques	plaque	NOUN
dpc-3332	81	11	is	be	AUX
dpc-3332	81	12	not	not	PART
dpc-3332	81	13	the	the	DET
dpc-3332	81	14	same	same	ADJ
dpc-3332	81	15	,	,	PUNCT
dpc-3332	81	16	this	this	DET
dpc-3332	81	17	stage	stage	NOUN
dpc-3332	81	18	is	be	AUX
dpc-3332	81	19	divided	divide	VERB
dpc-3332	81	20	into	into	ADP
dpc-3332	81	21	two	two	NUM
dpc-3332	81	22	as	as	ADP
dpc-3332	81	23	t1a	t1a	PUNCT
dpc-3332	81	24	and	and	CCONJ
dpc-3332	81	25	t1b	t1b	PROPN
dpc-3332	81	26	in	in	ADP
dpc-3332	81	27	the	the	DET
dpc-3332	81	28	final	final	ADJ
dpc-3332	81	29	classification	classification	NOUN
dpc-3332	81	30	(	(	PUNCT
dpc-3332	81	31	14	14	NUM
dpc-3332	81	32	)	)	PUNCT
dpc-3332	81	33	.	.	PUNCT
dpc-3332	82	1	t1a	t1a	NOUN
dpc-3332	82	2	consists	consist	VERB
dpc-3332	82	3	of	of	ADP
dpc-3332	82	4	patches	patch	NOUN
dpc-3332	82	5	only	only	ADV
dpc-3332	82	6	,	,	PUNCT
dpc-3332	82	7	while	while	SCONJ
dpc-3332	82	8	t1b	t1b	PROPN
dpc-3332	82	9	consists	consist	VERB
dpc-3332	82	10	of	of	ADP
dpc-3332	82	11	plaques	plaque	NOUN
dpc-3332	82	12	±	±	NOUN
dpc-3332	82	13	patches	patch	NOUN
dpc-3332	82	14	.	.	PUNCT
dpc-3332	83	1	these	these	DET
dpc-3332	83	2	patients	patient	NOUN
dpc-3332	83	3	are	be	AUX
dpc-3332	83	4	also	also	ADV
dpc-3332	83	5	considered	consider	VERB
dpc-3332	83	6	stage	stage	PROPN
dpc-3332	83	7	ia	ia	PROPN
dpc-3332	83	8	.	.	PUNCT
dpc-3332	84	1	t2	t2	PROPN
dpc-3332	84	2	represents	represent	VERB
dpc-3332	84	3	patients	patient	NOUN
dpc-3332	84	4	with	with	ADP
dpc-3332	84	5	patches	patch	NOUN
dpc-3332	84	6	and/or	and/or	CCONJ
dpc-3332	84	7	plaques	plaque	NOUN
dpc-3332	84	8	in	in	ADP
dpc-3332	84	9	>	>	ADP
dpc-3332	84	10	10	10	NUM
dpc-3332	84	11	%	%	NOUN
dpc-3332	84	12	of	of	ADP
dpc-3332	84	13	the	the	DET
dpc-3332	84	14	body	body	NOUN
dpc-3332	84	15	.	.	PUNCT
dpc-3332	85	1	t2a	t2a	ADP
dpc-3332	85	2	consists	consist	NOUN
dpc-3332	85	3	of	of	ADP
dpc-3332	85	4	patches	patch	NOUN
dpc-3332	85	5	only	only	ADV
dpc-3332	85	6	,	,	PUNCT
dpc-3332	85	7	while	while	SCONJ
dpc-3332	85	8	t2b	t2b	PROPN
dpc-3332	85	9	consists	consist	VERB
dpc-3332	85	10	of	of	ADP
dpc-3332	85	11	plaque	plaque	NOUN
dpc-3332	85	12	±	±	NOUN
dpc-3332	85	13	patches	patch	NOUN
dpc-3332	85	14	.	.	PUNCT
dpc-3332	86	1	there	there	PRON
dpc-3332	86	2	was	be	VERB
dpc-3332	86	3	not	not	PART
dpc-3332	86	4	a	a	DET
dpc-3332	86	5	statistically	statistically	ADV
dpc-3332	86	6	significant	significant	ADJ
dpc-3332	86	7	difference	difference	NOUN
dpc-3332	86	8	between	between	ADP
dpc-3332	86	9	the	the	DET
dpc-3332	86	10	car	car	NOUN
dpc-3332	86	11	values	value	NOUN
dpc-3332	86	12	of	of	ADP
dpc-3332	86	13	the	the	DET
dpc-3332	86	14	patients	patient	NOUN
dpc-3332	86	15	,	,	PUNCT
dpc-3332	86	16	stages	stage	NOUN
dpc-3332	86	17	,	,	PUNCT
dpc-3332	86	18	and	and	CCONJ
dpc-3332	86	19	those	those	PRON
dpc-3332	86	20	with	with	ADP
dpc-3332	86	21	only	only	ADJ
dpc-3332	86	22	skin	skin	NOUN
dpc-3332	86	23	involvement	involvement	NOUN
dpc-3332	86	24	and	and	CCONJ
dpc-3332	86	25	those	those	PRON
dpc-3332	86	26	with	with	ADP
dpc-3332	86	27	lymph	lymph	NOUN
dpc-3332	86	28	node	node	NOUN
dpc-3332	86	29	and	and	CCONJ
dpc-3332	86	30	systemic	systemic	ADJ
dpc-3332	86	31	involvement	involvement	NOUN
dpc-3332	86	32	(	(	PUNCT
dpc-3332	86	33	table	table	NOUN
dpc-3332	86	34	2	2	NUM
dpc-3332	86	35	)	)	PUNCT
dpc-3332	86	36	.	.	PUNCT
dpc-3332	87	1	16	16	NUM
dpc-3332	87	2	patients	patient	NOUN
dpc-3332	87	3	had	have	VERB
dpc-3332	87	4	progressive	progressive	ADJ
dpc-3332	87	5	disease	disease	NOUN
dpc-3332	87	6	(	(	PUNCT
dpc-3332	87	7	13	13	NUM
dpc-3332	87	8	m	m	NOUN
dpc-3332	87	9	,	,	PUNCT
dpc-3332	87	10	3	3	NUM
dpc-3332	87	11	f	f	NOUN
dpc-3332	87	12	)	)	PUNCT
dpc-3332	87	13	.	.	PUNCT
dpc-3332	88	1	lymphocyte	lymphocyte	ADJ
dpc-3332	88	2	count	count	NOUN
dpc-3332	88	3	,	,	PUNCT
dpc-3332	88	4	sedimentation	sedimentation	NOUN
dpc-3332	88	5	,	,	PUNCT
dpc-3332	88	6	ldh	ldh	NOUN
dpc-3332	88	7	and	and	CCONJ
dpc-3332	88	8	beta2	beta2	PROPN
dpc-3332	88	9	microglobulin	microglobulin	PROPN
dpc-3332	88	10	were	be	AUX
dpc-3332	88	11	found	find	VERB
dpc-3332	88	12	to	to	PART
dpc-3332	88	13	be	be	AUX
dpc-3332	88	14	associated	associate	VERB
dpc-3332	88	15	with	with	ADP
dpc-3332	88	16	poor	poor	ADJ
dpc-3332	88	17	prognosis	prognosis	NOUN
dpc-3332	88	18	in	in	ADP
dpc-3332	88	19	these	these	DET
dpc-3332	88	20	patients	patient	NOUN
dpc-3332	88	21	.	.	PUNCT
dpc-3332	89	1	patients	patient	NOUN
dpc-3332	89	2	with	with	ADP
dpc-3332	89	3	disease	disease	NOUN
dpc-3332	89	4	progression	progression	NOUN
dpc-3332	89	5	(	(	PUNCT
dpc-3332	89	6	n	n	NOUN
dpc-3332	89	7	=	=	SYM
dpc-3332	89	8	16	16	NUM
dpc-3332	89	9	)	)	PUNCT
dpc-3332	89	10	had	have	VERB
dpc-3332	89	11	a	a	DET
dpc-3332	89	12	median	median	ADJ
dpc-3332	89	13	value	value	NOUN
dpc-3332	89	14	of	of	ADP
dpc-3332	89	15	car	car	NOUN
dpc-3332	89	16	0.94	0.94	NUM
dpc-3332	89	17	(	(	PUNCT
dpc-3332	89	18	0.42	0.42	NUM
dpc-3332	89	19	-	-	NUM
dpc-3332	89	20	7.51	7.51	NUM
dpc-3332	89	21	)	)	PUNCT
dpc-3332	89	22	and	and	CCONJ
dpc-3332	89	23	the	the	DET
dpc-3332	89	24	median	median	ADJ
dpc-3332	89	25	value	value	NOUN
dpc-3332	89	26	of	of	ADP
dpc-3332	89	27	car	car	NOUN
dpc-3332	89	28	(	(	PUNCT
dpc-3332	89	29	n:44	n:44	ADJ
dpc-3332	89	30	)	)	PUNCT
dpc-3332	89	31	was	be	AUX
dpc-3332	89	32	0.91	0.91	NUM
dpc-3332	89	33	(	(	PUNCT
dpc-3332	89	34	0.12	0.12	NUM
dpc-3332	89	35	-	-	SYM
dpc-3332	89	36	4.57	4.57	NUM
dpc-3332	89	37	)	)	PUNCT
dpc-3332	89	38	in	in	ADP
dpc-3332	89	39	the	the	DET
dpc-3332	89	40	group	group	NOUN
dpc-3332	89	41	of	of	ADP
dpc-3332	89	42	patients	patient	NOUN
dpc-3332	89	43	without	without	ADP
dpc-3332	89	44	disease	disease	NOUN
dpc-3332	89	45	progression	progression	NOUN
dpc-3332	89	46	.	.	PUNCT
dpc-3332	90	1	the	the	DET
dpc-3332	90	2	car	car	NOUN
dpc-3332	90	3	value	value	NOUN
dpc-3332	90	4	had	have	VERB
dpc-3332	90	5	no	no	DET
dpc-3332	90	6	prognostic	prognostic	ADJ
dpc-3332	90	7	significance	significance	NOUN
dpc-3332	90	8	(	(	PUNCT
dpc-3332	90	9	p	p	X
dpc-3332	90	10	>	>	X
dpc-3332	90	11	0.05	0.05	NUM
dpc-3332	90	12	)	)	PUNCT
dpc-3332	90	13	(	(	PUNCT
dpc-3332	90	14	table	table	NOUN
dpc-3332	90	15	3	3	NUM
dpc-3332	90	16	)	)	PUNCT
dpc-3332	90	17	.	.	PUNCT
dpc-3332	91	1	conclusions	conclusion	NOUN
dpc-3332	91	2	mf	mf	VERB
dpc-3332	91	3	,	,	PUNCT
dpc-3332	91	4	the	the	DET
dpc-3332	91	5	most	most	ADV
dpc-3332	91	6	common	common	ADJ
dpc-3332	91	7	ctcl	ctcl	NOUN
dpc-3332	91	8	,	,	PUNCT
dpc-3332	91	9	is	be	AUX
dpc-3332	91	10	characterized	characterize	VERB
dpc-3332	91	11	by	by	ADP
dpc-3332	91	12	the	the	DET
dpc-3332	91	13	clonal	clonal	ADJ
dpc-3332	91	14	proliferation	proliferation	NOUN
dpc-3332	91	15	of	of	ADP
dpc-3332	91	16	skin	skin	NOUN
dpc-3332	91	17	homing	home	VERB
dpc-3332	91	18	mature	mature	ADJ
dpc-3332	91	19	t	t	NOUN
dpc-3332	91	20	-	-	PUNCT
dpc-3332	91	21	cells	cell	NOUN
dpc-3332	91	22	in	in	ADP
dpc-3332	91	23	chronically	chronically	ADV
dpc-3332	91	24	inflamed	inflame	VERB
dpc-3332	91	25	skin	skin	NOUN
dpc-3332	91	26	lesions	lesion	NOUN
dpc-3332	91	27	.	.	PUNCT
dpc-3332	92	1	malignant	malignant	ADJ
dpc-3332	92	2	t	t	PROPN
dpc-3332	92	3	-	-	PUNCT
dpc-3332	92	4	cells	cell	NOUN
dpc-3332	92	5	create	create	VERB
dpc-3332	92	6	a	a	DET
dpc-3332	92	7	chronic	chronic	ADJ
dpc-3332	92	8	inflammatory	inflammatory	ADJ
dpc-3332	92	9	environment	environment	NOUN
dpc-3332	92	10	in	in	ADP
dpc-3332	92	11	which	which	PRON
dpc-3332	92	12	they	they	PRON
dpc-3332	92	13	take	take	VERB
dpc-3332	92	14	control	control	NOUN
dpc-3332	92	15	of	of	ADP
dpc-3332	92	16	the	the	DET
dpc-3332	92	17	inflammatory	inflammatory	ADJ
dpc-3332	92	18	environment	environment	NOUN
dpc-3332	92	19	,	,	PUNCT
dpc-3332	92	20	suppressing	suppress	VERB
dpc-3332	92	21	cellular	cellular	ADJ
dpc-3332	92	22	immunity	immunity	NOUN
dpc-3332	92	23	and	and	CCONJ
dpc-3332	92	24	anti	anti	ADJ
dpc-3332	92	25	-	-	ADJ
dpc-3332	92	26	tumor	tumor	ADJ
dpc-3332	92	27	responses	response	NOUN
dpc-3332	92	28	,	,	PUNCT
dpc-3332	92	29	while	while	SCONJ
dpc-3332	92	30	fostering	foster	VERB
dpc-3332	92	31	their	their	PRON
dpc-3332	92	32	own	own	ADJ
dpc-3332	92	33	expansion	expansion	NOUN
dpc-3332	92	34	[	[	X
dpc-3332	92	35	15	15	NUM
dpc-3332	92	36	]	]	PUNCT
dpc-3332	92	37	.	.	PUNCT
dpc-3332	93	1	the	the	DET
dpc-3332	93	2	median	median	ADJ
dpc-3332	93	3	time	time	NOUN
dpc-3332	93	4	from	from	ADP
dpc-3332	93	5	onset	onset	NOUN
dpc-3332	93	6	of	of	ADP
dpc-3332	93	7	symptoms	symptom	NOUN
dpc-3332	93	8	to	to	ADP
dpc-3332	93	9	diagnosis	diagnosis	NOUN
dpc-3332	93	10	is	be	AUX
dpc-3332	93	11	3	3	NUM
dpc-3332	93	12	to	to	PART
dpc-3332	93	13	4	4	NUM
dpc-3332	93	14	years	year	NOUN
dpc-3332	93	15	,	,	PUNCT
dpc-3332	93	16	also	also	ADV
dpc-3332	93	17	it	it	PRON
dpc-3332	93	18	can	can	AUX
dpc-3332	93	19	be	be	AUX
dpc-3332	93	20	decades	decade	NOUN
dpc-3332	93	21	.	.	PUNCT
dpc-3332	94	1	clinicopathological	clinicopathological	ADJ
dpc-3332	94	2	correlation	correlation	NOUN
dpc-3332	94	3	is	be	AUX
dpc-3332	94	4	necessary	necessary	ADJ
dpc-3332	94	5	for	for	ADP
dpc-3332	94	6	the	the	DET
dpc-3332	94	7	diagnosis	diagnosis	NOUN
dpc-3332	94	8	of	of	ADP
dpc-3332	94	9	mf	mf	NOUN
dpc-3332	94	10	.	.	PUNCT
dpc-3332	95	1	making	make	VERB
dpc-3332	95	2	the	the	DET
dpc-3332	95	3	diagnosis	diagnosis	NOUN
dpc-3332	95	4	is	be	AUX
dpc-3332	95	5	difficult	difficult	ADJ
dpc-3332	95	6	for	for	ADP
dpc-3332	95	7	both	both	CCONJ
dpc-3332	95	8	the	the	DET
dpc-3332	95	9	pathologist	pathologist	NOUN
dpc-3332	95	10	and	and	CCONJ
dpc-3332	95	11	the	the	DET
dpc-3332	95	12	clinician	clinician	NOUN
dpc-3332	95	13	because	because	SCONJ
dpc-3332	95	14	the	the	DET
dpc-3332	95	15	findings	finding	NOUN
dpc-3332	95	16	are	be	AUX
dpc-3332	95	17	non	non	ADJ
dpc-3332	95	18	-	-	ADJ
dpc-3332	95	19	specific	specific	ADJ
dpc-3332	95	20	.	.	PUNCT
dpc-3332	96	1	classical	classical	ADJ
dpc-3332	96	2	form	form	NOUN
dpc-3332	96	3	of	of	ADP
dpc-3332	96	4	mf	mf	NOUN
dpc-3332	96	5	presents	present	NOUN
dpc-3332	96	6	as	as	ADP
dpc-3332	96	7	persistent	persistent	ADJ
dpc-3332	96	8	,	,	PUNCT
dpc-3332	96	9	progressive	progressive	ADJ
dpc-3332	96	10	erythematous	erythematous	ADJ
dpc-3332	96	11	table	table	NOUN
dpc-3332	96	12	1	1	NUM
dpc-3332	96	13	.	.	PUNCT
dpc-3332	96	14	comparison	comparison	NOUN
dpc-3332	96	15	of	of	ADP
dpc-3332	96	16	the	the	DET
dpc-3332	96	17	laboratory	laboratory	NOUN
dpc-3332	96	18	findings	finding	NOUN
dpc-3332	96	19	of	of	ADP
dpc-3332	96	20	the	the	DET
dpc-3332	96	21	patient	patient	ADJ
dpc-3332	96	22	and	and	CCONJ
dpc-3332	96	23	control	control	NOUN
dpc-3332	96	24	group	group	NOUN
dpc-3332	96	25	control	control	PROPN
dpc-3332	96	26	median	median	PROPN
dpc-3332	96	27	(	(	PUNCT
dpc-3332	96	28	min.-max	min.-max	X
dpc-3332	96	29	.	.	PUNCT
dpc-3332	96	30	)	)	PUNCT
dpc-3332	97	1	patient	patient	ADJ
dpc-3332	97	2	median	median	NOUN
dpc-3332	97	3	(	(	PUNCT
dpc-3332	97	4	min.-max	min.-max	X
dpc-3332	97	5	.	.	PUNCT
dpc-3332	97	6	)	)	PUNCT
dpc-3332	97	7	statistical	statistical	ADJ
dpc-3332	97	8	analysis	analysis	NOUN
dpc-3332	97	9	z	z	PROPN
dpc-3332	97	10	/	/	SYM
dpc-3332	97	11	t	t	PROPN
dpc-3332	97	12	;	;	PUNCT
dpc-3332	97	13	p	p	PROPN
dpc-3332	97	14	crp	crp	PROPN
dpc-3332	97	15	1.80	1.80	NUM
dpc-3332	97	16	(	(	PUNCT
dpc-3332	97	17	0.0	0.0	NUM
dpc-3332	97	18	-	-	SYM
dpc-3332	97	19	4.78	4.78	NUM
dpc-3332	97	20	)	)	PUNCT
dpc-3332	97	21	3.84	3.84	NUM
dpc-3332	97	22	(	(	PUNCT
dpc-3332	97	23	0.5	0.5	NUM
dpc-3332	97	24	-	-	SYM
dpc-3332	97	25	26.0	26.0	NUM
dpc-3332	97	26	)	)	PUNCT
dpc-3332	97	27	6.461	6.461	NUM
dpc-3332	97	28	;	;	PUNCT
dpc-3332	97	29	<	<	X
dpc-3332	97	30	0.001	0.001	NUM
dpc-3332	97	31	sedimentation	sedimentation	NOUN
dpc-3332	97	32	3.0	3.0	NUM
dpc-3332	97	33	(	(	PUNCT
dpc-3332	97	34	1.76	1.76	NUM
dpc-3332	97	35	-	-	SYM
dpc-3332	97	36	23.0	23.0	NUM
dpc-3332	97	37	)	)	PUNCT
dpc-3332	97	38	10.5	10.5	NUM
dpc-3332	97	39	(	(	PUNCT
dpc-3332	97	40	0.0	0.0	NUM
dpc-3332	97	41	-	-	SYM
dpc-3332	97	42	41.0	41.0	NUM
dpc-3332	97	43	)	)	PUNCT
dpc-3332	97	44	4.266	4.266	NUM
dpc-3332	97	45	;	;	PUNCT
dpc-3332	97	46	<	<	X
dpc-3332	97	47	0.001	0.001	NUM
dpc-3332	97	48	albumin	albumin	ADJ
dpc-3332	97	49	4.6	4.6	NUM
dpc-3332	97	50	(	(	PUNCT
dpc-3332	97	51	4.0	4.0	NUM
dpc-3332	97	52	-	-	NUM
dpc-3332	97	53	5.43	5.43	NUM
dpc-3332	97	54	)	)	PUNCT
dpc-3332	97	55	4.38	4.38	NUM
dpc-3332	97	56	(	(	PUNCT
dpc-3332	97	57	3.38	3.38	NUM
dpc-3332	97	58	-	-	SYM
dpc-3332	97	59	5.08	5.08	NUM
dpc-3332	97	60	)	)	PUNCT
dpc-3332	97	61	2.930	2.930	NUM
dpc-3332	97	62	;	;	PUNCT
dpc-3332	97	63	0.009	0.009	NUM
dpc-3332	97	64	neutrophil	neutrophil	ADJ
dpc-3332	97	65	3715	3715	NUM
dpc-3332	97	66	(	(	PUNCT
dpc-3332	97	67	1600	1600	NUM
dpc-3332	97	68	-	-	SYM
dpc-3332	97	69	8810	8810	NUM
dpc-3332	97	70	)	)	PUNCT
dpc-3332	97	71	4170	4170	NUM
dpc-3332	97	72	(	(	PUNCT
dpc-3332	97	73	0.0	0.0	NUM
dpc-3332	97	74	-	-	SYM
dpc-3332	97	75	15.6	15.6	NUM
dpc-3332	97	76	)	)	PUNCT
dpc-3332	97	77	1.738	1.738	NUM
dpc-3332	97	78	;	;	PUNCT
dpc-3332	97	79	0.082	0.082	NUM
dpc-3332	97	80	eosinophil	eosinophil	ADJ
dpc-3332	97	81	130.0	130.0	NUM
dpc-3332	97	82	(	(	PUNCT
dpc-3332	97	83	10.0	10.0	NUM
dpc-3332	97	84	-	-	SYM
dpc-3332	97	85	800.0	800.0	NUM
dpc-3332	97	86	)	)	PUNCT
dpc-3332	97	87	200.0	200.0	NUM
dpc-3332	97	88	(	(	PUNCT
dpc-3332	97	89	10.0	10.0	NUM
dpc-3332	97	90	-	-	PUNCT
dpc-3332	97	91	2610.0	2610.0	NUM
dpc-3332	97	92	)	)	PUNCT
dpc-3332	97	93	1.961	1.961	NUM
dpc-3332	97	94	;	;	PUNCT
dpc-3332	97	95	0.05	0.05	NUM
dpc-3332	97	96	car	car	NOUN
dpc-3332	97	97	0.39	0.39	NUM
dpc-3332	97	98	(	(	PUNCT
dpc-3332	97	99	0.0	0.0	NUM
dpc-3332	97	100	-	-	SYM
dpc-3332	97	101	1.11	1.11	NUM
dpc-3332	97	102	)	)	PUNCT
dpc-3332	97	103	0.91	0.91	NUM
dpc-3332	97	104	(	(	PUNCT
dpc-3332	97	105	0.12	0.12	NUM
dpc-3332	97	106	-	-	NUM
dpc-3332	97	107	7.51	7.51	NUM
dpc-3332	97	108	)	)	PUNCT
dpc-3332	97	109	6.629	6.629	NUM
dpc-3332	97	110	;	;	PUNCT
dpc-3332	97	111	<	<	X
dpc-3332	97	112	0.001	0.001	NUM
dpc-3332	97	113	n	n	CCONJ
dpc-3332	97	114	/	/	SYM
dpc-3332	97	115	l	l	NOUN
dpc-3332	97	116	1.78	1.78	NUM
dpc-3332	97	117	(	(	PUNCT
dpc-3332	97	118	0.81	0.81	NUM
dpc-3332	97	119	-	-	SYM
dpc-3332	97	120	5.58	5.58	NUM
dpc-3332	97	121	)	)	PUNCT
dpc-3332	97	122	2.02	2.02	NUM
dpc-3332	97	123	(	(	PUNCT
dpc-3332	97	124	0.0	0.0	NUM
dpc-3332	97	125	-	-	SYM
dpc-3332	97	126	15.6	15.6	NUM
dpc-3332	97	127	)	)	PUNCT
dpc-3332	97	128	1.653	1.653	NUM
dpc-3332	97	129	;	;	PUNCT
dpc-3332	97	130	0.098	0.098	NUM
dpc-3332	97	131	lymphocyte	lymphocyte	NOUN
dpc-3332	97	132	2045.0	2045.0	NUM
dpc-3332	97	133	(	(	PUNCT
dpc-3332	97	134	1110.0	1110.0	NUM
dpc-3332	97	135	-	-	SYM
dpc-3332	97	136	3950.0	3950.0	NUM
dpc-3332	97	137	)	)	PUNCT
dpc-3332	97	138	2035.0	2035.0	NUM
dpc-3332	97	139	(	(	PUNCT
dpc-3332	97	140	500.0	500.0	NUM
dpc-3332	97	141	-	-	SYM
dpc-3332	97	142	4860.0	4860.0	NUM
dpc-3332	97	143	)	)	PUNCT
dpc-3332	97	144	0.558	0.558	NUM
dpc-3332	97	145	;	;	PUNCT
dpc-3332	97	146	0.578	0.578	NUM
dpc-3332	97	147	platelet	platelet	NOUN
dpc-3332	97	148	246.0	246.0	NUM
dpc-3332	97	149	(	(	PUNCT
dpc-3332	97	150	143.0	143.0	NUM
dpc-3332	97	151	-	-	SYM
dpc-3332	97	152	357.0	357.0	NUM
dpc-3332	97	153	)	)	PUNCT
dpc-3332	97	154	256.0	256.0	NUM
dpc-3332	97	155	(	(	PUNCT
dpc-3332	97	156	128.0	128.0	NUM
dpc-3332	97	157	-	-	SYM
dpc-3332	97	158	418.0	418.0	NUM
dpc-3332	97	159	)	)	PUNCT
dpc-3332	97	160	1.817	1.817	NUM
dpc-3332	97	161	;	;	PUNCT
dpc-3332	97	162	0.072	0.072	NUM
dpc-3332	97	163	car	car	NOUN
dpc-3332	97	164	=	=	SYM
dpc-3332	97	165	crp	crp	NOUN
dpc-3332	97	166	to	to	ADP
dpc-3332	97	167	albumin	albumin	ADJ
dpc-3332	97	168	ratio	ratio	NOUN
dpc-3332	97	169	;	;	PUNCT
dpc-3332	97	170	crp	crp	X
dpc-3332	97	171	=	=	SYM
dpc-3332	97	172	c	c	PROPN
dpc-3332	97	173	reactive	reactive	ADJ
dpc-3332	97	174	protein	protein	NOUN
dpc-3332	97	175	;	;	PUNCT
dpc-3332	97	176	n	n	CCONJ
dpc-3332	97	177	/	/	SYM
dpc-3332	97	178	l	l	NOUN
dpc-3332	97	179	:	:	PUNCT
dpc-3332	97	180	neutrophil	neutrophil	ADJ
dpc-3332	97	181	to	to	ADP
dpc-3332	97	182	lymphocyte	lymphocyte	ADJ
dpc-3332	97	183	ratio	ratio	NOUN
dpc-3332	97	184	.	.	PUNCT
dpc-3332	98	1	table	table	NOUN
dpc-3332	98	2	2	2	NUM
dpc-3332	98	3	.	.	X
dpc-3332	98	4	relationship	relationship	NOUN
dpc-3332	98	5	between	between	ADP
dpc-3332	98	6	patients	patient	NOUN
dpc-3332	98	7	c	c	NOUN
dpc-3332	98	8	-	-	PUNCT
dpc-3332	98	9	reactive	reactive	ADJ
dpc-3332	98	10	protein	protein	NOUN
dpc-3332	98	11	to	to	ADP
dpc-3332	98	12	albumin	albumin	ADJ
dpc-3332	98	13	ratio	ratio	NOUN
dpc-3332	98	14	values	value	NOUN
dpc-3332	98	15	and	and	CCONJ
dpc-3332	98	16	stage	stage	NOUN
dpc-3332	98	17	stage	stage	NOUN
dpc-3332	98	18	n	n	PROPN
dpc-3332	98	19	(	(	PUNCT
dpc-3332	98	20	%	%	INTJ
dpc-3332	98	21	)	)	PUNCT
dpc-3332	98	22	c	c	NOUN
dpc-3332	98	23	-	-	PUNCT
dpc-3332	98	24	reactive	reactive	ADJ
dpc-3332	98	25	protein	protein	NOUN
dpc-3332	98	26	to	to	ADP
dpc-3332	98	27	albumin	albumin	ADJ
dpc-3332	98	28	ratio	ratio	NOUN
dpc-3332	98	29	median	median	PROPN
dpc-3332	98	30	(	(	PUNCT
dpc-3332	98	31	min	min	NOUN
dpc-3332	98	32	-	-	PUNCT
dpc-3332	98	33	max	max	NOUN
dpc-3332	98	34	)	)	PUNCT
dpc-3332	98	35	ia	ia	PROPN
dpc-3332	98	36	t1a	t1a	PROPN
dpc-3332	98	37	7	7	NUM
dpc-3332	98	38	(	(	PUNCT
dpc-3332	98	39	11.7	11.7	NUM
dpc-3332	98	40	)	)	PUNCT
dpc-3332	98	41	0.73	0.73	NUM
dpc-3332	98	42	(	(	PUNCT
dpc-3332	98	43	0.26	0.26	NUM
dpc-3332	98	44	-	-	SYM
dpc-3332	98	45	1.48	1.48	NUM
dpc-3332	98	46	)	)	PUNCT
dpc-3332	98	47	t1b	t1b	PROPN
dpc-3332	98	48	2	2	NUM
dpc-3332	98	49	(	(	PUNCT
dpc-3332	98	50	3.3	3.3	NUM
dpc-3332	98	51	)	)	PUNCT
dpc-3332	98	52	0,91	0,91	NOUN
dpc-3332	99	1	(	(	PUNCT
dpc-3332	99	2	0.32	0.32	NUM
dpc-3332	99	3	-	-	SYM
dpc-3332	99	4	1.49	1.49	NUM
dpc-3332	99	5	)	)	PUNCT
dpc-3332	99	6	ib	ib	NOUN
dpc-3332	99	7	t2a	t2a	ADP
dpc-3332	99	8	2	2	NUM
dpc-3332	99	9	(	(	PUNCT
dpc-3332	99	10	3.3	3.3	NUM
dpc-3332	99	11	)	)	PUNCT
dpc-3332	99	12	1.14	1.14	NUM
dpc-3332	99	13	(	(	PUNCT
dpc-3332	99	14	0.78	0.78	NUM
dpc-3332	99	15	-	-	SYM
dpc-3332	99	16	1.50	1.50	NUM
dpc-3332	99	17	)	)	PUNCT
dpc-3332	99	18	t2b	t2b	PROPN
dpc-3332	99	19	0	0	NUM
dpc-3332	99	20	(	(	PUNCT
dpc-3332	99	21	0.0	0.0	NUM
dpc-3332	99	22	)	)	PUNCT
dpc-3332	99	23	iia	iia	NOUN
dpc-3332	99	24	34	34	NUM
dpc-3332	99	25	(	(	PUNCT
dpc-3332	99	26	56.7	56.7	NUM
dpc-3332	99	27	)	)	PUNCT
dpc-3332	99	28	0.91	0.91	NUM
dpc-3332	99	29	(	(	PUNCT
dpc-3332	99	30	0.12	0.12	NUM
dpc-3332	99	31	-	-	SYM
dpc-3332	99	32	4.24	4.24	NUM
dpc-3332	99	33	)	)	PUNCT
dpc-3332	99	34	iib	iib	NOUN
dpc-3332	99	35	6	6	NUM
dpc-3332	99	36	(	(	PUNCT
dpc-3332	99	37	10.0	10.0	NUM
dpc-3332	99	38	)	)	PUNCT
dpc-3332	99	39	0.97	0.97	NUM
dpc-3332	99	40	(	(	PUNCT
dpc-3332	99	41	0.44	0.44	NUM
dpc-3332	99	42	-	-	NUM
dpc-3332	99	43	7.51	7.51	NUM
dpc-3332	99	44	)	)	PUNCT
dpc-3332	99	45	iiia	iiia	ADP
dpc-3332	99	46	0	0	NUM
dpc-3332	99	47	(	(	PUNCT
dpc-3332	99	48	0.0	0.0	NUM
dpc-3332	99	49	)	)	PUNCT
dpc-3332	99	50	iiib	iiib	NOUN
dpc-3332	99	51	7	7	NUM
dpc-3332	99	52	(	(	PUNCT
dpc-3332	99	53	11.7	11.7	NUM
dpc-3332	99	54	)	)	PUNCT
dpc-3332	99	55	1.37	1.37	NUM
dpc-3332	99	56	(	(	PUNCT
dpc-3332	99	57	0.44	0.44	NUM
dpc-3332	99	58	-	-	SYM
dpc-3332	99	59	2.30	2.30	NUM
dpc-3332	99	60	)	)	PUNCT
dpc-3332	99	61	iva	iva	NOUN
dpc-3332	99	62	2	2	NUM
dpc-3332	99	63	(	(	PUNCT
dpc-3332	99	64	3.3	3.3	NUM
dpc-3332	99	65	)	)	PUNCT
dpc-3332	99	66	1.07	1.07	NUM
dpc-3332	99	67	(	(	PUNCT
dpc-3332	99	68	1.04	1.04	NUM
dpc-3332	99	69	-	-	SYM
dpc-3332	99	70	1.09	1.09	NUM
dpc-3332	99	71	)	)	PUNCT
dpc-3332	99	72	4	4	NUM
dpc-3332	99	73	original	original	ADJ
dpc-3332	99	74	article	article	NOUN
dpc-3332	99	75	|	|	ADV
dpc-3332	99	76	dermatol	dermatol	ADJ
dpc-3332	99	77	pract	pract	NOUN
dpc-3332	99	78	concept	concept	NOUN
dpc-3332	99	79	.	.	PUNCT
dpc-3332	100	1	2024;14(2):e2024097	2024;14(2):e2024097	NUM
dpc-3332	100	2	table	table	NOUN
dpc-3332	100	3	3	3	NUM
dpc-3332	100	4	.	.	PUNCT
dpc-3332	101	1	distribution	distribution	NOUN
dpc-3332	101	2	of	of	ADP
dpc-3332	101	3	patients	patient	NOUN
dpc-3332	101	4	in	in	ADP
dpc-3332	101	5	the	the	DET
dpc-3332	101	6	study	study	NOUN
dpc-3332	101	7	group	group	NOUN
dpc-3332	101	8	according	accord	VERB
dpc-3332	101	9	to	to	ADP
dpc-3332	101	10	variables	variable	NOUN
dpc-3332	101	11	thought	think	VERB
dpc-3332	101	12	to	to	PART
dpc-3332	101	13	be	be	AUX
dpc-3332	101	14	related	relate	VERB
dpc-3332	101	15	to	to	ADP
dpc-3332	101	16	 	 	SPACE
dpc-3332	101	17	their	their	PRON
dpc-3332	101	18	prognosis	prognosis	NOUN
dpc-3332	101	19	poor	poor	ADJ
dpc-3332	101	20	prognosis	prognosis	NOUN
dpc-3332	101	21	(	(	PUNCT
dpc-3332	101	22	n	n	NOUN
dpc-3332	101	23	=	=	SYM
dpc-3332	101	24	16	16	NUM
dpc-3332	101	25	)	)	PUNCT
dpc-3332	101	26	median	median	NOUN
dpc-3332	101	27	(	(	PUNCT
dpc-3332	101	28	min	min	NOUN
dpc-3332	101	29	-	-	PUNCT
dpc-3332	101	30	max	max	NOUN
dpc-3332	101	31	)	)	PUNCT
dpc-3332	101	32	good	good	ADJ
dpc-3332	101	33	prognosis	prognosis	NOUN
dpc-3332	101	34	(	(	PUNCT
dpc-3332	101	35	n	n	NOUN
dpc-3332	101	36	=	=	SYM
dpc-3332	101	37	44	44	NUM
dpc-3332	101	38	)	)	PUNCT
dpc-3332	101	39	median	median	NOUN
dpc-3332	101	40	(	(	PUNCT
dpc-3332	101	41	min	min	NOUN
dpc-3332	101	42	-	-	PUNCT
dpc-3332	101	43	max	max	NOUN
dpc-3332	101	44	)	)	PUNCT
dpc-3332	101	45	t	t	PROPN
dpc-3332	101	46	-	-	PUNCT
dpc-3332	101	47	test	test	NOUN
dpc-3332	101	48	;	;	PUNCT
dpc-3332	101	49	p	p	X
dpc-3332	101	50	beta2	beta2	PROPN
dpc-3332	101	51	microglobulin	microglobulin	PROPN
dpc-3332	101	52	2.40	2.40	NUM
dpc-3332	101	53	(	(	PUNCT
dpc-3332	101	54	1.53	1.53	NUM
dpc-3332	101	55	-	-	NUM
dpc-3332	101	56	4.09	4.09	NUM
dpc-3332	101	57	)	)	PUNCT
dpc-3332	101	58	1.96	1.96	NUM
dpc-3332	101	59	(	(	PUNCT
dpc-3332	101	60	1.18	1.18	NUM
dpc-3332	101	61	-	-	SYM
dpc-3332	101	62	3.77	3.77	NUM
dpc-3332	101	63	)	)	PUNCT
dpc-3332	101	64	2.281	2.281	NUM
dpc-3332	101	65	;	;	PUNCT
dpc-3332	101	66	0.023	0.023	NUM
dpc-3332	101	67	crp	crp	NOUN
dpc-3332	101	68	3.72	3.72	NUM
dpc-3332	101	69	(	(	PUNCT
dpc-3332	101	70	1.70	1.70	NUM
dpc-3332	101	71	-	-	SYM
dpc-3332	101	72	26.0	26.0	NUM
dpc-3332	101	73	)	)	PUNCT
dpc-3332	101	74	3.89	3.89	NUM
dpc-3332	101	75	(	(	PUNCT
dpc-3332	101	76	0.50	0.50	NUM
dpc-3332	101	77	-	-	SYM
dpc-3332	101	78	19.0	19.0	NUM
dpc-3332	101	79	)	)	PUNCT
dpc-3332	101	80	0.478	0.478	NUM
dpc-3332	101	81	;	;	PUNCT
dpc-3332	101	82	0.633	0.633	NUM
dpc-3332	101	83	sedimentation	sedimentation	NOUN
dpc-3332	101	84	4.00	4.00	NUM
dpc-3332	101	85	(	(	PUNCT
dpc-3332	101	86	0.0	0.0	NUM
dpc-3332	101	87	-	-	SYM
dpc-3332	101	88	29.0	29.0	NUM
dpc-3332	101	89	)	)	PUNCT
dpc-3332	101	90	11.0	11.0	NUM
dpc-3332	101	91	(	(	PUNCT
dpc-3332	101	92	2.0	2.0	NUM
dpc-3332	101	93	-	-	SYM
dpc-3332	101	94	41.0	41.0	NUM
dpc-3332	101	95	)	)	PUNCT
dpc-3332	101	96	2.079	2.079	NUM
dpc-3332	101	97	;	;	PUNCT
dpc-3332	101	98	0.038	0.038	NUM
dpc-3332	101	99	albumin	albumin	NOUN
dpc-3332	101	100	4.45	4.45	NUM
dpc-3332	101	101	(	(	PUNCT
dpc-3332	101	102	3.38	3.38	NUM
dpc-3332	101	103	-	-	SYM
dpc-3332	101	104	4.9	4.9	NUM
dpc-3332	101	105	)	)	PUNCT
dpc-3332	101	106	4.5	4.5	NUM
dpc-3332	101	107	(	(	PUNCT
dpc-3332	101	108	3.48	3.48	NUM
dpc-3332	101	109	-	-	SYM
dpc-3332	101	110	5.08	5.08	NUM
dpc-3332	101	111	)	)	PUNCT
dpc-3332	101	112	0.831	0.831	NUM
dpc-3332	101	113	;	;	PUNCT
dpc-3332	101	114	0.406	0.406	NUM
dpc-3332	101	115	neutrophil	neutrophil	ADJ
dpc-3332	101	116	2.87	2.87	NUM
dpc-3332	101	117	(	(	PUNCT
dpc-3332	101	118	0.82	0.82	NUM
dpc-3332	101	119	-	-	SYM
dpc-3332	101	120	15.60	15.60	NUM
dpc-3332	101	121	)	)	PUNCT
dpc-3332	101	122	1.99	1.99	NUM
dpc-3332	101	123	(	(	PUNCT
dpc-3332	101	124	0.00	0.00	NUM
dpc-3332	101	125	-	-	SYM
dpc-3332	101	126	4.87	4.87	NUM
dpc-3332	101	127	)	)	PUNCT
dpc-3332	101	128	0.157	0.157	NUM
dpc-3332	101	129	;	;	PUNCT
dpc-3332	101	130	0.878	0.878	NUM
dpc-3332	101	131	eosinophil	eosinophil	ADJ
dpc-3332	101	132	200.0	200.0	NUM
dpc-3332	101	133	(	(	PUNCT
dpc-3332	101	134	10.0	10.0	NUM
dpc-3332	101	135	-	-	SYM
dpc-3332	101	136	1400.0	1400.0	NUM
dpc-3332	101	137	)	)	PUNCT
dpc-3332	101	138	200.0	200.0	NUM
dpc-3332	101	139	(	(	PUNCT
dpc-3332	101	140	10.0	10.0	NUM
dpc-3332	101	141	-	-	PUNCT
dpc-3332	101	142	2610.0	2610.0	NUM
dpc-3332	101	143	)	)	PUNCT
dpc-3332	101	144	0.241	0.241	NUM
dpc-3332	101	145	;	;	PUNCT
dpc-3332	101	146	0.809	0.809	NUM
dpc-3332	101	147	car	car	NOUN
dpc-3332	101	148	0.94	0.94	NUM
dpc-3332	101	149	(	(	PUNCT
dpc-3332	101	150	0.42	0.42	NUM
dpc-3332	101	151	-	-	NUM
dpc-3332	101	152	7.51	7.51	NUM
dpc-3332	101	153	)	)	PUNCT
dpc-3332	101	154	0.91	0.91	NUM
dpc-3332	101	155	(	(	PUNCT
dpc-3332	101	156	0.12	0.12	NUM
dpc-3332	101	157	-	-	SYM
dpc-3332	101	158	4.57	4.57	NUM
dpc-3332	101	159	)	)	PUNCT
dpc-3332	101	160	0.301	0.301	NUM
dpc-3332	101	161	;	;	PUNCT
dpc-3332	101	162	0.763	0.763	NUM
dpc-3332	101	163	n	n	CCONJ
dpc-3332	101	164	/	/	SYM
dpc-3332	101	165	l	l	NOUN
dpc-3332	101	166	2.87	2.87	NUM
dpc-3332	101	167	(	(	PUNCT
dpc-3332	101	168	0.82	0.82	NUM
dpc-3332	101	169	-	-	SYM
dpc-3332	101	170	15.60	15.60	NUM
dpc-3332	101	171	)	)	PUNCT
dpc-3332	101	172	1.99	1.99	NUM
dpc-3332	101	173	(	(	PUNCT
dpc-3332	101	174	0.0	0.0	NUM
dpc-3332	101	175	-	-	SYM
dpc-3332	101	176	4.87	4.87	NUM
dpc-3332	101	177	)	)	PUNCT
dpc-3332	101	178	1.639	1.639	NUM
dpc-3332	101	179	;	;	PUNCT
dpc-3332	101	180	0.101	0.101	NUM
dpc-3332	101	181	disease	disease	NOUN
dpc-3332	101	182	duration	duration	NOUN
dpc-3332	101	183	3.0	3.0	NUM
dpc-3332	101	184	(	(	PUNCT
dpc-3332	101	185	1.0	1.0	NUM
dpc-3332	101	186	-	-	SYM
dpc-3332	101	187	21.0	21.0	NUM
dpc-3332	101	188	)	)	PUNCT
dpc-3332	101	189	4.0	4.0	NUM
dpc-3332	101	190	(	(	PUNCT
dpc-3332	101	191	0.50	0.50	NUM
dpc-3332	101	192	-	-	SYM
dpc-3332	101	193	35.0	35.0	NUM
dpc-3332	101	194	)	)	PUNCT
dpc-3332	101	195	0.575	0.575	NUM
dpc-3332	101	196	;	;	PUNCT
dpc-3332	101	197	0.565	0.565	NUM
dpc-3332	101	198	lymphocyte	lymphocyte	NOUN
dpc-3332	101	199	1800.0	1800.0	NUM
dpc-3332	101	200	(	(	PUNCT
dpc-3332	101	201	500.0	500.0	NUM
dpc-3332	101	202	-	-	SYM
dpc-3332	101	203	4000.0	4000.0	NUM
dpc-3332	101	204	)	)	PUNCT
dpc-3332	101	205	2100.0	2100.0	NUM
dpc-3332	101	206	(	(	PUNCT
dpc-3332	101	207	1000.0	1000.0	NUM
dpc-3332	101	208	-	-	SYM
dpc-3332	101	209	4860.0	4860.0	NUM
dpc-3332	101	210	)	)	PUNCT
dpc-3332	101	211	2.124	2.124	NUM
dpc-3332	101	212	;	;	PUNCT
dpc-3332	101	213	0.046	0.046	NUM
dpc-3332	101	214	platelet	platelet	NOUN
dpc-3332	101	215	230.0	230.0	NUM
dpc-3332	101	216	(	(	PUNCT
dpc-3332	101	217	128.0	128.0	NUM
dpc-3332	101	218	-	-	SYM
dpc-3332	101	219	418.0	418.0	NUM
dpc-3332	101	220	)	)	PUNCT
dpc-3332	101	221	271.0	271.0	NUM
dpc-3332	101	222	(	(	PUNCT
dpc-3332	101	223	187.0	187.0	NUM
dpc-3332	101	224	-	-	SYM
dpc-3332	101	225	406.0	406.0	NUM
dpc-3332	101	226	)	)	PUNCT
dpc-3332	101	227	1.298	1.298	NUM
dpc-3332	101	228	;	;	PUNCT
dpc-3332	101	229	0.210	0.210	NUM
dpc-3332	101	230	ldh	ldh	VERB
dpc-3332	101	231	214.0	214.0	NUM
dpc-3332	101	232	(	(	PUNCT
dpc-3332	101	233	173.0	173.0	NUM
dpc-3332	101	234	-	-	SYM
dpc-3332	101	235	399.0	399.0	NUM
dpc-3332	101	236	)	)	PUNCT
dpc-3332	101	237	187.0	187.0	NUM
dpc-3332	101	238	(	(	PUNCT
dpc-3332	101	239	145.0	145.0	NUM
dpc-3332	101	240	-	-	SYM
dpc-3332	101	241	403.0	403.0	NUM
dpc-3332	101	242	)	)	PUNCT
dpc-3332	101	243	2.684	2.684	NUM
dpc-3332	101	244	;	;	PUNCT
dpc-3332	101	245	0.007	0.007	NUM
dpc-3332	101	246	car	car	NOUN
dpc-3332	101	247	=	=	SYM
dpc-3332	101	248	crp	crp	NOUN
dpc-3332	101	249	to	to	ADP
dpc-3332	101	250	albumin	albumin	ADJ
dpc-3332	101	251	ratio	ratio	NOUN
dpc-3332	101	252	;	;	PUNCT
dpc-3332	101	253	crp	crp	X
dpc-3332	101	254	=	=	SYM
dpc-3332	101	255	c	c	PROPN
dpc-3332	101	256	reactive	reactive	ADJ
dpc-3332	101	257	protein	protein	NOUN
dpc-3332	101	258	;	;	PUNCT
dpc-3332	101	259	ldh	ldh	ADJ
dpc-3332	101	260	=	=	SYM
dpc-3332	101	261	lactate	lactate	NOUN
dpc-3332	101	262	dehydrogenase	dehydrogenase	NOUN
dpc-3332	101	263	;	;	PUNCT
dpc-3332	101	264	n	n	CCONJ
dpc-3332	101	265	/	/	SYM
dpc-3332	101	266	l	l	NOUN
dpc-3332	101	267	:	:	PUNCT
dpc-3332	101	268	neutrophil	neutrophil	ADJ
dpc-3332	101	269	to	to	ADP
dpc-3332	101	270	lymphocyte	lymphocyte	ADJ
dpc-3332	101	271	ratio	ratio	NOUN
dpc-3332	101	272	.	.	PUNCT
dpc-3332	102	1	patches	patch	NOUN
dpc-3332	102	2	or	or	CCONJ
dpc-3332	102	3	plaques	plaque	NOUN
dpc-3332	102	4	of	of	ADP
dpc-3332	102	5	variable	variable	ADJ
dpc-3332	102	6	size	size	NOUN
dpc-3332	102	7	and	and	CCONJ
dpc-3332	102	8	shape	shape	NOUN
dpc-3332	102	9	,	,	PUNCT
dpc-3332	102	10	which	which	PRON
dpc-3332	102	11	have	have	VERB
dpc-3332	102	12	a	a	DET
dpc-3332	102	13	scaly	scaly	NOUN
dpc-3332	102	14	atrophic	atrophic	ADJ
dpc-3332	102	15	surface	surface	NOUN
dpc-3332	102	16	,	,	PUNCT
dpc-3332	102	17	located	locate	VERB
dpc-3332	102	18	on	on	ADP
dpc-3332	102	19	sun	sun	NOUN
dpc-3332	102	20	-	-	PUNCT
dpc-3332	102	21	protected	protect	VERB
dpc-3332	102	22	areas	area	NOUN
dpc-3332	102	23	.	.	PUNCT
dpc-3332	103	1	mf	mf	NOUN
dpc-3332	103	2	can	can	AUX
dpc-3332	103	3	appear	appear	VERB
dpc-3332	103	4	in	in	ADP
dpc-3332	103	5	many	many	ADJ
dpc-3332	103	6	clinical	clinical	ADJ
dpc-3332	103	7	forms	form	NOUN
dpc-3332	103	8	,	,	PUNCT
dpc-3332	103	9	except	except	SCONJ
dpc-3332	103	10	for	for	ADP
dpc-3332	103	11	the	the	DET
dpc-3332	103	12	classic	classic	ADJ
dpc-3332	103	13	patch	patch	ADJ
dpc-3332	103	14	-	-	PUNCT
dpc-3332	103	15	plaque	plaque	NOUN
dpc-3332	103	16	-	-	PUNCT
dpc-3332	103	17	tumor	tumor	NOUN
dpc-3332	103	18	type	type	NOUN
dpc-3332	103	19	.	.	PUNCT
dpc-3332	104	1	due	due	ADP
dpc-3332	104	2	to	to	ADP
dpc-3332	104	3	the	the	DET
dpc-3332	104	4	atypical	atypical	ADJ
dpc-3332	104	5	types	type	NOUN
dpc-3332	104	6	of	of	ADP
dpc-3332	104	7	mf	mf	NOUN
dpc-3332	104	8	,	,	PUNCT
dpc-3332	104	9	the	the	DET
dpc-3332	104	10	list	list	NOUN
dpc-3332	104	11	of	of	ADP
dpc-3332	104	12	diseases	disease	NOUN
dpc-3332	104	13	in	in	ADP
dpc-3332	104	14	the	the	DET
dpc-3332	104	15	differential	differential	ADJ
dpc-3332	104	16	diagnosis	diagnosis	NOUN
dpc-3332	104	17	of	of	ADP
dpc-3332	104	18	mf	mf	NOUN
dpc-3332	104	19	is	be	AUX
dpc-3332	104	20	quite	quite	ADV
dpc-3332	104	21	extensive	extensive	ADJ
dpc-3332	104	22	.	.	PUNCT
dpc-3332	105	1	this	this	PRON
dpc-3332	105	2	is	be	AUX
dpc-3332	105	3	why	why	SCONJ
dpc-3332	105	4	the	the	DET
dpc-3332	105	5	mf	mf	NOUN
dpc-3332	105	6	is	be	AUX
dpc-3332	105	7	known	know	VERB
dpc-3332	105	8	as	as	ADP
dpc-3332	105	9	the	the	DET
dpc-3332	105	10	''	''	PUNCT
dpc-3332	105	11	great	great	ADJ
dpc-3332	105	12	imitator	imitator	NOUN
dpc-3332	105	13	''	''	PUNCT
dpc-3332	106	1	[	[	X
dpc-3332	106	2	1,3,16	1,3,16	NUM
dpc-3332	106	3	]	]	X
dpc-3332	106	4	.	.	PUNCT
dpc-3332	107	1	in	in	ADP
dpc-3332	107	2	cases	case	NOUN
dpc-3332	107	3	where	where	SCONJ
dpc-3332	107	4	there	there	PRON
dpc-3332	107	5	is	be	VERB
dpc-3332	107	6	no	no	DET
dpc-3332	107	7	clinical	clinical	ADJ
dpc-3332	107	8	and	and	CCONJ
dpc-3332	107	9	pathological	pathological	ADJ
dpc-3332	107	10	agreement	agreement	NOUN
dpc-3332	107	11	on	on	ADP
dpc-3332	107	12	the	the	DET
dpc-3332	107	13	diagnosis	diagnosis	NOUN
dpc-3332	107	14	of	of	ADP
dpc-3332	107	15	mf	mf	NOUN
dpc-3332	107	16	,	,	PUNCT
dpc-3332	107	17	multiple	multiple	ADJ
dpc-3332	107	18	biopsies	biopsy	NOUN
dpc-3332	107	19	should	should	AUX
dpc-3332	107	20	be	be	AUX
dpc-3332	107	21	taken	take	VERB
dpc-3332	107	22	from	from	ADP
dpc-3332	107	23	the	the	DET
dpc-3332	107	24	lesions	lesion	NOUN
dpc-3332	107	25	at	at	ADP
dpc-3332	107	26	regular	regular	ADJ
dpc-3332	107	27	intervals	interval	NOUN
dpc-3332	107	28	.	.	PUNCT
dpc-3332	108	1	the	the	DET
dpc-3332	108	2	patient	patient	NOUN
dpc-3332	108	3	should	should	AUX
dpc-3332	108	4	be	be	AUX
dpc-3332	108	5	informed	inform	VERB
dpc-3332	108	6	and	and	CCONJ
dpc-3332	108	7	should	should	AUX
dpc-3332	108	8	not	not	PART
dpc-3332	108	9	be	be	AUX
dpc-3332	108	10	excluded	exclude	VERB
dpc-3332	108	11	from	from	ADP
dpc-3332	108	12	follow	follow	NOUN
dpc-3332	108	13	-	-	PUNCT
dpc-3332	108	14	up	up	NOUN
dpc-3332	108	15	.	.	PUNCT
dpc-3332	109	1	the	the	DET
dpc-3332	109	2	degree	degree	NOUN
dpc-3332	109	3	of	of	ADP
dpc-3332	109	4	skin	skin	NOUN
dpc-3332	109	5	involvement	involvement	NOUN
dpc-3332	109	6	and	and	CCONJ
dpc-3332	109	7	the	the	DET
dpc-3332	109	8	presence	presence	NOUN
dpc-3332	109	9	of	of	ADP
dpc-3332	109	10	extracutaneous	extracutaneous	ADJ
dpc-3332	109	11	disease	disease	NOUN
dpc-3332	109	12	are	be	AUX
dpc-3332	109	13	the	the	DET
dpc-3332	109	14	most	most	ADV
dpc-3332	109	15	important	important	ADJ
dpc-3332	109	16	criteria	criterion	NOUN
dpc-3332	109	17	for	for	ADP
dpc-3332	109	18	long	long	ADJ
dpc-3332	109	19	-	-	PUNCT
dpc-3332	109	20	term	term	NOUN
dpc-3332	109	21	life	life	NOUN
dpc-3332	109	22	expectancy	expectancy	NOUN
dpc-3332	109	23	in	in	ADP
dpc-3332	109	24	mf	mf	PROPN
dpc-3332	109	25	.	.	PUNCT
dpc-3332	110	1	therefore	therefore	ADV
dpc-3332	110	2	the	the	DET
dpc-3332	110	3	tnmb	tnmb	PROPN
dpc-3332	110	4	(	(	PUNCT
dpc-3332	110	5	tumor	tumor	NOUN
dpc-3332	110	6	,	,	PUNCT
dpc-3332	110	7	node	node	NOUN
dpc-3332	110	8	,	,	PUNCT
dpc-3332	110	9	metastasis	metastasis	NOUN
dpc-3332	110	10	,	,	PUNCT
dpc-3332	110	11	blood	blood	NOUN
dpc-3332	110	12	)	)	PUNCT
dpc-3332	110	13	staging	staging	NOUN
dpc-3332	110	14	remains	remain	VERB
dpc-3332	110	15	an	an	DET
dpc-3332	110	16	important	important	ADJ
dpc-3332	110	17	prognostic	prognostic	ADJ
dpc-3332	110	18	factor	factor	NOUN
dpc-3332	110	19	in	in	ADP
dpc-3332	110	20	mf	mf	PROPN
dpc-3332	110	21	.	.	PUNCT
dpc-3332	111	1	this	this	DET
dpc-3332	111	2	classification	classification	NOUN
dpc-3332	111	3	has	have	VERB
dpc-3332	111	4	9	9	NUM
dpc-3332	111	5	-	-	PUNCT
dpc-3332	111	6	level	level	NOUN
dpc-3332	111	7	and	and	CCONJ
dpc-3332	111	8	early	early	ADJ
dpc-3332	111	9	stage	stage	NOUN
dpc-3332	111	10	includes	include	VERB
dpc-3332	111	11	stages	stage	NOUN
dpc-3332	111	12	ia	ia	PROPN
dpc-3332	111	13	,	,	PUNCT
dpc-3332	111	14	ib	ib	NOUN
dpc-3332	111	15	and	and	CCONJ
dpc-3332	111	16	iia	iia	PROPN
dpc-3332	111	17	.	.	PUNCT
dpc-3332	112	1	other	other	ADJ
dpc-3332	112	2	stages	stage	NOUN
dpc-3332	112	3	known	know	VERB
dpc-3332	112	4	as	as	ADP
dpc-3332	112	5	advanced	advanced	ADJ
dpc-3332	112	6	or	or	CCONJ
dpc-3332	112	7	tumor	tumor	NOUN
dpc-3332	112	8	stage	stage	NOUN
dpc-3332	112	9	.	.	PUNCT
dpc-3332	113	1	mf	mf	NOUN
dpc-3332	113	2	may	may	AUX
dpc-3332	113	3	remain	remain	VERB
dpc-3332	113	4	stable	stable	ADJ
dpc-3332	113	5	or	or	CCONJ
dpc-3332	113	6	may	may	AUX
dpc-3332	113	7	progress	progress	VERB
dpc-3332	113	8	to	to	ADP
dpc-3332	113	9	an	an	DET
dpc-3332	113	10	advanced	advanced	ADJ
dpc-3332	113	11	stage	stage	NOUN
dpc-3332	113	12	or	or	CCONJ
dpc-3332	113	13	a	a	DET
dpc-3332	113	14	sezary	sezary	ADJ
dpc-3332	113	15	syndrome	syndrome	NOUN
dpc-3332	113	16	.	.	PUNCT
dpc-3332	114	1	although	although	SCONJ
dpc-3332	114	2	the	the	DET
dpc-3332	114	3	disease	disease	NOUN
dpc-3332	114	4	progresses	progress	VERB
dpc-3332	114	5	with	with	ADP
dpc-3332	114	6	a	a	DET
dpc-3332	114	7	poor	poor	ADJ
dpc-3332	114	8	prognosis	prognosis	NOUN
dpc-3332	114	9	in	in	ADP
dpc-3332	114	10	advanced	advanced	ADJ
dpc-3332	114	11	stages	stage	NOUN
dpc-3332	114	12	,	,	PUNCT
dpc-3332	114	13	patients	patient	NOUN
dpc-3332	114	14	with	with	ADP
dpc-3332	114	15	mf	mf	PRON
dpc-3332	114	16	having	have	VERB
dpc-3332	114	17	t1	t1	NOUN
dpc-3332	114	18	stage	stage	NOUN
dpc-3332	114	19	have	have	VERB
dpc-3332	114	20	a	a	DET
dpc-3332	114	21	similar	similar	ADJ
dpc-3332	114	22	life	life	NOUN
dpc-3332	114	23	expectancy	expectancy	NOUN
dpc-3332	114	24	to	to	ADP
dpc-3332	114	25	that	that	PRON
dpc-3332	114	26	of	of	ADP
dpc-3332	114	27	control	control	NOUN
dpc-3332	114	28	populations	population	NOUN
dpc-3332	114	29	[	[	X
dpc-3332	114	30	2,17	2,17	X
dpc-3332	114	31	]	]	PUNCT
dpc-3332	114	32	.	.	PUNCT
dpc-3332	115	1	in	in	ADP
dpc-3332	115	2	addition	addition	NOUN
dpc-3332	115	3	,	,	PUNCT
dpc-3332	115	4	factors	factor	NOUN
dpc-3332	115	5	such	such	ADJ
dpc-3332	115	6	as	as	ADP
dpc-3332	115	7	male	male	ADJ
dpc-3332	115	8	gender	gender	NOUN
dpc-3332	115	9	,	,	PUNCT
dpc-3332	115	10	older	old	ADJ
dpc-3332	115	11	age	age	NOUN
dpc-3332	115	12	,	,	PUNCT
dpc-3332	115	13	histopathological	histopathological	ADJ
dpc-3332	115	14	type	type	NOUN
dpc-3332	115	15	(	(	PUNCT
dpc-3332	115	16	folliculotropic	folliculotropic	ADJ
dpc-3332	115	17	mf	mf	NOUN
dpc-3332	115	18	,	,	PUNCT
dpc-3332	115	19	poor	poor	ADJ
dpc-3332	115	20	prognostic	prognostic	NOUN
dpc-3332	115	21	)	)	PUNCT
dpc-3332	115	22	,	,	PUNCT
dpc-3332	115	23	large	large	ADJ
dpc-3332	115	24	cell	cell	NOUN
dpc-3332	115	25	transformation	transformation	NOUN
dpc-3332	115	26	,	,	PUNCT
dpc-3332	115	27	high	high	ADJ
dpc-3332	115	28	serum	serum	NOUN
dpc-3332	115	29	beta2	beta2	PROPN
dpc-3332	115	30	-	-	PUNCT
dpc-3332	115	31	microglobulin	microglobulin	PROPN
dpc-3332	115	32	and	and	CCONJ
dpc-3332	115	33	lactate	lactate	PROPN
dpc-3332	115	34	dehydrogenase	dehydrogenase	PROPN
dpc-3332	115	35	ldh	ldh	PROPN
dpc-3332	115	36	levels	level	NOUN
dpc-3332	115	37	,	,	PUNCT
dpc-3332	115	38	and	and	CCONJ
dpc-3332	115	39	peripheral	peripheral	ADJ
dpc-3332	115	40	eosinophilia	eosinophilia	NOUN
dpc-3332	115	41	have	have	AUX
dpc-3332	115	42	been	be	AUX
dpc-3332	115	43	shown	show	VERB
dpc-3332	115	44	to	to	PART
dpc-3332	115	45	be	be	AUX
dpc-3332	115	46	important	important	ADJ
dpc-3332	115	47	in	in	ADP
dpc-3332	115	48	prognosis	prognosis	NOUN
dpc-3332	115	49	.	.	PUNCT
dpc-3332	116	1	recently	recently	ADV
dpc-3332	116	2	,	,	PUNCT
dpc-3332	116	3	the	the	DET
dpc-3332	116	4	high	high	ADJ
dpc-3332	116	5	neutrophil	neutrophil	ADJ
dpc-3332	116	6	-	-	PUNCT
dpc-3332	116	7	lymphocyte	lymphocyte	NOUN
dpc-3332	116	8	ratio	ratio	NOUN
dpc-3332	116	9	has	have	AUX
dpc-3332	116	10	been	be	AUX
dpc-3332	116	11	added	add	VERB
dpc-3332	116	12	to	to	ADP
dpc-3332	116	13	this	this	DET
dpc-3332	116	14	list	list	NOUN
dpc-3332	116	15	[	[	X
dpc-3332	116	16	2,18,19	2,18,19	NUM
dpc-3332	116	17	]	]	PUNCT
dpc-3332	116	18	.	.	PUNCT
dpc-3332	117	1	our	our	PRON
dpc-3332	117	2	study	study	NOUN
dpc-3332	117	3	also	also	ADV
dpc-3332	117	4	confirmed	confirm	VERB
dpc-3332	117	5	previous	previous	ADJ
dpc-3332	117	6	findings	finding	NOUN
dpc-3332	117	7	and	and	CCONJ
dpc-3332	117	8	concluded	conclude	VERB
dpc-3332	117	9	that	that	SCONJ
dpc-3332	117	10	the	the	DET
dpc-3332	117	11	beta2	beta2	PROPN
dpc-3332	117	12	microglobulin	microglobulin	PROPN
dpc-3332	117	13	,	,	PUNCT
dpc-3332	117	14	sedimentation	sedimentation	NOUN
dpc-3332	117	15	and	and	CCONJ
dpc-3332	117	16	ldh	ldh	PROPN
dpc-3332	117	17	is	be	AUX
dpc-3332	117	18	associated	associate	VERB
dpc-3332	117	19	with	with	ADP
dpc-3332	117	20	a	a	DET
dpc-3332	117	21	poor	poor	ADJ
dpc-3332	117	22	prognosis	prognosis	NOUN
dpc-3332	117	23	[	[	X
dpc-3332	117	24	20	20	NUM
dpc-3332	117	25	]	]	PUNCT
dpc-3332	117	26	.	.	PUNCT
dpc-3332	118	1	anticipating	anticipate	VERB
dpc-3332	118	2	prognosis	prognosis	NOUN
dpc-3332	118	3	in	in	ADP
dpc-3332	118	4	patients	patient	NOUN
dpc-3332	118	5	may	may	AUX
dpc-3332	118	6	be	be	AUX
dpc-3332	118	7	important	important	ADJ
dpc-3332	118	8	in	in	ADP
dpc-3332	118	9	terms	term	NOUN
dpc-3332	118	10	of	of	ADP
dpc-3332	118	11	close	close	ADJ
dpc-3332	118	12	follow	follow	NOUN
dpc-3332	118	13	-	-	PUNCT
dpc-3332	118	14	up	up	NOUN
dpc-3332	118	15	of	of	ADP
dpc-3332	118	16	patients	patient	NOUN
dpc-3332	118	17	and	and	CCONJ
dpc-3332	118	18	therapies	therapy	NOUN
dpc-3332	118	19	to	to	PART
dpc-3332	118	20	be	be	AUX
dpc-3332	118	21	selected	select	VERB
dpc-3332	118	22	.	.	PUNCT
dpc-3332	119	1	crp	crp	PROPN
dpc-3332	119	2	is	be	AUX
dpc-3332	119	3	a	a	DET
dpc-3332	119	4	positive	positive	ADJ
dpc-3332	119	5	acute	acute	ADJ
dpc-3332	119	6	-	-	PUNCT
dpc-3332	119	7	phase	phase	NOUN
dpc-3332	119	8	reactant	reactant	NOUN
dpc-3332	119	9	secreted	secrete	VERB
dpc-3332	119	10	by	by	ADP
dpc-3332	119	11	the	the	DET
dpc-3332	119	12	liver	liver	NOUN
dpc-3332	119	13	during	during	ADP
dpc-3332	119	14	the	the	DET
dpc-3332	119	15	inflammatory	inflammatory	ADJ
dpc-3332	119	16	processes	process	NOUN
dpc-3332	119	17	.	.	PUNCT
dpc-3332	120	1	multiple	multiple	ADJ
dpc-3332	120	2	studies	study	NOUN
dpc-3332	120	3	have	have	AUX
dpc-3332	120	4	demonstrated	demonstrate	VERB
dpc-3332	120	5	that	that	SCONJ
dpc-3332	120	6	elevated	elevate	VERB
dpc-3332	120	7	serum	serum	NOUN
dpc-3332	120	8	crp	crp	PROPN
dpc-3332	120	9	levels	level	NOUN
dpc-3332	120	10	are	be	AUX
dpc-3332	120	11	associated	associate	VERB
dpc-3332	120	12	with	with	ADP
dpc-3332	120	13	a	a	DET
dpc-3332	120	14	poor	poor	ADJ
dpc-3332	120	15	prognosis	prognosis	NOUN
dpc-3332	120	16	for	for	ADP
dpc-3332	120	17	various	various	ADJ
dpc-3332	120	18	solid	solid	ADJ
dpc-3332	120	19	tumors	tumor	NOUN
dpc-3332	120	20	and	and	CCONJ
dpc-3332	120	21	lymphomas	lymphoma	NOUN
dpc-3332	120	22	[	[	PUNCT
dpc-3332	120	23	21	21	NUM
dpc-3332	120	24	-	-	SYM
dpc-3332	120	25	23	23	NUM
dpc-3332	120	26	]	]	PUNCT
dpc-3332	120	27	.	.	PUNCT
dpc-3332	121	1	we	we	PRON
dpc-3332	121	2	also	also	ADV
dpc-3332	121	3	found	find	VERB
dpc-3332	121	4	that	that	SCONJ
dpc-3332	121	5	crp	crp	PROPN
dpc-3332	121	6	levels	level	NOUN
dpc-3332	121	7	were	be	AUX
dpc-3332	121	8	significantly	significantly	ADV
dpc-3332	121	9	higher	high	ADJ
dpc-3332	121	10	in	in	ADP
dpc-3332	121	11	patients	patient	NOUN
dpc-3332	121	12	with	with	ADP
dpc-3332	121	13	mf	mf	NOUN
dpc-3332	121	14	than	than	ADP
dpc-3332	121	15	in	in	ADP
dpc-3332	121	16	the	the	DET
dpc-3332	121	17	control	control	NOUN
dpc-3332	121	18	group	group	NOUN
dpc-3332	121	19	.	.	PUNCT
dpc-3332	122	1	also	also	ADV
dpc-3332	122	2	,	,	PUNCT
dpc-3332	122	3	albumin	albumin	NOUN
dpc-3332	122	4	is	be	AUX
dpc-3332	122	5	a	a	DET
dpc-3332	122	6	negative	negative	ADJ
dpc-3332	122	7	acute	acute	ADJ
dpc-3332	122	8	-	-	PUNCT
dpc-3332	122	9	phase	phase	NOUN
dpc-3332	122	10	protein	protein	NOUN
dpc-3332	122	11	synthesized	synthesize	VERB
dpc-3332	122	12	by	by	ADP
dpc-3332	122	13	the	the	DET
dpc-3332	122	14	liver	liver	NOUN
dpc-3332	122	15	and	and	CCONJ
dpc-3332	122	16	reflects	reflect	VERB
dpc-3332	122	17	the	the	DET
dpc-3332	122	18	nutrition	nutrition	NOUN
dpc-3332	122	19	status	status	NOUN
dpc-3332	122	20	of	of	ADP
dpc-3332	122	21	the	the	DET
dpc-3332	122	22	host	host	NOUN
dpc-3332	122	23	.	.	PUNCT
dpc-3332	123	1	pretreatment	pretreatment	NOUN
dpc-3332	123	2	serum	serum	NOUN
dpc-3332	123	3	albumin	albumin	ADJ
dpc-3332	123	4	level	level	NOUN
dpc-3332	123	5	is	be	AUX
dpc-3332	123	6	a	a	DET
dpc-3332	123	7	known	know	VERB
dpc-3332	123	8	prognostic	prognostic	ADJ
dpc-3332	123	9	marker	marker	NOUN
dpc-3332	123	10	of	of	ADP
dpc-3332	123	11	several	several	ADJ
dpc-3332	123	12	solid	solid	ADJ
dpc-3332	123	13	malignancies	malignancy	NOUN
dpc-3332	123	14	and	and	CCONJ
dpc-3332	123	15	several	several	ADJ
dpc-3332	123	16	hematological	hematological	ADJ
dpc-3332	123	17	malignancies	malignancy	NOUN
dpc-3332	123	18	[	[	X
dpc-3332	123	19	24	24	NUM
dpc-3332	123	20	-	-	SYM
dpc-3332	123	21	26	26	NUM
dpc-3332	123	22	]	]	PUNCT
dpc-3332	123	23	.	.	PUNCT
dpc-3332	124	1	therefore	therefore	ADV
dpc-3332	124	2	,	,	PUNCT
dpc-3332	124	3	car	car	NOUN
dpc-3332	124	4	,	,	PUNCT
dpc-3332	124	5	a	a	DET
dpc-3332	124	6	combined	combined	ADJ
dpc-3332	124	7	model	model	NOUN
dpc-3332	124	8	of	of	ADP
dpc-3332	124	9	both	both	DET
dpc-3332	124	10	crp	crp	PROPN
dpc-3332	124	11	and	and	CCONJ
dpc-3332	124	12	albumin	albumin	NOUN
dpc-3332	124	13	,	,	PUNCT
dpc-3332	124	14	demonstrated	demonstrate	VERB
dpc-3332	124	15	the	the	DET
dpc-3332	124	16	outcome	outcome	NOUN
dpc-3332	124	17	of	of	ADP
dpc-3332	124	18	the	the	DET
dpc-3332	124	19	disease	disease	NOUN
dpc-3332	124	20	in	in	ADP
dpc-3332	124	21	some	some	DET
dpc-3332	124	22	diseases	disease	NOUN
dpc-3332	124	23	better	well	ADV
dpc-3332	124	24	than	than	ADP
dpc-3332	124	25	either	either	PRON
dpc-3332	124	26	would	would	AUX
dpc-3332	124	27	show	show	VERB
dpc-3332	124	28	individually	individually	ADV
dpc-3332	124	29	[	[	X
dpc-3332	124	30	5	5	NUM
dpc-3332	124	31	-	-	SYM
dpc-3332	124	32	11	11	NUM
dpc-3332	124	33	]	]	PUNCT
dpc-3332	124	34	.	.	PUNCT
dpc-3332	125	1	in	in	ADP
dpc-3332	125	2	addition	addition	NOUN
dpc-3332	125	3	the	the	DET
dpc-3332	125	4	usability	usability	NOUN
dpc-3332	125	5	of	of	ADP
dpc-3332	125	6	car	car	NOUN
dpc-3332	125	7	,	,	PUNCT
dpc-3332	125	8	an	an	DET
dpc-3332	125	9	inexpensive	inexpensive	ADJ
dpc-3332	125	10	parameter	parameter	NOUN
dpc-3332	125	11	that	that	PRON
dpc-3332	125	12	can	can	AUX
dpc-3332	125	13	be	be	AUX
dpc-3332	125	14	easily	easily	ADV
dpc-3332	125	15	calculated	calculate	VERB
dpc-3332	125	16	from	from	ADP
dpc-3332	125	17	the	the	DET
dpc-3332	125	18	biochemistry	biochemistry	NOUN
dpc-3332	125	19	profile	profile	NOUN
dpc-3332	125	20	,	,	PUNCT
dpc-3332	125	21	was	be	AUX
dpc-3332	125	22	evaluated	evaluate	VERB
dpc-3332	125	23	in	in	ADP
dpc-3332	125	24	our	our	PRON
dpc-3332	125	25	study	study	NOUN
dpc-3332	125	26	.	.	PUNCT
dpc-3332	126	1	in	in	ADP
dpc-3332	126	2	this	this	DET
dpc-3332	126	3	study	study	NOUN
dpc-3332	126	4	,	,	PUNCT
dpc-3332	126	5	we	we	PRON
dpc-3332	126	6	found	find	VERB
dpc-3332	126	7	the	the	DET
dpc-3332	126	8	median	median	ADJ
dpc-3332	126	9	car	car	NOUN
dpc-3332	126	10	value	value	NOUN
dpc-3332	126	11	significantly	significantly	ADV
dpc-3332	126	12	higher	higher	ADV
dpc-3332	126	13	in	in	ADP
dpc-3332	126	14	patients	patient	NOUN
dpc-3332	126	15	with	with	ADP
dpc-3332	126	16	mf	mf	NOUN
dpc-3332	126	17	than	than	ADP
dpc-3332	126	18	in	in	ADP
dpc-3332	126	19	the	the	DET
dpc-3332	126	20	control	control	NOUN
dpc-3332	126	21	group	group	NOUN
dpc-3332	126	22	.	.	PUNCT
dpc-3332	127	1	as	as	SCONJ
dpc-3332	127	2	we	we	PRON
dpc-3332	127	3	mentioned	mention	VERB
dpc-3332	127	4	before	before	ADV
dpc-3332	127	5	,	,	PUNCT
dpc-3332	127	6	it	it	PRON
dpc-3332	127	7	can	can	AUX
dpc-3332	127	8	take	take	VERB
dpc-3332	127	9	years	year	NOUN
dpc-3332	127	10	to	to	PART
dpc-3332	127	11	make	make	VERB
dpc-3332	127	12	a	a	DET
dpc-3332	127	13	definitive	definitive	ADJ
dpc-3332	127	14	diagnosis	diagnosis	NOUN
dpc-3332	127	15	of	of	ADP
dpc-3332	127	16	mf	mf	NOUN
dpc-3332	127	17	.	.	PUNCT
dpc-3332	128	1	we	we	PRON
dpc-3332	128	2	think	think	VERB
dpc-3332	128	3	that	that	SCONJ
dpc-3332	128	4	the	the	DET
dpc-3332	128	5	car	car	NOUN
dpc-3332	128	6	can	can	AUX
dpc-3332	128	7	be	be	AUX
dpc-3332	128	8	used	use	VERB
dpc-3332	128	9	as	as	ADP
dpc-3332	128	10	an	an	DET
dpc-3332	128	11	additional	additional	ADJ
dpc-3332	128	12	indicator	indicator	NOUN
dpc-3332	128	13	to	to	PART
dpc-3332	128	14	guide	guide	VERB
dpc-3332	128	15	us	we	PRON
dpc-3332	128	16	in	in	ADP
dpc-3332	128	17	the	the	DET
dpc-3332	128	18	direction	direction	NOUN
dpc-3332	128	19	of	of	ADP
dpc-3332	128	20	mf	mf	NOUN
dpc-3332	128	21	in	in	ADP
dpc-3332	128	22	patients	patient	NOUN
dpc-3332	128	23	with	with	ADP
dpc-3332	128	24	suspected	suspect	VERB
dpc-3332	128	25	mf	mf	NOUN
dpc-3332	128	26	.	.	PUNCT
dpc-3332	129	1	we	we	PRON
dpc-3332	129	2	suggest	suggest	VERB
dpc-3332	129	3	that	that	SCONJ
dpc-3332	129	4	in	in	ADP
dpc-3332	129	5	patients	patient	NOUN
dpc-3332	129	6	with	with	ADP
dpc-3332	129	7	suspected	suspect	VERB
dpc-3332	129	8	mf	mf	NOUN
dpc-3332	129	9	,	,	PUNCT
dpc-3332	129	10	those	those	PRON
dpc-3332	129	11	with	with	ADP
dpc-3332	129	12	high	high	ADJ
dpc-3332	129	13	car	car	NOUN
dpc-3332	129	14	should	should	AUX
dpc-3332	129	15	be	be	AUX
dpc-3332	129	16	followed	follow	VERB
dpc-3332	129	17	more	more	ADV
dpc-3332	129	18	closely	closely	ADV
dpc-3332	129	19	.	.	PUNCT
dpc-3332	130	1	since	since	SCONJ
dpc-3332	130	2	car	car	NOUN
dpc-3332	130	3	has	have	AUX
dpc-3332	130	4	been	be	AUX
dpc-3332	130	5	used	use	VERB
dpc-3332	130	6	as	as	ADP
dpc-3332	130	7	an	an	DET
dpc-3332	130	8	indicator	indicator	NOUN
dpc-3332	130	9	of	of	ADP
dpc-3332	130	10	inflammation	inflammation	NOUN
dpc-3332	130	11	,	,	PUNCT
dpc-3332	130	12	its	its	PRON
dpc-3332	130	13	use	use	NOUN
dpc-3332	130	14	in	in	ADP
dpc-3332	130	15	the	the	DET
dpc-3332	130	16	assessment	assessment	NOUN
dpc-3332	130	17	of	of	ADP
dpc-3332	130	18	severity	severity	NOUN
dpc-3332	130	19	and	and	CCONJ
dpc-3332	130	20	activity	activity	NOUN
dpc-3332	130	21	of	of	ADP
dpc-3332	130	22	diseases	disease	NOUN
dpc-3332	130	23	involving	involve	VERB
dpc-3332	130	24	the	the	DET
dpc-3332	130	25	skin	skin	NOUN
dpc-3332	130	26	such	such	ADJ
dpc-3332	130	27	as	as	ADP
dpc-3332	130	28	psoriasis	psoriasis	NOUN
dpc-3332	130	29	and	and	CCONJ
dpc-3332	130	30	behcet	behcet	NOUN
dpc-3332	130	31	disease	disease	NOUN
dpc-3332	130	32	.	.	PUNCT
dpc-3332	131	1	it	it	PRON
dpc-3332	131	2	has	have	AUX
dpc-3332	131	3	been	be	AUX
dpc-3332	131	4	shown	show	VERB
dpc-3332	131	5	that	that	SCONJ
dpc-3332	131	6	the	the	DET
dpc-3332	131	7	car	car	NOUN
dpc-3332	131	8	value	value	NOUN
dpc-3332	131	9	in	in	ADP
dpc-3332	131	10	psoriasis	psoriasis	NOUN
dpc-3332	131	11	patients	patient	NOUN
dpc-3332	131	12	decreased	decrease	VERB
dpc-3332	131	13	significantly	significantly	ADV
dpc-3332	131	14	after	after	ADP
dpc-3332	131	15	treatment	treatment	NOUN
dpc-3332	131	16	with	with	ADP
dpc-3332	131	17	a	a	DET
dpc-3332	131	18	biologic	biologic	ADJ
dpc-3332	131	19	agent	agent	NOUN
dpc-3332	131	20	.	.	PUNCT
dpc-3332	132	1	thus	thus	ADV
dpc-3332	132	2	,	,	PUNCT
dpc-3332	132	3	it	it	PRON
dpc-3332	132	4	has	have	AUX
dpc-3332	132	5	been	be	AUX
dpc-3332	132	6	shown	show	VERB
dpc-3332	132	7	that	that	DET
dpc-3332	132	8	car	car	NOUN
dpc-3332	132	9	can	can	AUX
dpc-3332	132	10	be	be	AUX
dpc-3332	132	11	a	a	DET
dpc-3332	132	12	good	good	ADJ
dpc-3332	132	13	indicator	indicator	NOUN
dpc-3332	132	14	original	original	ADJ
dpc-3332	132	15	article	article	NOUN
dpc-3332	132	16	|	|	ADV
dpc-3332	132	17	dermatol	dermatol	ADJ
dpc-3332	132	18	pract	pract	NOUN
dpc-3332	132	19	concept	concept	NOUN
dpc-3332	132	20	.	.	PUNCT
dpc-3332	133	1	2024;14(2):e2024097	2024;14(2):e2024097	NUM
dpc-3332	133	2	5	5	NUM
dpc-3332	133	3	of	of	ADP
dpc-3332	133	4	the	the	DET
dpc-3332	133	5	severity	severity	NOUN
dpc-3332	133	6	of	of	ADP
dpc-3332	133	7	systemic	systemic	ADJ
dpc-3332	133	8	inflammation	inflammation	NOUN
dpc-3332	133	9	in	in	ADP
dpc-3332	133	10	psoriasis	psoriasis	NOUN
dpc-3332	133	11	[	[	X
dpc-3332	133	12	8	8	NUM
dpc-3332	133	13	]	]	PUNCT
dpc-3332	133	14	.	.	PUNCT
dpc-3332	134	1	it	it	PRON
dpc-3332	134	2	has	have	AUX
dpc-3332	134	3	been	be	AUX
dpc-3332	134	4	shown	show	VERB
dpc-3332	134	5	that	that	SCONJ
dpc-3332	134	6	in	in	ADP
dpc-3332	134	7	patients	patient	NOUN
dpc-3332	134	8	with	with	ADP
dpc-3332	134	9	chronic	chronic	ADJ
dpc-3332	134	10	uveitis	uveitis	NOUN
dpc-3332	134	11	such	such	ADJ
dpc-3332	134	12	as	as	ADP
dpc-3332	134	13	behcet	behcet	NOUN
dpc-3332	134	14	disease	disease	NOUN
dpc-3332	134	15	,	,	PUNCT
dpc-3332	134	16	car	car	NOUN
dpc-3332	134	17	may	may	AUX
dpc-3332	134	18	be	be	AUX
dpc-3332	134	19	a	a	DET
dpc-3332	134	20	marker	marker	NOUN
dpc-3332	134	21	for	for	ADP
dpc-3332	134	22	acute	acute	ADJ
dpc-3332	134	23	uveitis	uveitis	NOUN
dpc-3332	134	24	.	.	PUNCT
dpc-3332	135	1	car	car	NOUN
dpc-3332	135	2	is	be	AUX
dpc-3332	135	3	an	an	DET
dpc-3332	135	4	important	important	ADJ
dpc-3332	135	5	parameter	parameter	NOUN
dpc-3332	135	6	in	in	ADP
dpc-3332	135	7	determining	determine	VERB
dpc-3332	135	8	the	the	DET
dpc-3332	135	9	activation	activation	NOUN
dpc-3332	135	10	of	of	ADP
dpc-3332	135	11	the	the	DET
dpc-3332	135	12	uveitis	uveitis	NOUN
dpc-3332	135	13	and	and	CCONJ
dpc-3332	135	14	correlated	correlate	VERB
dpc-3332	135	15	with	with	ADP
dpc-3332	135	16	the	the	DET
dpc-3332	135	17	severity	severity	NOUN
dpc-3332	135	18	of	of	ADP
dpc-3332	135	19	intraocular	intraocular	ADJ
dpc-3332	135	20	inflammation	inflammation	NOUN
dpc-3332	135	21	in	in	ADP
dpc-3332	135	22	uveitis	uveitis	NOUN
dpc-3332	135	23	[	[	X
dpc-3332	135	24	12,13	12,13	NUM
dpc-3332	135	25	]	]	PUNCT
dpc-3332	135	26	.	.	PUNCT
dpc-3332	136	1	the	the	DET
dpc-3332	136	2	prognostic	prognostic	ADJ
dpc-3332	136	3	value	value	NOUN
dpc-3332	136	4	of	of	ADP
dpc-3332	136	5	car	car	NOUN
dpc-3332	136	6	and	and	CCONJ
dpc-3332	136	7	its	its	PRON
dpc-3332	136	8	association	association	NOUN
dpc-3332	136	9	with	with	ADP
dpc-3332	136	10	the	the	DET
dpc-3332	136	11	advanced	advanced	ADJ
dpc-3332	136	12	tumor	tumor	NOUN
dpc-3332	136	13	have	have	AUX
dpc-3332	136	14	been	be	AUX
dpc-3332	136	15	established	establish	VERB
dpc-3332	136	16	quite	quite	ADV
dpc-3332	136	17	clearly	clearly	ADV
dpc-3332	136	18	in	in	ADP
dpc-3332	136	19	various	various	ADJ
dpc-3332	136	20	solid	solid	ADJ
dpc-3332	136	21	organ	organ	NOUN
dpc-3332	136	22	tumors	tumor	NOUN
dpc-3332	136	23	recently	recently	ADV
dpc-3332	136	24	.	.	PUNCT
dpc-3332	137	1	the	the	DET
dpc-3332	137	2	prognostic	prognostic	ADJ
dpc-3332	137	3	importance	importance	NOUN
dpc-3332	137	4	of	of	ADP
dpc-3332	137	5	car	car	NOUN
dpc-3332	137	6	value	value	NOUN
dpc-3332	137	7	in	in	ADP
dpc-3332	137	8	pancreatic	pancreatic	ADJ
dpc-3332	137	9	cancer	cancer	NOUN
dpc-3332	137	10	,	,	PUNCT
dpc-3332	137	11	which	which	PRON
dpc-3332	137	12	is	be	AUX
dpc-3332	137	13	one	one	NUM
dpc-3332	137	14	of	of	ADP
dpc-3332	137	15	the	the	DET
dpc-3332	137	16	cancers	cancer	NOUN
dpc-3332	137	17	with	with	ADP
dpc-3332	137	18	the	the	DET
dpc-3332	137	19	poor	poor	ADJ
dpc-3332	137	20	prognosis	prognosis	NOUN
dpc-3332	137	21	,	,	PUNCT
dpc-3332	137	22	has	have	AUX
dpc-3332	137	23	been	be	AUX
dpc-3332	137	24	investigated	investigate	VERB
dpc-3332	137	25	many	many	ADJ
dpc-3332	137	26	times	time	NOUN
dpc-3332	137	27	.	.	PUNCT
dpc-3332	138	1	it	it	PRON
dpc-3332	138	2	has	have	AUX
dpc-3332	138	3	been	be	AUX
dpc-3332	138	4	shown	show	VERB
dpc-3332	138	5	that	that	SCONJ
dpc-3332	138	6	the	the	DET
dpc-3332	138	7	car	car	NOUN
dpc-3332	138	8	value	value	NOUN
dpc-3332	138	9	increases	increase	NOUN
dpc-3332	138	10	in	in	ADP
dpc-3332	138	11	advanced	advanced	ADJ
dpc-3332	138	12	disease	disease	NOUN
dpc-3332	138	13	and	and	CCONJ
dpc-3332	138	14	it	it	PRON
dpc-3332	138	15	has	have	AUX
dpc-3332	138	16	been	be	AUX
dpc-3332	138	17	reported	report	VERB
dpc-3332	138	18	that	that	SCONJ
dpc-3332	138	19	the	the	DET
dpc-3332	138	20	car	car	NOUN
dpc-3332	138	21	value	value	NOUN
dpc-3332	138	22	is	be	AUX
dpc-3332	138	23	associated	associate	VERB
dpc-3332	138	24	with	with	ADP
dpc-3332	138	25	prognosis	prognosis	NOUN
dpc-3332	138	26	.	.	PUNCT
dpc-3332	139	1	the	the	DET
dpc-3332	139	2	car	car	NOUN
dpc-3332	139	3	value	value	NOUN
dpc-3332	139	4	is	be	AUX
dpc-3332	139	5	also	also	ADV
dpc-3332	139	6	shown	show	VERB
dpc-3332	139	7	to	to	PART
dpc-3332	139	8	be	be	AUX
dpc-3332	139	9	useful	useful	ADJ
dpc-3332	139	10	in	in	ADP
dpc-3332	139	11	monitoring	monitor	VERB
dpc-3332	139	12	the	the	DET
dpc-3332	139	13	effectiveness	effectiveness	NOUN
dpc-3332	139	14	of	of	ADP
dpc-3332	139	15	chemotherapy	chemotherapy	NOUN
dpc-3332	139	16	in	in	ADP
dpc-3332	139	17	pancreatic	pancreatic	ADJ
dpc-3332	139	18	cancer	cancer	NOUN
dpc-3332	140	1	[	[	X
dpc-3332	140	2	7,27	7,27	NUM
dpc-3332	140	3	-	-	SYM
dpc-3332	140	4	29	29	NUM
dpc-3332	140	5	]	]	PUNCT
dpc-3332	140	6	.	.	PUNCT
dpc-3332	141	1	in	in	ADP
dpc-3332	141	2	a	a	DET
dpc-3332	141	3	study	study	NOUN
dpc-3332	141	4	conducted	conduct	VERB
dpc-3332	141	5	in	in	ADP
dpc-3332	141	6	200	200	NUM
dpc-3332	141	7	patients	patient	NOUN
dpc-3332	141	8	with	with	ADP
dpc-3332	141	9	newly	newly	ADV
dpc-3332	141	10	diagnosed	diagnose	VERB
dpc-3332	141	11	non	non	ADJ
dpc-3332	141	12	-	-	ADJ
dpc-3332	141	13	metastatic	metastatic	ADJ
dpc-3332	141	14	breast	breast	NOUN
dpc-3332	141	15	cancer	cancer	NOUN
dpc-3332	141	16	,	,	PUNCT
dpc-3332	141	17	it	it	PRON
dpc-3332	141	18	was	be	AUX
dpc-3332	141	19	shown	show	VERB
dpc-3332	141	20	that	that	SCONJ
dpc-3332	141	21	increased	increase	VERB
dpc-3332	141	22	car	car	NOUN
dpc-3332	141	23	rate	rate	NOUN
dpc-3332	141	24	is	be	AUX
dpc-3332	141	25	associated	associate	VERB
dpc-3332	141	26	with	with	ADP
dpc-3332	141	27	a	a	DET
dpc-3332	141	28	high	high	ADJ
dpc-3332	141	29	risk	risk	NOUN
dpc-3332	141	30	of	of	ADP
dpc-3332	141	31	recurrence	recurrence	NOUN
dpc-3332	141	32	or	or	CCONJ
dpc-3332	141	33	death	death	NOUN
dpc-3332	141	34	in	in	ADP
dpc-3332	141	35	patients	patient	NOUN
dpc-3332	141	36	with	with	ADP
dpc-3332	141	37	breast	breast	NOUN
dpc-3332	141	38	cancer	cancer	NOUN
dpc-3332	141	39	.	.	PUNCT
dpc-3332	142	1	in	in	ADP
dpc-3332	142	2	addition	addition	NOUN
dpc-3332	142	3	,	,	PUNCT
dpc-3332	142	4	the	the	DET
dpc-3332	142	5	cut	cut	VERB
dpc-3332	142	6	-	-	PUNCT
dpc-3332	142	7	off	off	ADP
dpc-3332	142	8	value	value	NOUN
dpc-3332	142	9	was	be	AUX
dpc-3332	142	10	found	find	VERB
dpc-3332	142	11	to	to	PART
dpc-3332	142	12	be	be	AUX
dpc-3332	142	13	lower	low	ADJ
dpc-3332	142	14	in	in	ADP
dpc-3332	142	15	studies	study	NOUN
dpc-3332	142	16	conducted	conduct	VERB
dpc-3332	142	17	in	in	ADP
dpc-3332	142	18	breast	breast	NOUN
dpc-3332	142	19	cancer	cancer	NOUN
dpc-3332	142	20	compared	compare	VERB
dpc-3332	142	21	to	to	ADP
dpc-3332	142	22	studies	study	NOUN
dpc-3332	142	23	in	in	ADP
dpc-3332	142	24	other	other	ADJ
dpc-3332	142	25	malignancies	malignancy	NOUN
dpc-3332	142	26	.	.	PUNCT
dpc-3332	143	1	it	it	PRON
dpc-3332	143	2	was	be	AUX
dpc-3332	143	3	interpreted	interpret	VERB
dpc-3332	143	4	that	that	SCONJ
dpc-3332	143	5	the	the	DET
dpc-3332	143	6	cut	cut	VERB
dpc-3332	143	7	-	-	PUNCT
dpc-3332	143	8	off	off	ADP
dpc-3332	143	9	value	value	NOUN
dpc-3332	143	10	increased	increase	VERB
dpc-3332	143	11	as	as	SCONJ
dpc-3332	143	12	more	more	ADJ
dpc-3332	143	13	patients	patient	NOUN
dpc-3332	143	14	with	with	ADP
dpc-3332	143	15	advanced	advanced	ADJ
dpc-3332	143	16	disease	disease	NOUN
dpc-3332	143	17	were	be	AUX
dpc-3332	143	18	included	include	VERB
dpc-3332	143	19	in	in	ADP
dpc-3332	143	20	the	the	DET
dpc-3332	143	21	study	study	NOUN
dpc-3332	143	22	[	[	X
dpc-3332	143	23	30	30	NUM
dpc-3332	143	24	]	]	PUNCT
dpc-3332	143	25	.	.	PUNCT
dpc-3332	144	1	in	in	ADP
dpc-3332	144	2	another	another	DET
dpc-3332	144	3	study	study	NOUN
dpc-3332	144	4	,	,	PUNCT
dpc-3332	144	5	high	high	ADJ
dpc-3332	144	6	car	car	NOUN
dpc-3332	144	7	was	be	AUX
dpc-3332	144	8	significantly	significantly	ADV
dpc-3332	144	9	associated	associate	VERB
dpc-3332	144	10	with	with	ADP
dpc-3332	144	11	short	short	ADJ
dpc-3332	144	12	-	-	PUNCT
dpc-3332	144	13	term	term	NOUN
dpc-3332	144	14	survival	survival	NOUN
dpc-3332	144	15	prognosis	prognosis	NOUN
dpc-3332	144	16	of	of	ADP
dpc-3332	144	17	terminal	terminal	ADJ
dpc-3332	144	18	cancer	cancer	NOUN
dpc-3332	144	19	patients	patient	NOUN
dpc-3332	144	20	[	[	X
dpc-3332	144	21	31	31	NUM
dpc-3332	144	22	]	]	PUNCT
dpc-3332	144	23	.	.	PUNCT
dpc-3332	145	1	in	in	ADP
dpc-3332	145	2	a	a	DET
dpc-3332	145	3	study	study	NOUN
dpc-3332	145	4	in	in	ADP
dpc-3332	145	5	which	which	PRON
dpc-3332	145	6	192	192	NUM
dpc-3332	145	7	patients	patient	NOUN
dpc-3332	145	8	with	with	ADP
dpc-3332	145	9	acute	acute	ADJ
dpc-3332	145	10	pancreatitis	pancreatitis	PROPN
dpc-3332	145	11	were	be	AUX
dpc-3332	145	12	evaluated	evaluate	VERB
dpc-3332	145	13	;	;	PUNCT
dpc-3332	145	14	the	the	DET
dpc-3332	145	15	car	car	NOUN
dpc-3332	145	16	was	be	AUX
dpc-3332	145	17	found	find	VERB
dpc-3332	145	18	to	to	PART
dpc-3332	145	19	be	be	AUX
dpc-3332	145	20	the	the	DET
dpc-3332	145	21	prognostic	prognostic	ADJ
dpc-3332	145	22	score	score	NOUN
dpc-3332	145	23	in	in	ADP
dpc-3332	145	24	acute	acute	ADJ
dpc-3332	145	25	pancreatitis	pancreatitis	PROPN
dpc-3332	146	1	[	[	X
dpc-3332	146	2	9	9	NUM
dpc-3332	146	3	]	]	PUNCT
dpc-3332	146	4	.	.	PUNCT
dpc-3332	147	1	in	in	ADP
dpc-3332	147	2	our	our	PRON
dpc-3332	147	3	study	study	NOUN
dpc-3332	147	4	,	,	PUNCT
dpc-3332	147	5	there	there	PRON
dpc-3332	147	6	was	be	VERB
dpc-3332	147	7	no	no	DET
dpc-3332	147	8	association	association	NOUN
dpc-3332	147	9	with	with	ADP
dpc-3332	147	10	car	car	NOUN
dpc-3332	147	11	value	value	NOUN
dpc-3332	147	12	and	and	CCONJ
dpc-3332	147	13	prognosis	prognosis	NOUN
dpc-3332	147	14	.	.	PUNCT
dpc-3332	148	1	we	we	PRON
dpc-3332	148	2	compared	compare	VERB
dpc-3332	148	3	the	the	DET
dpc-3332	148	4	crp	crp	PROPN
dpc-3332	148	5	,	,	PUNCT
dpc-3332	148	6	albumin	albumin	NOUN
dpc-3332	148	7	,	,	PUNCT
dpc-3332	148	8	and	and	CCONJ
dpc-3332	148	9	car	car	NOUN
dpc-3332	148	10	values	value	NOUN
dpc-3332	148	11	with	with	ADP
dpc-3332	148	12	the	the	DET
dpc-3332	148	13	control	control	NOUN
dpc-3332	148	14	group	group	NOUN
dpc-3332	148	15	,	,	PUNCT
dpc-3332	148	16	we	we	PRON
dpc-3332	148	17	found	find	VERB
dpc-3332	148	18	a	a	DET
dpc-3332	148	19	significant	significant	ADJ
dpc-3332	148	20	difference	difference	NOUN
dpc-3332	148	21	in	in	ADP
dpc-3332	148	22	mf	mf	NOUN
dpc-3332	148	23	.	.	PUNCT
dpc-3332	149	1	but	but	CCONJ
dpc-3332	149	2	we	we	PRON
dpc-3332	149	3	did	do	AUX
dpc-3332	149	4	not	not	PART
dpc-3332	149	5	find	find	VERB
dpc-3332	149	6	any	any	PRON
dpc-3332	149	7	of	of	ADP
dpc-3332	149	8	the	the	DET
dpc-3332	149	9	crp	crp	PROPN
dpc-3332	149	10	,	,	PUNCT
dpc-3332	149	11	albumin	albumin	NOUN
dpc-3332	149	12	,	,	PUNCT
dpc-3332	149	13	and	and	CCONJ
dpc-3332	149	14	car	car	NOUN
dpc-3332	149	15	values	value	NOUN
dpc-3332	149	16	associated	associate	VERB
dpc-3332	149	17	with	with	ADP
dpc-3332	149	18	prognosis	prognosis	NOUN
dpc-3332	149	19	.	.	PUNCT
dpc-3332	150	1	it	it	PRON
dpc-3332	150	2	well	well	ADV
dpc-3332	150	3	known	know	VERB
dpc-3332	150	4	that	that	SCONJ
dpc-3332	150	5	the	the	DET
dpc-3332	150	6	prognosis	prognosis	NOUN
dpc-3332	150	7	of	of	ADP
dpc-3332	150	8	patients	patient	NOUN
dpc-3332	150	9	with	with	ADP
dpc-3332	150	10	cancer	cancer	NOUN
dpc-3332	150	11	is	be	AUX
dpc-3332	150	12	associated	associate	VERB
dpc-3332	150	13	with	with	ADP
dpc-3332	150	14	the	the	DET
dpc-3332	150	15	clinical	clinical	ADJ
dpc-3332	150	16	stage	stage	NOUN
dpc-3332	150	17	of	of	ADP
dpc-3332	150	18	cancer	cancer	NOUN
dpc-3332	150	19	.	.	PUNCT
dpc-3332	151	1	mf	mf	PROPN
dpc-3332	151	2	is	be	AUX
dpc-3332	151	3	t	t	NOUN
dpc-3332	151	4	-	-	PUNCT
dpc-3332	151	5	cell	cell	NOUN
dpc-3332	151	6	skin	skin	NOUN
dpc-3332	151	7	lymphoma	lymphoma	NOUN
dpc-3332	151	8	.	.	PUNCT
dpc-3332	152	1	the	the	DET
dpc-3332	152	2	prognosis	prognosis	NOUN
dpc-3332	152	3	is	be	AUX
dpc-3332	152	4	good	good	ADJ
dpc-3332	152	5	unless	unless	SCONJ
dpc-3332	152	6	there	there	PRON
dpc-3332	152	7	is	be	VERB
dpc-3332	152	8	systemic	systemic	ADJ
dpc-3332	152	9	involvement	involvement	NOUN
dpc-3332	152	10	.	.	PUNCT
dpc-3332	153	1	especially	especially	ADV
dpc-3332	153	2	distant	distant	ADJ
dpc-3332	153	3	metastases	metastasis	NOUN
dpc-3332	153	4	and	and	CCONJ
dpc-3332	153	5	the	the	DET
dpc-3332	153	6	development	development	NOUN
dpc-3332	153	7	of	of	ADP
dpc-3332	153	8	sezary	sezary	ADJ
dpc-3332	153	9	syndrome	syndrome	NOUN
dpc-3332	153	10	(	(	PUNCT
dpc-3332	153	11	advanced	advanced	ADJ
dpc-3332	153	12	stage	stage	NOUN
dpc-3332	153	13	disease	disease	NOUN
dpc-3332	153	14	)	)	PUNCT
dpc-3332	153	15	are	be	AUX
dpc-3332	153	16	the	the	DET
dpc-3332	153	17	main	main	ADJ
dpc-3332	153	18	reasons	reason	NOUN
dpc-3332	153	19	that	that	PRON
dpc-3332	153	20	shorten	shorten	VERB
dpc-3332	153	21	the	the	DET
dpc-3332	153	22	life	life	NOUN
dpc-3332	153	23	span	span	NOUN
dpc-3332	153	24	.	.	PUNCT
dpc-3332	154	1	only	only	ADV
dpc-3332	154	2	one	one	NUM
dpc-3332	154	3	of	of	ADP
dpc-3332	154	4	our	our	PRON
dpc-3332	154	5	patients	patient	NOUN
dpc-3332	154	6	had	have	VERB
dpc-3332	154	7	sezary	sezary	ADJ
dpc-3332	154	8	syndrome	syndrome	NOUN
dpc-3332	154	9	,	,	PUNCT
dpc-3332	154	10	and	and	CCONJ
dpc-3332	154	11	one	one	NUM
dpc-3332	154	12	had	have	VERB
dpc-3332	154	13	n2	n2	ADJ
dpc-3332	154	14	lymph	lymph	NOUN
dpc-3332	154	15	node	node	NOUN
dpc-3332	154	16	involvement	involvement	NOUN
dpc-3332	154	17	.	.	PUNCT
dpc-3332	155	1	systemic	systemic	ADJ
dpc-3332	155	2	metastasis	metastasis	NOUN
dpc-3332	155	3	was	be	AUX
dpc-3332	155	4	not	not	PART
dpc-3332	155	5	observed	observe	VERB
dpc-3332	155	6	in	in	ADP
dpc-3332	155	7	any	any	PRON
dpc-3332	155	8	of	of	ADP
dpc-3332	155	9	the	the	DET
dpc-3332	155	10	patients	patient	NOUN
dpc-3332	155	11	.	.	PUNCT
dpc-3332	156	1	while	while	SCONJ
dpc-3332	156	2	designing	design	VERB
dpc-3332	156	3	the	the	DET
dpc-3332	156	4	study	study	NOUN
dpc-3332	156	5	,	,	PUNCT
dpc-3332	156	6	we	we	PRON
dpc-3332	156	7	also	also	ADV
dpc-3332	156	8	considered	consider	VERB
dpc-3332	156	9	tumor	tumor	NOUN
dpc-3332	156	10	development	development	NOUN
dpc-3332	156	11	and	and	CCONJ
dpc-3332	156	12	transition	transition	NOUN
dpc-3332	156	13	to	to	ADP
dpc-3332	156	14	advanced	advanced	ADJ
dpc-3332	156	15	stages	stage	NOUN
dpc-3332	156	16	as	as	ADP
dpc-3332	156	17	poor	poor	ADJ
dpc-3332	156	18	prognosis	prognosis	NOUN
dpc-3332	156	19	.	.	PUNCT
dpc-3332	157	1	however	however	ADV
dpc-3332	157	2	,	,	PUNCT
dpc-3332	157	3	while	while	SCONJ
dpc-3332	157	4	tumor	tumor	NOUN
dpc-3332	157	5	development	development	NOUN
dpc-3332	157	6	detected	detect	VERB
dpc-3332	157	7	15	15	NUM
dpc-3332	157	8	%	%	NOUN
dpc-3332	157	9	of	of	ADP
dpc-3332	157	10	our	our	PRON
dpc-3332	157	11	patients	patient	NOUN
dpc-3332	157	12	,	,	PUNCT
dpc-3332	157	13	none	none	NOUN
dpc-3332	157	14	of	of	ADP
dpc-3332	157	15	these	these	DET
dpc-3332	157	16	patients	patient	NOUN
dpc-3332	157	17	progressed	progress	VERB
dpc-3332	157	18	to	to	PART
dpc-3332	157	19	stage	stage	VERB
dpc-3332	157	20	4	4	NUM
dpc-3332	157	21	,	,	PUNCT
dpc-3332	157	22	which	which	PRON
dpc-3332	157	23	is	be	AUX
dpc-3332	157	24	systemic	systemic	ADJ
dpc-3332	157	25	involvement	involvement	NOUN
dpc-3332	157	26	.	.	PUNCT
dpc-3332	158	1	also	also	ADV
dpc-3332	158	2	in	in	ADP
dpc-3332	158	3	a	a	DET
dpc-3332	158	4	study	study	NOUN
dpc-3332	158	5	conducted	conduct	VERB
dpc-3332	158	6	in	in	ADP
dpc-3332	158	7	patients	patient	NOUN
dpc-3332	158	8	with	with	ADP
dpc-3332	158	9	pancreatic	pancreatic	ADJ
dpc-3332	158	10	cancer	cancer	NOUN
dpc-3332	158	11	,	,	PUNCT
dpc-3332	158	12	it	it	PRON
dpc-3332	158	13	was	be	AUX
dpc-3332	158	14	shown	show	VERB
dpc-3332	158	15	that	that	SCONJ
dpc-3332	158	16	car	car	NOUN
dpc-3332	158	17	has	have	VERB
dpc-3332	158	18	prognostic	prognostic	ADJ
dpc-3332	158	19	importance	importance	NOUN
dpc-3332	158	20	only	only	ADV
dpc-3332	158	21	in	in	ADP
dpc-3332	158	22	stage	stage	NOUN
dpc-3332	158	23	3	3	NUM
dpc-3332	158	24	-	-	SYM
dpc-3332	158	25	4	4	NUM
dpc-3332	158	26	(	(	PUNCT
dpc-3332	158	27	advanced	advanced	ADJ
dpc-3332	158	28	stage	stage	NOUN
dpc-3332	158	29	)	)	PUNCT
dpc-3332	158	30	patients	patient	NOUN
dpc-3332	158	31	[	[	X
dpc-3332	158	32	27	27	NUM
dpc-3332	158	33	]	]	PUNCT
dpc-3332	158	34	.	.	PUNCT
dpc-3332	159	1	these	these	DET
dpc-3332	159	2	reasons	reason	NOUN
dpc-3332	159	3	may	may	AUX
dpc-3332	159	4	have	have	AUX
dpc-3332	159	5	caused	cause	VERB
dpc-3332	159	6	that	that	SCONJ
dpc-3332	159	7	crp	crp	PROPN
dpc-3332	159	8	,	,	PUNCT
dpc-3332	159	9	albumin	albumin	NOUN
dpc-3332	159	10	,	,	PUNCT
dpc-3332	159	11	and	and	CCONJ
dpc-3332	159	12	car	car	NOUN
dpc-3332	159	13	values	value	NOUN
dpc-3332	159	14	were	be	AUX
dpc-3332	159	15	not	not	PART
dpc-3332	159	16	related	relate	VERB
dpc-3332	159	17	to	to	PART
dpc-3332	159	18	prognosis	prognosis	NOUN
dpc-3332	159	19	in	in	ADP
dpc-3332	159	20	mf	mf	X
dpc-3332	159	21	.	.	PUNCT
dpc-3332	160	1	there	there	PRON
dpc-3332	160	2	were	be	VERB
dpc-3332	160	3	several	several	ADJ
dpc-3332	160	4	limitations	limitation	NOUN
dpc-3332	160	5	to	to	ADP
dpc-3332	160	6	our	our	PRON
dpc-3332	160	7	study	study	NOUN
dpc-3332	160	8	.	.	PUNCT
dpc-3332	161	1	possible	possible	ADJ
dpc-3332	161	2	missing	miss	VERB
dpc-3332	161	3	data	datum	NOUN
dpc-3332	161	4	due	due	ADJ
dpc-3332	161	5	to	to	ADP
dpc-3332	161	6	being	be	AUX
dpc-3332	161	7	a	a	DET
dpc-3332	161	8	retrospective	retrospective	ADJ
dpc-3332	161	9	study	study	NOUN
dpc-3332	161	10	.	.	PUNCT
dpc-3332	162	1	the	the	DET
dpc-3332	162	2	collection	collection	NOUN
dpc-3332	162	3	of	of	ADP
dpc-3332	162	4	variables	variable	NOUN
dpc-3332	162	5	from	from	ADP
dpc-3332	162	6	a	a	DET
dpc-3332	162	7	small	small	ADJ
dpc-3332	162	8	group	group	NOUN
dpc-3332	162	9	of	of	ADP
dpc-3332	162	10	patients	patient	NOUN
dpc-3332	162	11	at	at	ADP
dpc-3332	162	12	a	a	DET
dpc-3332	162	13	single	single	ADJ
dpc-3332	162	14	center	center	NOUN
dpc-3332	162	15	makes	make	VERB
dpc-3332	162	16	it	it	PRON
dpc-3332	162	17	difficult	difficult	ADJ
dpc-3332	162	18	to	to	PART
dpc-3332	162	19	generalize	generalize	VERB
dpc-3332	162	20	these	these	DET
dpc-3332	162	21	results	result	NOUN
dpc-3332	162	22	to	to	ADP
dpc-3332	162	23	the	the	DET
dpc-3332	162	24	general	general	ADJ
dpc-3332	162	25	population	population	NOUN
dpc-3332	162	26	.	.	PUNCT
dpc-3332	163	1	in	in	ADP
dpc-3332	163	2	our	our	PRON
dpc-3332	163	3	study	study	NOUN
dpc-3332	163	4	,	,	PUNCT
dpc-3332	163	5	the	the	DET
dpc-3332	163	6	number	number	NOUN
dpc-3332	163	7	of	of	ADP
dpc-3332	163	8	patients	patient	NOUN
dpc-3332	163	9	classified	classify	VERB
dpc-3332	163	10	as	as	SCONJ
dpc-3332	163	11	iia	iia	PROPN
dpc-3332	163	12	is	be	AUX
dpc-3332	163	13	higher	high	ADJ
dpc-3332	163	14	.	.	PUNCT
dpc-3332	164	1	most	most	ADJ
dpc-3332	164	2	stage	stage	NOUN
dpc-3332	164	3	i	i	PRON
dpc-3332	164	4	patients	patient	NOUN
dpc-3332	164	5	can	can	AUX
dpc-3332	164	6	be	be	AUX
dpc-3332	164	7	followed	follow	VERB
dpc-3332	164	8	up	up	ADP
dpc-3332	164	9	in	in	ADP
dpc-3332	164	10	external	external	ADJ
dpc-3332	164	11	centres	centre	NOUN
dpc-3332	164	12	with	with	ADP
dpc-3332	164	13	other	other	ADJ
dpc-3332	164	14	diagnoses	diagnosis	NOUN
dpc-3332	164	15	due	due	ADP
dpc-3332	164	16	to	to	ADP
dpc-3332	164	17	diagnostic	diagnostic	ADJ
dpc-3332	164	18	difficulties	difficulty	NOUN
dpc-3332	164	19	.	.	PUNCT
dpc-3332	165	1	since	since	SCONJ
dpc-3332	165	2	the	the	DET
dpc-3332	165	3	possibility	possibility	NOUN
dpc-3332	165	4	of	of	ADP
dpc-3332	165	5	systemic	systemic	ADJ
dpc-3332	165	6	involvement	involvement	NOUN
dpc-3332	165	7	is	be	AUX
dpc-3332	165	8	low	low	ADJ
dpc-3332	165	9	in	in	ADP
dpc-3332	165	10	stage	stage	NOUN
dpc-3332	165	11	i	i	PRON
dpc-3332	165	12	disease	disease	VERB
dpc-3332	165	13	,	,	PUNCT
dpc-3332	165	14	they	they	PRON
dpc-3332	165	15	can	can	AUX
dpc-3332	165	16	be	be	AUX
dpc-3332	165	17	followed	follow	VERB
dpc-3332	165	18	up	up	ADP
dpc-3332	165	19	by	by	ADP
dpc-3332	165	20	physicians	physician	NOUN
dpc-3332	165	21	in	in	ADP
dpc-3332	165	22	secondary	secondary	ADJ
dpc-3332	165	23	care	care	NOUN
dpc-3332	165	24	hospitals	hospital	NOUN
dpc-3332	165	25	.	.	PUNCT
dpc-3332	166	1	since	since	SCONJ
dpc-3332	166	2	our	our	PRON
dpc-3332	166	3	center	center	NOUN
dpc-3332	166	4	is	be	AUX
dpc-3332	166	5	a	a	DET
dpc-3332	166	6	3rd	3rd	ADJ
dpc-3332	166	7	step	step	NOUN
dpc-3332	166	8	treatment	treatment	NOUN
dpc-3332	166	9	center	center	NOUN
dpc-3332	166	10	,	,	PUNCT
dpc-3332	166	11	there	there	PRON
dpc-3332	166	12	are	be	VERB
dpc-3332	166	13	few	few	ADJ
dpc-3332	166	14	stage	stage	NOUN
dpc-3332	166	15	i	i	PRON
dpc-3332	166	16	patients	patient	NOUN
dpc-3332	166	17	.	.	PUNCT
dpc-3332	167	1	stage	stage	NOUN
dpc-3332	167	2	iii	iii	NUM
dpc-3332	167	3	disease	disease	NOUN
dpc-3332	167	4	is	be	AUX
dpc-3332	167	5	a	a	DET
dpc-3332	167	6	rare	rare	ADJ
dpc-3332	167	7	stage	stage	NOUN
dpc-3332	167	8	.	.	PUNCT
dpc-3332	168	1	therefore	therefore	ADV
dpc-3332	168	2	,	,	PUNCT
dpc-3332	168	3	there	there	PRON
dpc-3332	168	4	are	be	VERB
dpc-3332	168	5	few	few	ADJ
dpc-3332	168	6	erythrodermic	erythrodermic	ADJ
dpc-3332	168	7	patients	patient	NOUN
dpc-3332	168	8	in	in	ADP
dpc-3332	168	9	our	our	PRON
dpc-3332	168	10	study	study	NOUN
dpc-3332	168	11	group	group	NOUN
dpc-3332	168	12	.	.	PUNCT
dpc-3332	169	1	stage	stage	NOUN
dpc-3332	169	2	iv	iv	NUM
dpc-3332	169	3	patients	patient	NOUN
dpc-3332	169	4	are	be	AUX
dpc-3332	169	5	followed	follow	VERB
dpc-3332	169	6	up	up	ADP
dpc-3332	169	7	by	by	ADP
dpc-3332	169	8	hematology	hematology	NOUN
dpc-3332	169	9	because	because	SCONJ
dpc-3332	169	10	they	they	PRON
dpc-3332	169	11	represent	represent	VERB
dpc-3332	169	12	advanced	advanced	ADJ
dpc-3332	169	13	stage	stage	NOUN
dpc-3332	169	14	and	and	CCONJ
dpc-3332	169	15	metastatic	metastatic	ADJ
dpc-3332	169	16	patient	patient	NOUN
dpc-3332	169	17	group	group	NOUN
dpc-3332	169	18	.	.	PUNCT
dpc-3332	170	1	however	however	ADV
dpc-3332	170	2	,	,	PUNCT
dpc-3332	170	3	this	this	PRON
dpc-3332	170	4	does	do	AUX
dpc-3332	170	5	not	not	PART
dpc-3332	170	6	reduce	reduce	VERB
dpc-3332	170	7	the	the	DET
dpc-3332	170	8	reliability	reliability	NOUN
dpc-3332	170	9	of	of	ADP
dpc-3332	170	10	our	our	PRON
dpc-3332	170	11	study	study	NOUN
dpc-3332	170	12	.	.	PUNCT
dpc-3332	171	1	as	as	SCONJ
dpc-3332	171	2	it	it	PRON
dpc-3332	171	3	is	be	AUX
dpc-3332	171	4	known	know	VERB
dpc-3332	171	5	,	,	PUNCT
dpc-3332	171	6	only	only	ADV
dpc-3332	171	7	skin	skin	NOUN
dpc-3332	171	8	involvement	involvement	NOUN
dpc-3332	171	9	occurs	occur	VERB
dpc-3332	171	10	in	in	ADP
dpc-3332	171	11	stage	stage	NOUN
dpc-3332	171	12	i	i	PRON
dpc-3332	171	13	disease	disease	VERB
dpc-3332	171	14	.	.	PUNCT
dpc-3332	172	1	in	in	ADP
dpc-3332	172	2	a	a	DET
dpc-3332	172	3	disease	disease	NOUN
dpc-3332	172	4	that	that	PRON
dpc-3332	172	5	is	be	AUX
dpc-3332	172	6	very	very	ADV
dpc-3332	172	7	difficult	difficult	ADJ
dpc-3332	172	8	to	to	PART
dpc-3332	172	9	diagnose	diagnose	VERB
dpc-3332	172	10	in	in	ADP
dpc-3332	172	11	the	the	DET
dpc-3332	172	12	early	early	ADJ
dpc-3332	172	13	stage	stage	NOUN
dpc-3332	172	14	,	,	PUNCT
dpc-3332	172	15	elevated	elevated	ADJ
dpc-3332	172	16	systemic	systemic	ADJ
dpc-3332	172	17	markers	marker	NOUN
dpc-3332	172	18	are	be	AUX
dpc-3332	172	19	not	not	PART
dpc-3332	172	20	expected	expect	VERB
dpc-3332	172	21	because	because	SCONJ
dpc-3332	172	22	systemic	systemic	ADJ
dpc-3332	172	23	involvement	involvement	NOUN
dpc-3332	172	24	is	be	AUX
dpc-3332	172	25	not	not	PART
dpc-3332	172	26	common	common	ADJ
dpc-3332	172	27	.	.	PUNCT
dpc-3332	173	1	additional	additional	ADJ
dpc-3332	173	2	prospective	prospective	ADJ
dpc-3332	173	3	studies	study	NOUN
dpc-3332	173	4	with	with	ADP
dpc-3332	173	5	larger	large	ADJ
dpc-3332	173	6	patient	patient	ADJ
dpc-3332	173	7	populations	population	NOUN
dpc-3332	173	8	and	and	CCONJ
dpc-3332	173	9	with	with	ADP
dpc-3332	173	10	a	a	DET
dpc-3332	173	11	predominance	predominance	NOUN
dpc-3332	173	12	of	of	ADP
dpc-3332	173	13	advanced	advanced	ADJ
dpc-3332	173	14	-	-	PUNCT
dpc-3332	173	15	stage	stage	NOUN
dpc-3332	173	16	patients	patient	NOUN
dpc-3332	173	17	,	,	PUNCT
dpc-3332	173	18	involving	involve	VERB
dpc-3332	173	19	multiple	multiple	ADJ
dpc-3332	173	20	centers	center	NOUN
dpc-3332	173	21	are	be	AUX
dpc-3332	173	22	required	require	VERB
dpc-3332	173	23	to	to	PART
dpc-3332	173	24	evaluate	evaluate	VERB
dpc-3332	173	25	the	the	DET
dpc-3332	173	26	car	car	NOUN
dpc-3332	173	27	as	as	ADP
dpc-3332	173	28	a	a	DET
dpc-3332	173	29	prognostic	prognostic	ADJ
dpc-3332	173	30	predictor	predictor	NOUN
dpc-3332	173	31	.	.	PUNCT
dpc-3332	174	1	although	although	SCONJ
dpc-3332	174	2	car	car	NOUN
dpc-3332	174	3	has	have	AUX
dpc-3332	174	4	been	be	AUX
dpc-3332	174	5	demonstrated	demonstrate	VERB
dpc-3332	174	6	to	to	PART
dpc-3332	174	7	have	have	VERB
dpc-3332	174	8	a	a	DET
dpc-3332	174	9	prognostic	prognostic	ADJ
dpc-3332	174	10	role	role	NOUN
dpc-3332	174	11	in	in	ADP
dpc-3332	174	12	various	various	ADJ
dpc-3332	174	13	solid	solid	ADJ
dpc-3332	174	14	malignancies	malignancy	NOUN
dpc-3332	174	15	and	and	CCONJ
dpc-3332	174	16	inflammatory	inflammatory	ADJ
dpc-3332	174	17	diseases	disease	NOUN
dpc-3332	174	18	,	,	PUNCT
dpc-3332	174	19	it	it	PRON
dpc-3332	174	20	seems	seem	VERB
dpc-3332	174	21	that	that	SCONJ
dpc-3332	174	22	there	there	PRON
dpc-3332	174	23	is	be	VERB
dpc-3332	174	24	no	no	DET
dpc-3332	174	25	association	association	NOUN
dpc-3332	174	26	between	between	ADP
dpc-3332	174	27	the	the	DET
dpc-3332	174	28	car	car	NOUN
dpc-3332	174	29	and	and	CCONJ
dpc-3332	174	30	progression	progression	NOUN
dpc-3332	174	31	in	in	ADP
dpc-3332	174	32	stage	stage	NOUN
dpc-3332	174	33	in	in	ADP
dpc-3332	174	34	mf	mf	NOUN
dpc-3332	174	35	patients	patient	NOUN
dpc-3332	174	36	.	.	PUNCT
dpc-3332	175	1	but	but	CCONJ
dpc-3332	175	2	the	the	DET
dpc-3332	175	3	car	car	NOUN
dpc-3332	175	4	is	be	AUX
dpc-3332	175	5	significantly	significantly	ADV
dpc-3332	175	6	higher	high	ADJ
dpc-3332	175	7	in	in	ADP
dpc-3332	175	8	patients	patient	NOUN
dpc-3332	175	9	with	with	ADP
dpc-3332	175	10	mf	mf	NOUN
dpc-3332	175	11	than	than	ADP
dpc-3332	175	12	in	in	ADP
dpc-3332	175	13	the	the	DET
dpc-3332	175	14	control	control	NOUN
dpc-3332	175	15	group	group	NOUN
dpc-3332	175	16	.	.	PUNCT
dpc-3332	176	1	the	the	DET
dpc-3332	176	2	car	car	NOUN
dpc-3332	176	3	can	can	AUX
dpc-3332	176	4	be	be	AUX
dpc-3332	176	5	a	a	DET
dpc-3332	176	6	guide	guide	NOUN
dpc-3332	176	7	for	for	ADP
dpc-3332	176	8	us	we	PRON
dpc-3332	176	9	in	in	ADP
dpc-3332	176	10	cases	case	NOUN
dpc-3332	176	11	where	where	SCONJ
dpc-3332	176	12	we	we	PRON
dpc-3332	176	13	have	have	VERB
dpc-3332	176	14	difficulty	difficulty	NOUN
dpc-3332	176	15	in	in	ADP
dpc-3332	176	16	diagnosing	diagnose	VERB
dpc-3332	176	17	.	.	PUNCT
dpc-3332	177	1	references	reference	NOUN
dpc-3332	177	2	1	1	NUM
dpc-3332	177	3	.	.	PUNCT
dpc-3332	178	1	hodak	hodak	PROPN
dpc-3332	178	2	e	e	NOUN
dpc-3332	178	3	,	,	PUNCT
dpc-3332	178	4	amitay	amitay	ADJ
dpc-3332	178	5	-	-	PUNCT
dpc-3332	178	6	laish	laish	PROPN
dpc-3332	178	7	i.	i.	NOUN
dpc-3332	178	8	mycosis	mycosis	PROPN
dpc-3332	178	9	fungoides	fungoide	VERB
dpc-3332	178	10	:	:	PUNCT
dpc-3332	178	11	a	a	DET
dpc-3332	178	12	great	great	ADJ
dpc-3332	178	13	imitator	imitator	NOUN
dpc-3332	178	14	.	.	PUNCT
dpc-3332	179	1	clin	clin	PROPN
dpc-3332	179	2	dermatol	dermatol	NOUN
dpc-3332	179	3	.	.	PUNCT
dpc-3332	180	1	2019;37(3):255	2019;37(3):255	NUM
dpc-3332	180	2	-	-	SYM
dpc-3332	180	3	267	267	NUM
dpc-3332	180	4	.	.	PUNCT
dpc-3332	181	1	doi	doi	NOUN
dpc-3332	181	2	:	:	PUNCT
dpc-3332	181	3	10.1016	10.1016	NUM
dpc-3332	181	4	/	/	SYM
dpc-3332	181	5	j.clindermatol	j.clindermatol	X
dpc-3332	181	6	.2019.01.004	.2019.01.004	NOUN
dpc-3332	181	7	.	.	PUNCT
dpc-3332	182	1	pmid	pmid	NOUN
dpc-3332	182	2	:	:	PUNCT
dpc-3332	182	3	31178107	31178107	NUM
dpc-3332	182	4	.	.	PUNCT
dpc-3332	183	1	2	2	NUM
dpc-3332	183	2	.	.	X
dpc-3332	183	3	maguire	maguire	PROPN
dpc-3332	183	4	a	a	PROPN
dpc-3332	183	5	,	,	PUNCT
dpc-3332	183	6	puelles	puelles	PROPN
dpc-3332	183	7	j	j	PROPN
dpc-3332	183	8	,	,	PUNCT
dpc-3332	183	9	raboisson	raboisson	NOUN
dpc-3332	183	10	p	p	NOUN
dpc-3332	183	11	,	,	PUNCT
dpc-3332	183	12	chavda	chavda	NOUN
dpc-3332	183	13	r	r	NOUN
dpc-3332	183	14	,	,	PUNCT
dpc-3332	183	15	gabriel	gabriel	PROPN
dpc-3332	183	16	s	s	PROPN
dpc-3332	183	17	,	,	PUNCT
dpc-3332	183	18	thornton	thornton	PROPN
dpc-3332	183	19	s.	s.	PROPN
dpc-3332	183	20	early	early	ADJ
dpc-3332	183	21	-	-	PUNCT
dpc-3332	183	22	stage	stage	NOUN
dpc-3332	183	23	mycosis	mycosis	NOUN
dpc-3332	183	24	fungoides	fungoide	VERB
dpc-3332	183	25	:	:	PUNCT
dpc-3332	183	26	epidemiology	epidemiology	NOUN
dpc-3332	183	27	and	and	CCONJ
dpc-3332	183	28	prognosis	prognosis	NOUN
dpc-3332	183	29	.	.	PUNCT
dpc-3332	184	1	acta	acta	PROPN
dpc-3332	184	2	derm	derm	PROPN
dpc-3332	184	3	venereol	venereol	NOUN
dpc-3332	184	4	.	.	PUNCT
dpc-3332	185	1	2020;100(1):adv00013	2020;100(1):adv00013	X
dpc-3332	185	2	.	.	PUNCT
dpc-3332	185	3	doi	doi	NOUN
dpc-3332	185	4	:	:	PUNCT
dpc-3332	185	5	10.2340/00015555	10.2340/00015555	NUM
dpc-3332	185	6	-	-	SYM
dpc-3332	185	7	3367	3367	NUM
dpc-3332	185	8	.	.	PUNCT
dpc-3332	186	1	pmid	pmid	NOUN
dpc-3332	186	2	:	:	PUNCT
dpc-3332	186	3	31663598	31663598	NUM
dpc-3332	186	4	.	.	PUNCT
dpc-3332	187	1	pmcid	pmcid	NOUN
dpc-3332	187	2	:	:	PUNCT
dpc-3332	187	3	pmc9128921	pmc9128921	ADJ
dpc-3332	187	4	.	.	PUNCT
dpc-3332	188	1	3	3	X
dpc-3332	188	2	.	.	X
dpc-3332	188	3	hristov	hristov	PROPN
dpc-3332	188	4	ac	ac	PROPN
dpc-3332	188	5	,	,	PUNCT
dpc-3332	188	6	tejasvi	tejasvi	VERB
dpc-3332	188	7	t	t	PROPN
dpc-3332	188	8	,	,	PUNCT
dpc-3332	188	9	wilcox	wilcox	PROPN
dpc-3332	188	10	ra	ra	PROPN
dpc-3332	188	11	.	.	PROPN
dpc-3332	189	1	mycosis	mycosis	NOUN
dpc-3332	189	2	fungoides	fungoide	NOUN
dpc-3332	189	3	and	and	CCONJ
dpc-3332	189	4	sézary	sézary	ADJ
dpc-3332	189	5	syndrome	syndrome	NOUN
dpc-3332	189	6	:	:	PUNCT
dpc-3332	189	7	2019	2019	NUM
dpc-3332	189	8	update	update	NOUN
dpc-3332	189	9	on	on	ADP
dpc-3332	189	10	diagnosis	diagnosis	NOUN
dpc-3332	189	11	,	,	PUNCT
dpc-3332	189	12	risk	risk	NOUN
dpc-3332	189	13	-	-	PUNCT
dpc-3332	189	14	stratification	stratification	NOUN
dpc-3332	189	15	,	,	PUNCT
dpc-3332	189	16	and	and	CCONJ
dpc-3332	189	17	management	management	NOUN
dpc-3332	189	18	.	.	PUNCT
dpc-3332	189	19	am	be	AUX
dpc-3332	189	20	j	j	PROPN
dpc-3332	189	21	hematol	hematol	NOUN
dpc-3332	189	22	.	.	PUNCT
dpc-3332	190	1	2019;94(9):1027	2019;94(9):1027	NUM
dpc-3332	190	2	-	-	SYM
dpc-3332	190	3	1041	1041	NUM
dpc-3332	190	4	.	.	PUNCT
dpc-3332	191	1	doi	doi	NOUN
dpc-3332	191	2	:	:	PUNCT
dpc-3332	191	3	10.1002	10.1002	NUM
dpc-3332	191	4	/	/	SYM
dpc-3332	191	5	ajh.25577	ajh.25577	PROPN
dpc-3332	191	6	.	.	PUNCT
dpc-3332	192	1	pmid	pmid	NOUN
dpc-3332	192	2	:	:	PUNCT
dpc-3332	192	3	31313347	31313347	NUM
dpc-3332	192	4	.	.	PUNCT
dpc-3332	193	1	4	4	X
dpc-3332	193	2	.	.	X
dpc-3332	193	3	larocca	larocca	PROPN
dpc-3332	193	4	c	c	PROPN
dpc-3332	193	5	,	,	PUNCT
dpc-3332	193	6	kupper	kupper	ADJ
dpc-3332	193	7	t.	t.	NOUN
dpc-3332	193	8	mycosis	mycosis	NOUN
dpc-3332	193	9	fungoides	fungoide	NOUN
dpc-3332	193	10	and	and	CCONJ
dpc-3332	193	11	sézary	sézary	ADJ
dpc-3332	193	12	syndrome	syndrome	NOUN
dpc-3332	193	13	:	:	PUNCT
dpc-3332	193	14	an	an	DET
dpc-3332	193	15	update	update	NOUN
dpc-3332	193	16	.	.	PUNCT
dpc-3332	194	1	hematol	hematol	PROPN
dpc-3332	194	2	oncol	oncol	PROPN
dpc-3332	194	3	clin	clin	PROPN
dpc-3332	194	4	north	north	PROPN
dpc-3332	194	5	am	am	PROPN
dpc-3332	194	6	.	.	PUNCT
dpc-3332	195	1	2019;33(1):103	2019;33(1):103	NOUN
dpc-3332	195	2	-	-	SYM
dpc-3332	195	3	120	120	NUM
dpc-3332	195	4	.	.	PUNCT
dpc-3332	196	1	doi	doi	NOUN
dpc-3332	196	2	:	:	PUNCT
dpc-3332	196	3	10.1016	10.1016	NUM
dpc-3332	196	4	/	/	SYM
dpc-3332	196	5	j.hoc.2018.09.001	j.hoc.2018.09.001	NOUN
dpc-3332	196	6	.	.	PUNCT
dpc-3332	197	1	pmid	pmid	NOUN
dpc-3332	197	2	:	:	PUNCT
dpc-3332	197	3	30497668	30497668	NUM
dpc-3332	197	4	.	.	PUNCT
dpc-3332	198	1	pmcid	pmcid	NOUN
dpc-3332	198	2	:	:	PUNCT
dpc-3332	198	3	pmc7147244	pmc7147244	NOUN
dpc-3332	198	4	.	.	PUNCT
dpc-3332	199	1	5	5	X
dpc-3332	199	2	.	.	X
dpc-3332	199	3	kocatürk	kocatürk	PROPN
dpc-3332	199	4	m	m	PROPN
dpc-3332	199	5	,	,	PUNCT
dpc-3332	199	6	kocatürk	kocatürk	PROPN
dpc-3332	199	7	ö.	ö.	PROPN
dpc-3332	199	8	assessment	assessment	NOUN
dpc-3332	199	9	of	of	ADP
dpc-3332	199	10	relationship	relationship	NOUN
dpc-3332	199	11	between	between	ADP
dpc-3332	199	12	c	c	NOUN
dpc-3332	199	13	-	-	PUNCT
dpc-3332	199	14	reactive	reactive	ADJ
dpc-3332	199	15	protein	protein	NOUN
dpc-3332	199	16	to	to	ADP
dpc-3332	199	17	albumin	albumin	ADJ
dpc-3332	199	18	ratio	ratio	NOUN
dpc-3332	199	19	and	and	CCONJ
dpc-3332	199	20	90	90	NUM
dpc-3332	199	21	-	-	PUNCT
dpc-3332	199	22	day	day	NOUN
dpc-3332	199	23	mortality	mortality	NOUN
dpc-3332	199	24	in	in	ADP
dpc-3332	199	25	patients	patient	NOUN
dpc-3332	199	26	with	with	ADP
dpc-3332	199	27	acute	acute	ADJ
dpc-3332	199	28	ischaemic	ischaemic	ADJ
dpc-3332	199	29	stroke	stroke	NOUN
dpc-3332	199	30	.	.	PUNCT
dpc-3332	200	1	neurol	neurol	PROPN
dpc-3332	200	2	neurochir	neurochir	PROPN
dpc-3332	200	3	pol	pol	PROPN
dpc-3332	200	4	.	.	PUNCT
dpc-3332	201	1	2019;53(3):205	2019;53(3):205	NUM
dpc-3332	201	2	-	-	SYM
dpc-3332	201	3	211	211	NUM
dpc-3332	201	4	.	.	PUNCT
dpc-3332	202	1	doi	doi	NOUN
dpc-3332	202	2	:	:	PUNCT
dpc-3332	202	3	10.5603	10.5603	NUM
dpc-3332	202	4	/	/	SYM
dpc-3332	202	5	pjnns.a2019.0020	pjnns.a2019.0020	NOUN
dpc-3332	202	6	.	.	PUNCT
dpc-3332	203	1	pmid	pmid	NOUN
dpc-3332	203	2	:	:	PUNCT
dpc-3332	203	3	31145464	31145464	NUM
dpc-3332	203	4	.	.	PUNCT
dpc-3332	204	1	6	6	X
dpc-3332	204	2	.	.	X
dpc-3332	204	3	aseringec	aseringec	VERB
dpc-3332	204	4	akkececi	akkececi	PROPN
dpc-3332	204	5	n	n	SYM
dpc-3332	204	6	,	,	PUNCT
dpc-3332	204	7	yildirim	yildirim	PROPN
dpc-3332	204	8	cetin	cetin	VERB
dpc-3332	204	9	g	g	PROPN
dpc-3332	204	10	,	,	PUNCT
dpc-3332	204	11	gogebakan	gogebakan	PROPN
dpc-3332	204	12	h	h	NOUN
dpc-3332	204	13	,	,	PUNCT
dpc-3332	204	14	acipayam	acipayam	PROPN
dpc-3332	204	15	c.	c.	NOUN
dpc-3332	205	1	the	the	DET
dpc-3332	205	2	c	c	NOUN
dpc-3332	205	3	-	-	PUNCT
dpc-3332	205	4	reactive	reactive	ADJ
dpc-3332	205	5	protein	protein	NOUN
dpc-3332	205	6	/	/	SYM
dpc-3332	205	7	albumin	albumin	NOUN
dpc-3332	205	8	ratio	ratio	NOUN
dpc-3332	205	9	and	and	CCONJ
dpc-3332	205	10	complete	complete	ADJ
dpc-3332	205	11	blood	blood	NOUN
dpc-3332	205	12	count	count	NOUN
dpc-3332	205	13	parameters	parameter	NOUN
dpc-3332	205	14	as	as	ADP
dpc-3332	205	15	indicators	indicator	NOUN
dpc-3332	205	16	of	of	ADP
dpc-3332	205	17	disease	disease	NOUN
dpc-3332	205	18	activity	activity	NOUN
dpc-3332	205	19	in	in	ADP
dpc-3332	205	20	6	6	NUM
dpc-3332	205	21	original	original	ADJ
dpc-3332	205	22	article	article	NOUN
dpc-3332	205	23	|	|	ADV
dpc-3332	205	24	dermatol	dermatol	ADJ
dpc-3332	205	25	pract	pract	NOUN
dpc-3332	205	26	concept	concept	NOUN
dpc-3332	205	27	.	.	PUNCT
dpc-3332	206	1	2024;14(2):e2024097	2024;14(2):e2024097	NUM
dpc-3332	206	2	19	19	NUM
dpc-3332	206	3	.	.	PUNCT
dpc-3332	207	1	cengiz	cengiz	PROPN
dpc-3332	207	2	fp	fp	PROPN
dpc-3332	207	3	,	,	PUNCT
dpc-3332	207	4	emiroglu	emiroglu	PROPN
dpc-3332	207	5	n	n	CCONJ
dpc-3332	207	6	,	,	PUNCT
dpc-3332	207	7	ozkaya	ozkaya	PROPN
dpc-3332	207	8	db	db	PROPN
dpc-3332	207	9	,	,	PUNCT
dpc-3332	207	10	bahali	bahali	PROPN
dpc-3332	207	11	ag	ag	PROPN
dpc-3332	207	12	,	,	PUNCT
dpc-3332	207	13	su	su	PROPN
dpc-3332	207	14	o	o	PROPN
dpc-3332	207	15	,	,	PUNCT
dpc-3332	207	16	onsun	onsun	PROPN
dpc-3332	207	17	n.	n.	PROPN
dpc-3332	207	18	prognostic	prognostic	ADJ
dpc-3332	207	19	evaluation	evaluation	NOUN
dpc-3332	207	20	of	of	ADP
dpc-3332	207	21	neutrophil	neutrophil	ADJ
dpc-3332	207	22	/	/	SYM
dpc-3332	207	23	lymphocyte	lymphocyte	ADJ
dpc-3332	207	24	ratio	ratio	NOUN
dpc-3332	207	25	in	in	ADP
dpc-3332	207	26	patients	patient	NOUN
dpc-3332	207	27	with	with	ADP
dpc-3332	207	28	mycosis	mycosis	NOUN
dpc-3332	207	29	fungoides	fungoide	NOUN
dpc-3332	207	30	.	.	PUNCT
dpc-3332	208	1	ann	ann	PROPN
dpc-3332	208	2	clin	clin	PROPN
dpc-3332	208	3	lab	lab	PROPN
dpc-3332	208	4	sci	sci	PROPN
dpc-3332	208	5	.	.	PUNCT
dpc-3332	209	1	2017;47(1):25	2017;47(1):25	X
dpc-3332	209	2	-	-	SYM
dpc-3332	209	3	28	28	NUM
dpc-3332	209	4	.	.	PUNCT
dpc-3332	210	1	pmid	pmid	NOUN
dpc-3332	210	2	:	:	PUNCT
dpc-3332	210	3	28249912	28249912	NUM
dpc-3332	210	4	.	.	PUNCT
dpc-3332	211	1	20	20	NUM
dpc-3332	211	2	.	.	PUNCT
dpc-3332	212	1	nikolaou	nikolaou	PROPN
dpc-3332	212	2	v	v	PROPN
dpc-3332	212	3	,	,	PUNCT
dpc-3332	212	4	papadavid	papadavid	NOUN
dpc-3332	212	5	e	e	PROPN
dpc-3332	212	6	,	,	PUNCT
dpc-3332	212	7	patsatsi	patsatsi	PROPN
dpc-3332	212	8	a	a	PROPN
dpc-3332	212	9	,	,	PUNCT
dpc-3332	212	10	et	et	PROPN
dpc-3332	212	11	al	al	PROPN
dpc-3332	212	12	.	.	PROPN
dpc-3332	213	1	prognostic	prognostic	ADJ
dpc-3332	213	2	indicators	indicator	NOUN
dpc-3332	213	3	for	for	ADP
dpc-3332	213	4	mycosis	mycosis	NOUN
dpc-3332	213	5	fungoides	fungoide	NOUN
dpc-3332	213	6	in	in	ADP
dpc-3332	213	7	a	a	DET
dpc-3332	213	8	greek	greek	ADJ
dpc-3332	213	9	population	population	NOUN
dpc-3332	213	10	.	.	PUNCT
dpc-3332	214	1	br	br	PROPN
dpc-3332	214	2	j	j	PROPN
dpc-3332	214	3	dermatol	dermatol	NOUN
dpc-3332	214	4	.	.	PUNCT
dpc-3332	215	1	2017;176(5):1321	2017;176(5):1321	NUM
dpc-3332	215	2	-	-	SYM
dpc-3332	215	3	1330	1330	NUM
dpc-3332	215	4	.	.	PUNCT
dpc-3332	216	1	doi	doi	NOUN
dpc-3332	216	2	:	:	PUNCT
dpc-3332	216	3	10.1111	10.1111	NUM
dpc-3332	216	4	/	/	SYM
dpc-3332	216	5	bjd.15000	bjd.15000	NUM
dpc-3332	216	6	.	.	PUNCT
dpc-3332	217	1	pmid	pmid	NOUN
dpc-3332	217	2	:	:	PUNCT
dpc-3332	217	3	27552962	27552962	NUM
dpc-3332	217	4	.	.	PUNCT
dpc-3332	218	1	21	21	NUM
dpc-3332	218	2	.	.	PUNCT
dpc-3332	218	3	haase	haase	NOUN
dpc-3332	218	4	r	r	PROPN
dpc-3332	218	5	,	,	PUNCT
dpc-3332	218	6	vilser	vilser	NOUN
dpc-3332	218	7	c	c	NOUN
dpc-3332	218	8	,	,	PUNCT
dpc-3332	218	9	mauz	mauz	NOUN
dpc-3332	218	10	-	-	PUNCT
dpc-3332	218	11	körholz	körholz	ADJ
dpc-3332	218	12	c	c	NOUN
dpc-3332	218	13	,	,	PUNCT
dpc-3332	218	14	et	et	PROPN
dpc-3332	218	15	al	al	PROPN
dpc-3332	218	16	.	.	PUNCT
dpc-3332	218	17	evaluation	evaluation	NOUN
dpc-3332	218	18	of	of	ADP
dpc-3332	218	19	the	the	DET
dpc-3332	218	20	prognostic	prognostic	ADJ
dpc-3332	218	21	meaning	meaning	NOUN
dpc-3332	218	22	of	of	ADP
dpc-3332	218	23	c	c	NOUN
dpc-3332	218	24	-	-	PUNCT
dpc-3332	218	25	reactive	reactive	ADJ
dpc-3332	218	26	protein	protein	NOUN
dpc-3332	218	27	(	(	PUNCT
dpc-3332	218	28	crp	crp	NOUN
dpc-3332	218	29	)	)	PUNCT
dpc-3332	218	30	in	in	ADP
dpc-3332	218	31	children	child	NOUN
dpc-3332	218	32	and	and	CCONJ
dpc-3332	218	33	adolescents	adolescent	NOUN
dpc-3332	218	34	with	with	ADP
dpc-3332	218	35	classical	classical	ADJ
dpc-3332	218	36	hodgkin	hodgkin	NOUN
dpc-3332	218	37	's	's	PART
dpc-3332	218	38	lymphoma	lymphoma	NOUN
dpc-3332	218	39	(	(	PUNCT
dpc-3332	218	40	hl	hl	NOUN
dpc-3332	218	41	)	)	PUNCT
dpc-3332	218	42	.	.	PUNCT
dpc-3332	219	1	klin	klin	PROPN
dpc-3332	219	2	padiatr	padiatr	NOUN
dpc-3332	219	3	.	.	PUNCT
dpc-3332	220	1	2012;224(6):377	2012;224(6):377	NUM
dpc-3332	220	2	-	-	SYM
dpc-3332	220	3	381	381	NUM
dpc-3332	220	4	.	.	PUNCT
dpc-3332	220	5	doi	doi	NOUN
dpc-3332	220	6	:	:	PUNCT
dpc-3332	220	7	10.1055	10.1055	NUM
dpc-3332	220	8	/	/	SYM
dpc-3332	220	9	s-0032	s-0032	PROPN
dpc-3332	220	10	-	-	PUNCT
dpc-3332	220	11	1323824	1323824	NUM
dpc-3332	220	12	.	.	PUNCT
dpc-3332	221	1	pmid	pmid	NOUN
dpc-3332	221	2	:	:	PUNCT
dpc-3332	221	3	23047832	23047832	NUM
dpc-3332	221	4	.	.	PUNCT
dpc-3332	222	1	22	22	NUM
dpc-3332	222	2	.	.	PUNCT
dpc-3332	223	1	wieland	wieland	PROPN
dpc-3332	223	2	a	a	PROPN
dpc-3332	223	3	,	,	PUNCT
dpc-3332	223	4	kerbl	kerbl	PROPN
dpc-3332	223	5	r	r	NOUN
dpc-3332	223	6	,	,	PUNCT
dpc-3332	223	7	berghold	berghold	VERB
dpc-3332	223	8	a	a	PRON
dpc-3332	223	9	,	,	PUNCT
dpc-3332	223	10	schwinger	schwinger	NOUN
dpc-3332	223	11	w	w	PROPN
dpc-3332	223	12	,	,	PUNCT
dpc-3332	223	13	mann	mann	PROPN
dpc-3332	223	14	g	g	PROPN
dpc-3332	223	15	,	,	PUNCT
dpc-3332	223	16	urban	urban	ADJ
dpc-3332	223	17	c.	c.	PROPN
dpc-3332	223	18	c	c	NOUN
dpc-3332	223	19	-	-	PUNCT
dpc-3332	223	20	reactive	reactive	ADJ
dpc-3332	223	21	protein	protein	NOUN
dpc-3332	223	22	(	(	PUNCT
dpc-3332	223	23	crp	crp	PROPN
dpc-3332	223	24	)	)	PUNCT
dpc-3332	223	25	as	as	ADP
dpc-3332	223	26	tumor	tumor	NOUN
dpc-3332	223	27	marker	marker	NOUN
dpc-3332	223	28	in	in	ADP
dpc-3332	223	29	pediatric	pediatric	ADJ
dpc-3332	223	30	and	and	CCONJ
dpc-3332	223	31	adolescent	adolescent	ADJ
dpc-3332	223	32	patients	patient	NOUN
dpc-3332	223	33	with	with	ADP
dpc-3332	223	34	hodgkin	hodgkin	PROPN
dpc-3332	223	35	disease	disease	PROPN
dpc-3332	223	36	.	.	PUNCT
dpc-3332	224	1	med	med	ADJ
dpc-3332	224	2	pediatr	pediatr	PROPN
dpc-3332	224	3	oncol	oncol	NOUN
dpc-3332	224	4	.	.	PUNCT
dpc-3332	225	1	2003;41(1):21	2003;41(1):21	X
dpc-3332	225	2	-	-	SYM
dpc-3332	225	3	25	25	NUM
dpc-3332	225	4	.	.	PUNCT
dpc-3332	226	1	doi	doi	NOUN
dpc-3332	226	2	:	:	PUNCT
dpc-3332	226	3	10.1002	10.1002	NUM
dpc-3332	226	4	/	/	SYM
dpc-3332	226	5	mpo.10286	mpo.10286	NOUN
dpc-3332	226	6	.	.	PUNCT
dpc-3332	227	1	pmid	pmid	NOUN
dpc-3332	227	2	:	:	PUNCT
dpc-3332	227	3	12764738	12764738	NUM
dpc-3332	227	4	.	.	PUNCT
dpc-3332	228	1	23	23	NUM
dpc-3332	228	2	.	.	PUNCT
dpc-3332	229	1	allin	allin	PROPN
dpc-3332	229	2	kh	kh	PROPN
dpc-3332	229	3	,	,	PUNCT
dpc-3332	229	4	nordestgaard	nordestgaard	PROPN
dpc-3332	229	5	bg	bg	PROPN
dpc-3332	229	6	.	.	PROPN
dpc-3332	229	7	elevated	elevate	VERB
dpc-3332	229	8	c	c	NOUN
dpc-3332	229	9	-	-	ADJ
dpc-3332	229	10	reactive	reactive	ADJ
dpc-3332	229	11	protein	protein	NOUN
dpc-3332	229	12	in	in	ADP
dpc-3332	229	13	the	the	DET
dpc-3332	229	14	diagnosis	diagnosis	NOUN
dpc-3332	229	15	,	,	PUNCT
dpc-3332	229	16	prognosis	prognosis	NOUN
dpc-3332	229	17	,	,	PUNCT
dpc-3332	229	18	and	and	CCONJ
dpc-3332	229	19	cause	cause	NOUN
dpc-3332	229	20	of	of	ADP
dpc-3332	229	21	cancer	cancer	NOUN
dpc-3332	229	22	.	.	PUNCT
dpc-3332	230	1	crit	crit	PROPN
dpc-3332	230	2	rev	rev	PROPN
dpc-3332	230	3	clin	clin	PROPN
dpc-3332	230	4	lab	lab	PROPN
dpc-3332	230	5	sci	sci	PROPN
dpc-3332	230	6	.	.	PUNCT
dpc-3332	231	1	2011;48(4):155	2011;48(4):155	PROPN
dpc-3332	231	2	-	-	SYM
dpc-3332	231	3	170	170	NUM
dpc-3332	231	4	.	.	PUNCT
dpc-3332	232	1	doi	doi	NOUN
dpc-3332	232	2	:	:	PUNCT
dpc-3332	232	3	10.3109/10408363.2011.599831	10.3109/10408363.2011.599831	NUM
dpc-3332	232	4	.	.	PUNCT
dpc-3332	233	1	pmid	pmid	NOUN
dpc-3332	233	2	:	:	PUNCT
dpc-3332	233	3	22035340	22035340	NUM
dpc-3332	233	4	.	.	PUNCT
dpc-3332	234	1	24	24	NUM
dpc-3332	234	2	.	.	PUNCT
dpc-3332	235	1	gobbi	gobbi	PROPN
dpc-3332	235	2	pg	pg	PROPN
dpc-3332	235	3	,	,	PUNCT
dpc-3332	235	4	gendarini	gendarini	VERB
dpc-3332	235	5	a	a	DET
dpc-3332	235	6	,	,	PUNCT
dpc-3332	235	7	crema	crema	ADJ
dpc-3332	235	8	a	a	NOUN
dpc-3332	235	9	,	,	PUNCT
dpc-3332	235	10	et	et	PROPN
dpc-3332	235	11	al	al	PROPN
dpc-3332	235	12	.	.	PROPN
dpc-3332	235	13	serum	serum	PROPN
dpc-3332	235	14	albumin	albumin	PROPN
dpc-3332	235	15	in	in	ADP
dpc-3332	235	16	hodgkin	hodgkin	PROPN
dpc-3332	235	17	's	's	PART
dpc-3332	235	18	disease	disease	NOUN
dpc-3332	235	19	.	.	PUNCT
dpc-3332	236	1	cancer	cancer	NOUN
dpc-3332	236	2	.	.	PUNCT
dpc-3332	237	1	1985;55(2):389	1985;55(2):389	NUM
dpc-3332	237	2	-	-	PUNCT
dpc-3332	237	3	393	393	NUM
dpc-3332	237	4	.	.	PUNCT
dpc-3332	238	1	doi	doi	NOUN
dpc-3332	238	2	:	:	PUNCT
dpc-3332	238	3	10.1002/1097	10.1002/1097	NUM
dpc-3332	238	4	-	-	PUNCT
dpc-3332	238	5	0142(19850115)55:2<389::aid	0142(19850115)55:2<389::aid	NUM
dpc-3332	238	6	-	-	PUNCT
dpc-3332	238	7	cncr2820550216>3.0.co	cncr2820550216>3.0.co	NOUN
dpc-3332	238	8	;	;	PUNCT
dpc-3332	238	9	2	2	NUM
dpc-3332	238	10	-	-	PUNCT
dpc-3332	238	11	f.	f.	NOUN
dpc-3332	238	12	pmid	pmid	PROPN
dpc-3332	238	13	:	:	PUNCT
dpc-3332	238	14	2578086	2578086	NUM
dpc-3332	238	15	.	.	PUNCT
dpc-3332	239	1	25	25	NUM
dpc-3332	239	2	.	.	PUNCT
dpc-3332	240	1	bairey	bairey	PROPN
dpc-3332	240	2	o	o	NOUN
dpc-3332	240	3	,	,	PUNCT
dpc-3332	240	4	shacham	shacham	PROPN
dpc-3332	240	5	-	-	PUNCT
dpc-3332	240	6	abulafia	abulafia	PROPN
dpc-3332	240	7	a	a	PRON
dpc-3332	240	8	,	,	PUNCT
dpc-3332	240	9	shpilberg	shpilberg	PROPN
dpc-3332	240	10	o	o	PROPN
dpc-3332	240	11	,	,	PUNCT
dpc-3332	240	12	gurion	gurion	PROPN
dpc-3332	240	13	r.	r.	PROPN
dpc-3332	240	14	serum	serum	PROPN
dpc-3332	240	15	albumin	albumin	ADJ
dpc-3332	240	16	level	level	NOUN
dpc-3332	240	17	at	at	ADP
dpc-3332	240	18	diagnosis	diagnosis	NOUN
dpc-3332	240	19	of	of	ADP
dpc-3332	240	20	diffuse	diffuse	ADJ
dpc-3332	240	21	large	large	ADJ
dpc-3332	240	22	b	b	NOUN
dpc-3332	240	23	-	-	PUNCT
dpc-3332	240	24	cell	cell	NOUN
dpc-3332	240	25	lymphoma	lymphoma	NOUN
dpc-3332	240	26	:	:	PUNCT
dpc-3332	240	27	an	an	DET
dpc-3332	240	28	important	important	ADJ
dpc-3332	240	29	simple	simple	ADJ
dpc-3332	240	30	prognostic	prognostic	ADJ
dpc-3332	240	31	factor	factor	NOUN
dpc-3332	240	32	.	.	PUNCT
dpc-3332	241	1	hematol	hematol	PROPN
dpc-3332	241	2	oncol	oncol	ADJ
dpc-3332	241	3	.	.	PUNCT
dpc-3332	242	1	2016;34(4):184	2016;34(4):184	NUM
dpc-3332	242	2	-	-	SYM
dpc-3332	242	3	192	192	NUM
dpc-3332	242	4	.	.	PUNCT
dpc-3332	243	1	doi	doi	NOUN
dpc-3332	243	2	:	:	PUNCT
dpc-3332	243	3	10.1002	10.1002	NUM
dpc-3332	243	4	/	/	SYM
dpc-3332	243	5	hon.2233	hon.2233	NOUN
dpc-3332	243	6	.	.	PUNCT
dpc-3332	244	1	pmid	pmid	NOUN
dpc-3332	244	2	:	:	PUNCT
dpc-3332	244	3	26052918	26052918	NUM
dpc-3332	244	4	.	.	PUNCT
dpc-3332	245	1	26	26	NUM
dpc-3332	245	2	.	.	PUNCT
dpc-3332	246	1	gupta	gupta	PROPN
dpc-3332	246	2	d	d	PROPN
dpc-3332	246	3	,	,	PUNCT
dpc-3332	246	4	lis	lis	X
dpc-3332	246	5	cg	cg	NOUN
dpc-3332	246	6	.	.	PUNCT
dpc-3332	246	7	pretreatment	pretreatment	NOUN
dpc-3332	246	8	serum	serum	NOUN
dpc-3332	246	9	albumin	albumin	NOUN
dpc-3332	246	10	as	as	ADP
dpc-3332	246	11	a	a	DET
dpc-3332	246	12	predictor	predictor	NOUN
dpc-3332	246	13	of	of	ADP
dpc-3332	246	14	cancer	cancer	NOUN
dpc-3332	246	15	survival	survival	NOUN
dpc-3332	246	16	:	:	PUNCT
dpc-3332	246	17	a	a	DET
dpc-3332	246	18	systematic	systematic	ADJ
dpc-3332	246	19	review	review	NOUN
dpc-3332	246	20	of	of	ADP
dpc-3332	246	21	the	the	DET
dpc-3332	246	22	epidemiological	epidemiological	ADJ
dpc-3332	246	23	literature	literature	NOUN
dpc-3332	246	24	.	.	PUNCT
dpc-3332	247	1	nutr	nutr	PROPN
dpc-3332	247	2	j.	j.	PROPN
dpc-3332	247	3	2010;9:69	2010;9:69	PROPN
dpc-3332	247	4	.	.	PUNCT
dpc-3332	248	1	doi	doi	NOUN
dpc-3332	248	2	:	:	PUNCT
dpc-3332	248	3	10.1186/1475	10.1186/1475	NUM
dpc-3332	248	4	-	-	SYM
dpc-3332	248	5	2891	2891	NUM
dpc-3332	248	6	-	-	PUNCT
dpc-3332	248	7	9	9	NUM
dpc-3332	248	8	-	-	SYM
dpc-3332	248	9	69	69	NUM
dpc-3332	248	10	.	.	PUNCT
dpc-3332	249	1	pmid	pmid	NOUN
dpc-3332	249	2	:	:	PUNCT
dpc-3332	249	3	21176210	21176210	NUM
dpc-3332	249	4	.	.	PUNCT
dpc-3332	250	1	pmcid	pmcid	NOUN
dpc-3332	250	2	:	:	PUNCT
dpc-3332	250	3	pmc3019132	pmc3019132	NOUN
dpc-3332	250	4	.	.	PUNCT
dpc-3332	251	1	27	27	NUM
dpc-3332	251	2	.	.	PUNCT
dpc-3332	252	1	liu	liu	PROPN
dpc-3332	252	2	z	z	PROPN
dpc-3332	252	3	,	,	PUNCT
dpc-3332	252	4	jin	jin	PROPN
dpc-3332	252	5	k	k	PROPN
dpc-3332	252	6	,	,	PUNCT
dpc-3332	252	7	guo	guo	PROPN
dpc-3332	252	8	m	m	PROPN
dpc-3332	252	9	,	,	PUNCT
dpc-3332	252	10	et	et	PROPN
dpc-3332	252	11	al	al	PROPN
dpc-3332	252	12	.	.	PUNCT
dpc-3332	252	13	prognostic	prognostic	ADJ
dpc-3332	252	14	value	value	NOUN
dpc-3332	252	15	of	of	ADP
dpc-3332	252	16	the	the	DET
dpc-3332	252	17	crp	crp	PROPN
dpc-3332	252	18	/	/	SYM
dpc-3332	252	19	alb	alb	PROPN
dpc-3332	252	20	ratio	ratio	NOUN
dpc-3332	252	21	,	,	PUNCT
dpc-3332	252	22	a	a	DET
dpc-3332	252	23	novel	novel	ADJ
dpc-3332	252	24	inflammation	inflammation	NOUN
dpc-3332	252	25	-	-	PUNCT
dpc-3332	252	26	based	base	VERB
dpc-3332	252	27	score	score	NOUN
dpc-3332	252	28	in	in	ADP
dpc-3332	252	29	pancreatic	pancreatic	ADJ
dpc-3332	252	30	cancer	cancer	NOUN
dpc-3332	252	31	.	.	PUNCT
dpc-3332	253	1	ann	ann	PROPN
dpc-3332	253	2	surg	surg	PROPN
dpc-3332	253	3	oncol	oncol	PROPN
dpc-3332	253	4	.	.	PUNCT
dpc-3332	254	1	2017;24(2):561	2017;24(2):561	NUM
dpc-3332	254	2	-	-	PUNCT
dpc-3332	254	3	568	568	NUM
dpc-3332	254	4	.	.	PUNCT
dpc-3332	255	1	doi	doi	NOUN
dpc-3332	255	2	:	:	PUNCT
dpc-3332	255	3	10.1245	10.1245	NUM
dpc-3332	255	4	/	/	SYM
dpc-3332	255	5	s10434	s10434	PROPN
dpc-3332	255	6	-	-	PUNCT
dpc-3332	255	7	016	016	NUM
dpc-3332	255	8	-5579	-5579	NOUN
dpc-3332	255	9	-	-	PUNCT
dpc-3332	255	10	3	3	NUM
dpc-3332	255	11	.	.	PUNCT
dpc-3332	256	1	pmid	pmid	NOUN
dpc-3332	256	2	:	:	PUNCT
dpc-3332	256	3	27650825	27650825	NUM
dpc-3332	256	4	.	.	PUNCT
dpc-3332	257	1	28	28	NUM
dpc-3332	257	2	.	.	PUNCT
dpc-3332	257	3	vujic	vujic	PROPN
dpc-3332	257	4	j	j	PROPN
dpc-3332	257	5	,	,	PUNCT
dpc-3332	257	6	marsoner	marsoner	PROPN
dpc-3332	257	7	k	k	PROPN
dpc-3332	257	8	,	,	PUNCT
dpc-3332	257	9	wienerroither	wienerroither	ADP
dpc-3332	257	10	v	v	NOUN
dpc-3332	257	11	,	,	PUNCT
dpc-3332	257	12	mischinger	mischinger	PROPN
dpc-3332	257	13	hj	hj	PROPN
dpc-3332	257	14	,	,	PUNCT
dpc-3332	257	15	kornprat	kornprat	PROPN
dpc-3332	257	16	p.	p.	PROPN
dpc-3332	257	17	the	the	DET
dpc-3332	257	18	predictive	predictive	ADJ
dpc-3332	257	19	value	value	NOUN
dpc-3332	257	20	of	of	ADP
dpc-3332	257	21	the	the	DET
dpc-3332	257	22	crp	crp	PROPN
dpc-3332	257	23	-	-	PUNCT
dpc-3332	257	24	to	to	ADP
dpc-3332	257	25	-	-	PUNCT
dpc-3332	257	26	albumin	albumin	ADJ
dpc-3332	257	27	ratio	ratio	NOUN
dpc-3332	257	28	for	for	ADP
dpc-3332	257	29	patients	patient	NOUN
dpc-3332	257	30	with	with	ADP
dpc-3332	257	31	pancreatic	pancreatic	ADJ
dpc-3332	257	32	cancer	cancer	NOUN
dpc-3332	257	33	after	after	ADP
dpc-3332	257	34	curative	curative	ADJ
dpc-3332	257	35	resection	resection	NOUN
dpc-3332	257	36	:	:	PUNCT
dpc-3332	257	37	a	a	DET
dpc-3332	257	38	retrospective	retrospective	ADJ
dpc-3332	257	39	single	single	ADJ
dpc-3332	257	40	center	center	NOUN
dpc-3332	257	41	study	study	NOUN
dpc-3332	257	42	.	.	PUNCT
dpc-3332	258	1	in	in	ADP
dpc-3332	258	2	vivo	vivo	NOUN
dpc-3332	258	3	.	.	PUNCT
dpc-3332	259	1	2019;33(6):2071	2019;33(6):2071	PROPN
dpc-3332	259	2	-	-	PUNCT
dpc-3332	259	3	2078	2078	NUM
dpc-3332	259	4	.	.	PUNCT
dpc-3332	260	1	doi	doi	NOUN
dpc-3332	260	2	:	:	PUNCT
dpc-3332	260	3	10.21873	10.21873	NUM
dpc-3332	260	4	/invivo.11706	/invivo.11706	X
dpc-3332	260	5	.	.	PUNCT
dpc-3332	261	1	pmid	pmid	PROPN
dpc-3332	261	2	:	:	PUNCT
dpc-3332	261	3	31662540	31662540	NUM
dpc-3332	261	4	.	.	PUNCT
dpc-3332	262	1	pmcid	pmcid	NOUN
dpc-3332	262	2	:	:	PUNCT
dpc-3332	262	3	pmc6899080	pmc6899080	NOUN
dpc-3332	262	4	.	.	PUNCT
dpc-3332	263	1	29	29	NUM
dpc-3332	263	2	.	.	PUNCT
dpc-3332	264	1	fan	fan	PROPN
dpc-3332	264	2	z	z	PROPN
dpc-3332	264	3	,	,	PUNCT
dpc-3332	264	4	fan	fan	PROPN
dpc-3332	264	5	k	k	PROPN
dpc-3332	264	6	,	,	PUNCT
dpc-3332	264	7	gong	gong	PROPN
dpc-3332	264	8	y	y	PROPN
dpc-3332	264	9	,	,	PUNCT
dpc-3332	264	10	et	et	PROPN
dpc-3332	264	11	al	al	PROPN
dpc-3332	264	12	.	.	PUNCT
dpc-3332	265	1	the	the	DET
dpc-3332	265	2	crp	crp	PROPN
dpc-3332	265	3	/	/	SYM
dpc-3332	265	4	albumin	albumin	PROPN
dpc-3332	265	5	ratio	ratio	NOUN
dpc-3332	265	6	predicts	predict	VERB
dpc-3332	265	7	survival	survival	NOUN
dpc-3332	265	8	and	and	CCONJ
dpc-3332	265	9	monitors	monitor	VERB
dpc-3332	265	10	chemotherapeutic	chemotherapeutic	ADJ
dpc-3332	265	11	effectiveness	effectiveness	NOUN
dpc-3332	265	12	in	in	ADP
dpc-3332	265	13	patients	patient	NOUN
dpc-3332	265	14	with	with	ADP
dpc-3332	265	15	advanced	advanced	ADJ
dpc-3332	265	16	pancreatic	pancreatic	ADJ
dpc-3332	265	17	cancer	cancer	NOUN
dpc-3332	265	18	.	.	PUNCT
dpc-3332	266	1	cancer	cancer	NOUN
dpc-3332	266	2	manag	manag	PROPN
dpc-3332	266	3	res	re	NOUN
dpc-3332	266	4	.	.	PUNCT
dpc-3332	267	1	2019;11:8781	2019;11:8781	NUM
dpc-3332	267	2	-	-	SYM
dpc-3332	267	3	8788	8788	NUM
dpc-3332	267	4	.	.	PUNCT
dpc-3332	268	1	doi	doi	NOUN
dpc-3332	268	2	:	:	PUNCT
dpc-3332	268	3	10.2147	10.2147	NUM
dpc-3332	268	4	/	/	SYM
dpc-3332	268	5	cmar.s211363	cmar.s211363	NOUN
dpc-3332	268	6	.	.	PUNCT
dpc-3332	269	1	pmid	pmid	NOUN
dpc-3332	269	2	:	:	PUNCT
dpc-3332	269	3	31632137	31632137	NUM
dpc-3332	269	4	.	.	PUNCT
dpc-3332	270	1	pmcid	pmcid	NOUN
dpc-3332	270	2	:	:	PUNCT
dpc-3332	270	3	pmc6778322	pmc6778322	PROPN
dpc-3332	270	4	.	.	PUNCT
dpc-3332	271	1	30	30	NUM
dpc-3332	271	2	.	.	PUNCT
dpc-3332	272	1	zhou	zhou	PROPN
dpc-3332	272	2	l	l	PROPN
dpc-3332	272	3	,	,	PUNCT
dpc-3332	272	4	ma	ma	PROPN
dpc-3332	272	5	s	s	PROPN
dpc-3332	272	6	,	,	PUNCT
dpc-3332	272	7	balde	balde	NOUN
dpc-3332	272	8	ai	ai	VERB
dpc-3332	272	9	,	,	PUNCT
dpc-3332	272	10	han	han	PROPN
dpc-3332	272	11	s	s	PROPN
dpc-3332	272	12	,	,	PUNCT
dpc-3332	272	13	cai	cai	PROPN
dpc-3332	273	1	z	z	PROPN
dpc-3332	273	2	,	,	PUNCT
dpc-3332	273	3	li	li	PROPN
dpc-3332	273	4	z.	z.	PROPN
dpc-3332	274	1	a	a	DET
dpc-3332	274	2	retrospective	retrospective	ADJ
dpc-3332	274	3	propensity	propensity	NOUN
dpc-3332	274	4	score	score	NOUN
dpc-3332	274	5	matched	match	VERB
dpc-3332	274	6	study	study	NOUN
dpc-3332	274	7	of	of	ADP
dpc-3332	274	8	the	the	DET
dpc-3332	274	9	preoperative	preoperative	NOUN
dpc-3332	274	10	c	c	PROPN
dpc-3332	274	11	reactive	reactive	ADJ
dpc-3332	274	12	protein	protein	NOUN
dpc-3332	274	13	to	to	ADP
dpc-3332	274	14	albumin	albumin	ADJ
dpc-3332	274	15	ratio	ratio	NOUN
dpc-3332	274	16	and	and	CCONJ
dpc-3332	274	17	prognosis	prognosis	NOUN
dpc-3332	274	18	in	in	ADP
dpc-3332	274	19	patients	patient	NOUN
dpc-3332	274	20	with	with	ADP
dpc-3332	274	21	resectable	resectable	ADJ
dpc-3332	274	22	non	non	ADJ
dpc-3332	274	23	-	-	ADJ
dpc-3332	274	24	metastatic	metastatic	ADJ
dpc-3332	274	25	breast	breast	NOUN
dpc-3332	274	26	cancer	cancer	NOUN
dpc-3332	274	27	.	.	PUNCT
dpc-3332	275	1	med	med	PROPN
dpc-3332	275	2	sci	sci	PROPN
dpc-3332	275	3	monit	monit	PROPN
dpc-3332	275	4	.	.	PUNCT
dpc-3332	276	1	2019;25:4342	2019;25:4342	NUM
dpc-3332	276	2	-	-	SYM
dpc-3332	276	3	4352	4352	NUM
dpc-3332	276	4	.	.	PUNCT
dpc-3332	277	1	doi	doi	NOUN
dpc-3332	277	2	:	:	PUNCT
dpc-3332	277	3	10.12659	10.12659	NUM
dpc-3332	277	4	/	/	SYM
dpc-3332	277	5	msm.913684	msm.913684	NUM
dpc-3332	277	6	.	.	PUNCT
dpc-3332	278	1	pmid	pmid	NOUN
dpc-3332	278	2	:	:	PUNCT
dpc-3332	278	3	31182704	31182704	NUM
dpc-3332	278	4	.	.	PUNCT
dpc-3332	279	1	pmcid	pmcid	NOUN
dpc-3332	279	2	:	:	PUNCT
dpc-3332	279	3	pmc6582690	pmc6582690	NOUN
dpc-3332	279	4	.	.	PUNCT
dpc-3332	280	1	31	31	NUM
dpc-3332	280	2	.	.	X
dpc-3332	281	1	ju	ju	PROPN
dpc-3332	281	2	sy	sy	PROPN
dpc-3332	281	3	,	,	PUNCT
dpc-3332	281	4	ma	ma	PROPN
dpc-3332	281	5	sj	sj	PROPN
dpc-3332	281	6	.	.	PROPN
dpc-3332	281	7	high	high	ADJ
dpc-3332	281	8	c	c	NOUN
dpc-3332	281	9	-	-	ADJ
dpc-3332	281	10	reactive	reactive	ADJ
dpc-3332	281	11	protein	protein	NOUN
dpc-3332	281	12	to	to	ADP
dpc-3332	281	13	albumin	albumin	ADJ
dpc-3332	281	14	ratio	ratio	NOUN
dpc-3332	281	15	and	and	CCONJ
dpc-3332	281	16	the	the	DET
dpc-3332	281	17	short	short	ADJ
dpc-3332	281	18	-	-	PUNCT
dpc-3332	281	19	term	term	NOUN
dpc-3332	281	20	survival	survival	NOUN
dpc-3332	281	21	prognosis	prognosis	NOUN
dpc-3332	281	22	within	within	ADP
dpc-3332	281	23	30	30	NUM
dpc-3332	281	24	days	day	NOUN
dpc-3332	281	25	in	in	ADP
dpc-3332	281	26	terminal	terminal	ADJ
dpc-3332	281	27	cancer	cancer	NOUN
dpc-3332	281	28	patients	patient	NOUN
dpc-3332	281	29	receiving	receive	VERB
dpc-3332	281	30	palliative	palliative	ADJ
dpc-3332	281	31	care	care	NOUN
dpc-3332	281	32	in	in	ADP
dpc-3332	281	33	a	a	DET
dpc-3332	281	34	hospital	hospital	NOUN
dpc-3332	281	35	setting	setting	NOUN
dpc-3332	281	36	:	:	PUNCT
dpc-3332	281	37	a	a	DET
dpc-3332	281	38	retrospective	retrospective	ADJ
dpc-3332	281	39	analysis	analysis	NOUN
dpc-3332	281	40	.	.	PUNCT
dpc-3332	282	1	medicine	medicine	NOUN
dpc-3332	282	2	(	(	PUNCT
dpc-3332	282	3	baltimore	baltimore	PROPN
dpc-3332	282	4	)	)	PUNCT
dpc-3332	282	5	.	.	PUNCT
dpc-3332	283	1	2020;99(9):e19350	2020;99(9):e19350	X
dpc-3332	283	2	.	.	PUNCT
dpc-3332	283	3	doi	doi	NOUN
dpc-3332	283	4	:	:	PUNCT
dpc-3332	283	5	10.1097	10.1097	NUM
dpc-3332	283	6	/	/	SYM
dpc-3332	283	7	md.0000000000019350	md.0000000000019350	PROPN
dpc-3332	283	8	.	.	PUNCT
dpc-3332	284	1	pmid	pmid	NOUN
dpc-3332	284	2	:	:	PUNCT
dpc-3332	284	3	32118773	32118773	NUM
dpc-3332	284	4	.	.	PUNCT
dpc-3332	285	1	pmcid	pmcid	NOUN
dpc-3332	285	2	:	:	PUNCT
dpc-3332	285	3	pmc7478418	pmc7478418	NOUN
dpc-3332	285	4	.	.	PUNCT
dpc-3332	286	1	patients	patient	NOUN
dpc-3332	286	2	with	with	ADP
dpc-3332	286	3	takayasu	takayasu	PROPN
dpc-3332	286	4	arteritis	arteritis	NOUN
dpc-3332	286	5	.	.	PUNCT
dpc-3332	287	1	med	med	PROPN
dpc-3332	287	2	sci	sci	PROPN
dpc-3332	287	3	monit	monit	PROPN
dpc-3332	287	4	.	.	PUNCT
dpc-3332	288	1	2019;25:14011409	2019;25:14011409	NUM
dpc-3332	288	2	.	.	PUNCT
dpc-3332	288	3	doi	doi	NOUN
dpc-3332	288	4	:	:	PUNCT
dpc-3332	288	5	10.12659	10.12659	NUM
dpc-3332	288	6	/	/	SYM
dpc-3332	288	7	msm.912495	msm.912495	NOUN
dpc-3332	288	8	.	.	PUNCT
dpc-3332	289	1	pmid	pmid	NOUN
dpc-3332	289	2	:	:	PUNCT
dpc-3332	289	3	30792377	30792377	NUM
dpc-3332	289	4	.	.	PUNCT
dpc-3332	290	1	pmcid	pmcid	ADJ
dpc-3332	290	2	:	:	PUNCT
dpc-3332	290	3	pmc6396438	pmc6396438	NOUN
dpc-3332	290	4	.	.	PUNCT
dpc-3332	291	1	7	7	X
dpc-3332	291	2	.	.	X
dpc-3332	291	3	fu	fu	PROPN
dpc-3332	291	4	yj	yj	PROPN
dpc-3332	291	5	,	,	PUNCT
dpc-3332	291	6	li	li	PROPN
dpc-3332	291	7	kz	kz	PROPN
dpc-3332	291	8	,	,	PUNCT
dpc-3332	291	9	bai	bai	PROPN
dpc-3332	291	10	jh	jh	PROPN
dpc-3332	291	11	,	,	PUNCT
dpc-3332	291	12	liang	liang	PROPN
dpc-3332	291	13	zq	zq	PROPN
dpc-3332	291	14	.	.	PROPN
dpc-3332	292	1	c	c	X
dpc-3332	292	2	-	-	PUNCT
dpc-3332	292	3	reactive	reactive	ADJ
dpc-3332	292	4	protein	protein	NOUN
dpc-3332	292	5	/	/	SYM
dpc-3332	292	6	albumin	albumin	ADJ
dpc-3332	292	7	ratio	ratio	NOUN
dpc-3332	292	8	is	be	AUX
dpc-3332	292	9	a	a	DET
dpc-3332	292	10	prognostic	prognostic	ADJ
dpc-3332	292	11	indicator	indicator	NOUN
dpc-3332	292	12	in	in	ADP
dpc-3332	292	13	asians	asians	PROPN
dpc-3332	292	14	with	with	ADP
dpc-3332	292	15	pancreatic	pancreatic	ADJ
dpc-3332	292	16	cancers	cancer	NOUN
dpc-3332	292	17	:	:	PUNCT
dpc-3332	292	18	a	a	DET
dpc-3332	292	19	meta	meta	ADJ
dpc-3332	292	20	-	-	PUNCT
dpc-3332	292	21	analysis	analysis	NOUN
dpc-3332	292	22	.	.	PUNCT
dpc-3332	293	1	medicine	medicine	NOUN
dpc-3332	293	2	(	(	PUNCT
dpc-3332	293	3	baltimore	baltimore	PROPN
dpc-3332	293	4	)	)	PUNCT
dpc-3332	293	5	.	.	PUNCT
dpc-3332	294	1	2019;98(48):e18219	2019;98(48):e18219	NOUN
dpc-3332	294	2	.	.	PUNCT
dpc-3332	295	1	doi	doi	NOUN
dpc-3332	295	2	:	:	PUNCT
dpc-3332	295	3	10.1097	10.1097	NUM
dpc-3332	295	4	/	/	SYM
dpc-3332	295	5	md.0000000000018219	md.0000000000018219	PROPN
dpc-3332	295	6	.	.	PUNCT
dpc-3332	296	1	pmid	pmid	NOUN
dpc-3332	296	2	:	:	PUNCT
dpc-3332	296	3	31770284	31770284	NUM
dpc-3332	296	4	.	.	PUNCT
dpc-3332	297	1	pmcid	pmcid	NOUN
dpc-3332	297	2	:	:	PUNCT
dpc-3332	297	3	pmc6890269	pmc6890269	NOUN
dpc-3332	297	4	.	.	PUNCT
dpc-3332	298	1	8	8	NUM
dpc-3332	298	2	.	.	X
dpc-3332	298	3	tamer	tame	ADJ
dpc-3332	298	4	f	f	NOUN
dpc-3332	298	5	,	,	PUNCT
dpc-3332	298	6	avcı	avcı	PROPN
dpc-3332	298	7	e.	e.	PROPN
dpc-3332	298	8	serum	serum	PROPN
dpc-3332	298	9	c	c	NOUN
dpc-3332	298	10	-	-	ADJ
dpc-3332	298	11	reactive	reactive	ADJ
dpc-3332	298	12	protein	protein	NOUN
dpc-3332	298	13	to	to	ADP
dpc-3332	298	14	albumin	albumin	ADJ
dpc-3332	298	15	ratio	ratio	NOUN
dpc-3332	298	16	as	as	ADP
dpc-3332	298	17	a	a	DET
dpc-3332	298	18	novel	novel	ADJ
dpc-3332	298	19	inflammation	inflammation	NOUN
dpc-3332	298	20	biomarker	biomarker	NOUN
dpc-3332	298	21	in	in	ADP
dpc-3332	298	22	psoriasis	psoriasis	NOUN
dpc-3332	298	23	patients	patient	NOUN
dpc-3332	298	24	treated	treat	VERB
dpc-3332	298	25	with	with	ADP
dpc-3332	298	26	adalimumab	adalimumab	NOUN
dpc-3332	298	27	,	,	PUNCT
dpc-3332	298	28	ustekinumab	ustekinumab	NOUN
dpc-3332	298	29	,	,	PUNCT
dpc-3332	298	30	infliximab	infliximab	NOUN
dpc-3332	298	31	,	,	PUNCT
dpc-3332	298	32	and	and	CCONJ
dpc-3332	298	33	secukinumab	secukinumab	NOUN
dpc-3332	298	34	:	:	PUNCT
dpc-3332	298	35	a	a	DET
dpc-3332	298	36	retrospective	retrospective	ADJ
dpc-3332	298	37	study	study	NOUN
dpc-3332	298	38	.	.	PUNCT
dpc-3332	299	1	croat	croat	PROPN
dpc-3332	299	2	med	med	PROPN
dpc-3332	299	3	j.	j.	PROPN
dpc-3332	299	4	2020;61(4):333	2020;61(4):333	PROPN
dpc-3332	299	5	-	-	PUNCT
dpc-3332	299	6	337	337	NUM
dpc-3332	299	7	.	.	PUNCT
dpc-3332	300	1	doi	doi	NOUN
dpc-3332	300	2	:	:	PUNCT
dpc-3332	300	3	10.3325	10.3325	NUM
dpc-3332	300	4	/cmj.2020.61.333	/cmj.2020.61.333	PUNCT
dpc-3332	300	5	.	.	PUNCT
dpc-3332	301	1	pmid	pmid	NOUN
dpc-3332	301	2	:	:	PUNCT
dpc-3332	301	3	32881431	32881431	NUM
dpc-3332	301	4	.	.	PUNCT
dpc-3332	302	1	pmcid	pmcid	NOUN
dpc-3332	302	2	:	:	PUNCT
dpc-3332	302	3	pmc7480757	pmc7480757	NOUN
dpc-3332	302	4	.	.	PUNCT
dpc-3332	303	1	9	9	X
dpc-3332	303	2	.	.	X
dpc-3332	303	3	kaplan	kaplan	PROPN
dpc-3332	303	4	m	m	PROPN
dpc-3332	303	5	,	,	PUNCT
dpc-3332	303	6	ates	ates	PROPN
dpc-3332	303	7	i	i	PROPN
dpc-3332	303	8	,	,	PUNCT
dpc-3332	303	9	akpinar	akpinar	VERB
dpc-3332	303	10	my	my	PRON
dpc-3332	303	11	,	,	PUNCT
dpc-3332	303	12	et	et	PROPN
dpc-3332	303	13	al	al	PROPN
dpc-3332	303	14	.	.	PROPN
dpc-3332	303	15	predictive	predictive	ADJ
dpc-3332	303	16	value	value	NOUN
dpc-3332	303	17	of	of	ADP
dpc-3332	303	18	c	c	NOUN
dpc-3332	303	19	-	-	PUNCT
dpc-3332	303	20	reactive	reactive	ADJ
dpc-3332	303	21	protein	protein	NOUN
dpc-3332	303	22	/	/	SYM
dpc-3332	303	23	albumin	albumin	ADJ
dpc-3332	303	24	ratio	ratio	NOUN
dpc-3332	303	25	in	in	ADP
dpc-3332	303	26	acute	acute	PROPN
dpc-3332	303	27	pancreatitis	pancreatitis	PROPN
dpc-3332	303	28	.	.	PUNCT
dpc-3332	304	1	hepatobiliary	hepatobiliary	ADJ
dpc-3332	304	2	pancreat	pancreat	NOUN
dpc-3332	304	3	dis	dis	PROPN
dpc-3332	304	4	int	int	NOUN
dpc-3332	304	5	.	.	PUNCT
dpc-3332	305	1	2017;16(4):424	2017;16(4):424	NUM
dpc-3332	305	2	-	-	PUNCT
dpc-3332	305	3	430	430	NUM
dpc-3332	305	4	.	.	PUNCT
dpc-3332	306	1	doi	doi	NOUN
dpc-3332	306	2	:	:	PUNCT
dpc-3332	306	3	10.1016	10.1016	NUM
dpc-3332	306	4	/s1499	/s1499	ADJ
dpc-3332	306	5	-	-	PUNCT
dpc-3332	306	6	3872(17)60007	3872(17)60007	NUM
dpc-3332	306	7	-	-	SYM
dpc-3332	306	8	9	9	NUM
dpc-3332	306	9	.	.	PUNCT
dpc-3332	307	1	pmid	pmid	NOUN
dpc-3332	307	2	:	:	PUNCT
dpc-3332	307	3	28823374	28823374	NUM
dpc-3332	307	4	.	.	PUNCT
dpc-3332	308	1	10	10	NUM
dpc-3332	308	2	.	.	PUNCT
dpc-3332	309	1	kim	kim	PROPN
dpc-3332	309	2	mh	mh	PROPN
dpc-3332	309	3	,	,	PUNCT
dpc-3332	309	4	ahn	ahn	PROPN
dpc-3332	309	5	jy	jy	PROPN
dpc-3332	309	6	,	,	PUNCT
dpc-3332	309	7	et	et	PROPN
dpc-3332	309	8	al	al	PROPN
dpc-3332	309	9	.	.	PUNCT
dpc-3332	310	1	the	the	DET
dpc-3332	310	2	c	c	NOUN
dpc-3332	310	3	-	-	PUNCT
dpc-3332	310	4	reactive	reactive	ADJ
dpc-3332	310	5	protein	protein	NOUN
dpc-3332	310	6	/	/	SYM
dpc-3332	310	7	albumin	albumin	NOUN
dpc-3332	310	8	ratio	ratio	NOUN
dpc-3332	310	9	as	as	ADP
dpc-3332	310	10	an	an	DET
dpc-3332	310	11	independent	independent	ADJ
dpc-3332	310	12	predictor	predictor	NOUN
dpc-3332	310	13	of	of	ADP
dpc-3332	310	14	mortality	mortality	NOUN
dpc-3332	310	15	in	in	ADP
dpc-3332	310	16	patients	patient	NOUN
dpc-3332	310	17	with	with	ADP
dpc-3332	310	18	severe	severe	ADJ
dpc-3332	310	19	sepsis	sepsis	NOUN
dpc-3332	310	20	or	or	CCONJ
dpc-3332	310	21	septic	septic	ADJ
dpc-3332	310	22	shock	shock	NOUN
dpc-3332	310	23	treated	treat	VERB
dpc-3332	310	24	with	with	ADP
dpc-3332	310	25	early	early	ADJ
dpc-3332	310	26	goal	goal	NOUN
dpc-3332	310	27	-	-	PUNCT
dpc-3332	310	28	directed	direct	VERB
dpc-3332	310	29	therapy	therapy	NOUN
dpc-3332	310	30	.	.	PUNCT
dpc-3332	311	1	plos	plos	PROPN
dpc-3332	311	2	one	one	NUM
dpc-3332	311	3	.	.	PUNCT
dpc-3332	312	1	2015;10(7):e0132109	2015;10(7):e0132109	NUM
dpc-3332	312	2	.	.	PUNCT
dpc-3332	312	3	doi	doi	NOUN
dpc-3332	312	4	:	:	PUNCT
dpc-3332	312	5	10.1371	10.1371	NUM
dpc-3332	312	6	/	/	SYM
dpc-3332	312	7	journal	journal	NOUN
dpc-3332	312	8	.pone.0132109	.pone.0132109	VERB
dpc-3332	312	9	.	.	PUNCT
dpc-3332	313	1	pmid	pmid	NOUN
dpc-3332	313	2	:	:	PUNCT
dpc-3332	313	3	26158725	26158725	NUM
dpc-3332	313	4	.	.	PUNCT
dpc-3332	314	1	pmcid	pmcid	ADJ
dpc-3332	314	2	:	:	PUNCT
dpc-3332	314	3	pmc4497596	pmc4497596	NOUN
dpc-3332	314	4	.	.	PUNCT
dpc-3332	315	1	11	11	NUM
dpc-3332	315	2	.	.	X
dpc-3332	315	3	kalyoncuoglu	kalyoncuoglu	PROPN
dpc-3332	315	4	m	m	PROPN
dpc-3332	315	5	,	,	PUNCT
dpc-3332	315	6	durmus	durmus	PROPN
dpc-3332	315	7	g.	g.	PROPN
dpc-3332	315	8	relationship	relationship	NOUN
dpc-3332	315	9	between	between	ADP
dpc-3332	315	10	c	c	NOUN
dpc-3332	315	11	-	-	PUNCT
dpc-3332	315	12	reactive	reactive	ADJ
dpc-3332	315	13	protein	protein	NOUN
dpc-3332	315	14	-	-	PUNCT
dpc-3332	315	15	to	to	ADP
dpc-3332	315	16	-	-	PUNCT
dpc-3332	315	17	albumin	albumin	ADJ
dpc-3332	315	18	ratio	ratio	NOUN
dpc-3332	315	19	and	and	CCONJ
dpc-3332	315	20	the	the	DET
dpc-3332	315	21	extent	extent	NOUN
dpc-3332	315	22	of	of	ADP
dpc-3332	315	23	coronary	coronary	ADJ
dpc-3332	315	24	artery	artery	NOUN
dpc-3332	315	25	disease	disease	NOUN
dpc-3332	315	26	in	in	ADP
dpc-3332	315	27	patients	patient	NOUN
dpc-3332	315	28	with	with	ADP
dpc-3332	315	29	non	non	ADJ
dpc-3332	315	30	-	-	ADJ
dpc-3332	315	31	st	st	ADJ
dpc-3332	315	32	-	-	PUNCT
dpc-3332	315	33	elevated	elevated	ADJ
dpc-3332	315	34	myocardial	myocardial	ADJ
dpc-3332	315	35	infarction	infarction	NOUN
dpc-3332	315	36	.	.	PUNCT
dpc-3332	316	1	coron	coron	PROPN
dpc-3332	316	2	artery	artery	NOUN
dpc-3332	316	3	dis	dis	PROPN
dpc-3332	316	4	.	.	PUNCT
dpc-3332	317	1	2020;31(2):130	2020;31(2):130	NUM
dpc-3332	317	2	-	-	PUNCT
dpc-3332	317	3	136	136	NUM
dpc-3332	317	4	.	.	PUNCT
dpc-3332	318	1	doi	doi	NOUN
dpc-3332	318	2	:	:	PUNCT
dpc-3332	318	3	10.1097	10.1097	NUM
dpc-3332	318	4	/mca.0000000000000768	/mca.0000000000000768	NOUN
dpc-3332	318	5	.	.	PUNCT
dpc-3332	319	1	pmid	pmid	NOUN
dpc-3332	319	2	:	:	PUNCT
dpc-3332	319	3	31233399	31233399	NUM
dpc-3332	319	4	.	.	PUNCT
dpc-3332	320	1	12	12	NUM
dpc-3332	320	2	.	.	PUNCT
dpc-3332	321	1	kim	kim	PROPN
dpc-3332	321	2	m	m	PROPN
dpc-3332	321	3	,	,	PUNCT
dpc-3332	321	4	park	park	PROPN
dpc-3332	321	5	yg	yg	PROPN
dpc-3332	321	6	,	,	PUNCT
dpc-3332	321	7	park	park	NOUN
dpc-3332	321	8	yh	yh	PROPN
dpc-3332	321	9	.	.	PROPN
dpc-3332	322	1	c	c	X
dpc-3332	322	2	-	-	PUNCT
dpc-3332	322	3	reactive	reactive	ADJ
dpc-3332	322	4	protein	protein	NOUN
dpc-3332	322	5	/	/	SYM
dpc-3332	322	6	albumin	albumin	NOUN
dpc-3332	322	7	ratio	ratio	NOUN
dpc-3332	322	8	as	as	ADP
dpc-3332	322	9	an	an	DET
dpc-3332	322	10	indicator	indicator	NOUN
dpc-3332	322	11	of	of	ADP
dpc-3332	322	12	disease	disease	NOUN
dpc-3332	322	13	activity	activity	NOUN
dpc-3332	322	14	in	in	ADP
dpc-3332	322	15	behçet	behçet	PROPN
dpc-3332	322	16	's	's	PART
dpc-3332	322	17	disease	disease	NOUN
dpc-3332	322	18	and	and	CCONJ
dpc-3332	322	19	human	human	ADJ
dpc-3332	322	20	leukocyte	leukocyte	NOUN
dpc-3332	322	21	antigen	antigen	NOUN
dpc-3332	322	22	-	-	PUNCT
dpc-3332	322	23	b27	b27	NOUN
dpc-3332	322	24	-	-	PUNCT
dpc-3332	322	25	associated	associate	VERB
dpc-3332	322	26	uveitis	uveitis	NOUN
dpc-3332	322	27	.	.	PUNCT
dpc-3332	323	1	graefes	graefes	PROPN
dpc-3332	323	2	arch	arch	PROPN
dpc-3332	323	3	clin	clin	PROPN
dpc-3332	323	4	exp	exp	PROPN
dpc-3332	323	5	ophthalmol	ophthalmol	PROPN
dpc-3332	323	6	.	.	PUNCT
dpc-3332	324	1	2021;259(7):1985	2021;259(7):1985	NUM
dpc-3332	324	2	-	-	SYM
dpc-3332	324	3	1992	1992	NUM
dpc-3332	324	4	.	.	PUNCT
dpc-3332	325	1	doi	doi	NOUN
dpc-3332	325	2	:	:	PUNCT
dpc-3332	325	3	10.1007	10.1007	NUM
dpc-3332	325	4	/	/	SYM
dpc-3332	325	5	s00417	s00417	ADJ
dpc-3332	325	6	-	-	PUNCT
dpc-3332	325	7	021	021	NUM
dpc-3332	325	8	-05207	-05207	PROPN
dpc-3332	325	9	-	-	PUNCT
dpc-3332	325	10	y.	y.	PROPN
dpc-3332	325	11	pmid	pmid	PROPN
dpc-3332	325	12	:	:	PUNCT
dpc-3332	325	13	33929591	33929591	NUM
dpc-3332	325	14	.	.	PUNCT
dpc-3332	326	1	13	13	NUM
dpc-3332	326	2	.	.	PUNCT
dpc-3332	327	1	bozkurt	bozkurt	PROPN
dpc-3332	327	2	e	e	NOUN
dpc-3332	327	3	,	,	PUNCT
dpc-3332	327	4	muhafiz	muhafiz	ADJ
dpc-3332	327	5	e	e	NOUN
dpc-3332	327	6	,	,	PUNCT
dpc-3332	327	7	sengul	sengul	NOUN
dpc-3332	327	8	d	d	PROPN
dpc-3332	327	9	,	,	PUNCT
dpc-3332	327	10	uçak	uçak	PROPN
dpc-3332	327	11	t	t	PROPN
dpc-3332	327	12	,	,	PUNCT
dpc-3332	327	13	atum	atum	PROPN
dpc-3332	327	14	m.	m.	NOUN
dpc-3332	327	15	can	can	AUX
dpc-3332	327	16	the	the	DET
dpc-3332	327	17	crp/	crp/	ADJ
dpc-3332	327	18	albumin	albumin	ADJ
dpc-3332	327	19	ratio	ratio	NOUN
dpc-3332	327	20	be	be	AUX
dpc-3332	327	21	used	use	VERB
dpc-3332	327	22	as	as	ADP
dpc-3332	327	23	a	a	DET
dpc-3332	327	24	new	new	ADJ
dpc-3332	327	25	indicator	indicator	NOUN
dpc-3332	327	26	of	of	ADP
dpc-3332	327	27	activation	activation	NOUN
dpc-3332	327	28	in	in	ADP
dpc-3332	327	29	patients	patient	NOUN
dpc-3332	327	30	with	with	ADP
dpc-3332	327	31	uveitis	uveitis	NOUN
dpc-3332	327	32	?	?	PUNCT
dpc-3332	328	1	ocul	ocul	PROPN
dpc-3332	328	2	immunol	immunol	NOUN
dpc-3332	328	3	inflamm	inflamm	PROPN
dpc-3332	328	4	.	.	PUNCT
dpc-3332	329	1	2021;29(5):1017	2021;29(5):1017	PROPN
dpc-3332	329	2	-	-	PUNCT
dpc-3332	329	3	1022	1022	NUM
dpc-3332	329	4	.	.	PUNCT
dpc-3332	330	1	doi	doi	NOUN
dpc-3332	330	2	:	:	PUNCT
dpc-3332	330	3	10.1080/09273948.2020.1714061	10.1080/09273948.2020.1714061	NUM
dpc-3332	330	4	.	.	PUNCT
dpc-3332	331	1	pmid	pmid	NOUN
dpc-3332	331	2	:	:	PUNCT
dpc-3332	331	3	32125910	32125910	NUM
dpc-3332	331	4	.	.	PUNCT
dpc-3332	332	1	14	14	NUM
dpc-3332	332	2	.	.	PUNCT
dpc-3332	333	1	olsen	olsen	PROPN
dpc-3332	333	2	e	e	PROPN
dpc-3332	333	3	,	,	PUNCT
dpc-3332	333	4	vonderheid	vonderheid	NOUN
dpc-3332	333	5	e	e	PROPN
dpc-3332	333	6	,	,	PUNCT
dpc-3332	333	7	pimpinelli	pimpinelli	PROPN
dpc-3332	333	8	n	n	CCONJ
dpc-3332	333	9	,	,	PUNCT
dpc-3332	333	10	et	et	PROPN
dpc-3332	333	11	al	al	PROPN
dpc-3332	333	12	.	.	PUNCT
dpc-3332	334	1	revisions	revision	NOUN
dpc-3332	334	2	to	to	ADP
dpc-3332	334	3	the	the	DET
dpc-3332	334	4	staging	staging	NOUN
dpc-3332	334	5	and	and	CCONJ
dpc-3332	334	6	classification	classification	NOUN
dpc-3332	334	7	of	of	ADP
dpc-3332	334	8	mycosis	mycosis	NOUN
dpc-3332	334	9	fungoides	fungoide	NOUN
dpc-3332	334	10	and	and	CCONJ
dpc-3332	334	11	sezary	sezary	ADJ
dpc-3332	334	12	syndrome	syndrome	NOUN
dpc-3332	334	13	:	:	PUNCT
dpc-3332	334	14	a	a	DET
dpc-3332	334	15	proposal	proposal	NOUN
dpc-3332	334	16	of	of	ADP
dpc-3332	334	17	the	the	DET
dpc-3332	334	18	international	international	ADJ
dpc-3332	334	19	society	society	NOUN
dpc-3332	334	20	for	for	ADP
dpc-3332	334	21	cutaneous	cutaneous	ADJ
dpc-3332	334	22	lymphomas	lymphoma	NOUN
dpc-3332	334	23	(	(	PUNCT
dpc-3332	334	24	iscl	iscl	NOUN
dpc-3332	334	25	)	)	PUNCT
dpc-3332	334	26	and	and	CCONJ
dpc-3332	334	27	the	the	DET
dpc-3332	334	28	cutaneous	cutaneous	ADJ
dpc-3332	334	29	lymphoma	lymphoma	NOUN
dpc-3332	334	30	task	task	NOUN
dpc-3332	334	31	force	force	NOUN
dpc-3332	334	32	of	of	ADP
dpc-3332	334	33	the	the	DET
dpc-3332	334	34	european	european	PROPN
dpc-3332	334	35	organization	organization	PROPN
dpc-3332	334	36	of	of	ADP
dpc-3332	334	37	research	research	NOUN
dpc-3332	334	38	and	and	CCONJ
dpc-3332	334	39	treatment	treatment	NOUN
dpc-3332	334	40	of	of	ADP
dpc-3332	334	41	cancer	cancer	NOUN
dpc-3332	334	42	(	(	PUNCT
dpc-3332	334	43	eortc	eortc	ADJ
dpc-3332	334	44	)	)	PUNCT
dpc-3332	334	45	.	.	PUNCT
dpc-3332	335	1	blood	blood	NOUN
dpc-3332	335	2	.	.	PUNCT
dpc-3332	336	1	2007;110(6):1713	2007;110(6):1713	NUM
dpc-3332	336	2	-	-	SYM
dpc-3332	336	3	1722	1722	NUM
dpc-3332	336	4	.	.	PUNCT
dpc-3332	337	1	doi	doi	NOUN
dpc-3332	337	2	:	:	PUNCT
dpc-3332	337	3	10.1182	10.1182	NUM
dpc-3332	337	4	/blood-2007	/blood-2007	ADJ
dpc-3332	337	5	-	-	PUNCT
dpc-3332	337	6	03	03	NUM
dpc-3332	337	7	-	-	PUNCT
dpc-3332	337	8	055749	055749	NUM
dpc-3332	337	9	.	.	PUNCT
dpc-3332	338	1	pmid	pmid	NOUN
dpc-3332	338	2	:	:	PUNCT
dpc-3332	338	3	17540844	17540844	NUM
dpc-3332	338	4	.	.	PUNCT
dpc-3332	339	1	15	15	NUM
dpc-3332	339	2	.	.	PUNCT
dpc-3332	339	3	krejsgaard	krejsgaard	PROPN
dpc-3332	339	4	t	t	PROPN
dpc-3332	339	5	,	,	PUNCT
dpc-3332	339	6	lindahl	lindahl	PROPN
dpc-3332	339	7	lm	lm	PROPN
dpc-3332	339	8	,	,	PUNCT
dpc-3332	339	9	mongan	mongan	NOUN
dpc-3332	339	10	np	np	INTJ
dpc-3332	339	11	,	,	PUNCT
dpc-3332	339	12	et	et	PROPN
dpc-3332	339	13	al	al	PROPN
dpc-3332	339	14	.	.	PROPN
dpc-3332	340	1	malignant	malignant	ADJ
dpc-3332	340	2	inflammation	inflammation	NOUN
dpc-3332	340	3	in	in	ADP
dpc-3332	340	4	cutaneous	cutaneous	ADJ
dpc-3332	340	5	t	t	PROPN
dpc-3332	340	6	-	-	PUNCT
dpc-3332	340	7	cell	cell	NOUN
dpc-3332	340	8	lymphoma	lymphoma	NOUN
dpc-3332	340	9	-	-	PUNCT
dpc-3332	340	10	a	a	DET
dpc-3332	340	11	hostile	hostile	ADJ
dpc-3332	340	12	takeover	takeover	NOUN
dpc-3332	340	13	.	.	PUNCT
dpc-3332	341	1	semin	semin	PROPN
dpc-3332	341	2	immunopathol	immunopathol	PROPN
dpc-3332	341	3	.	.	PUNCT
dpc-3332	342	1	2017;39(3):269	2017;39(3):269	NUM
dpc-3332	342	2	-	-	PUNCT
dpc-3332	342	3	282	282	NUM
dpc-3332	342	4	.	.	PUNCT
dpc-3332	343	1	doi	doi	NOUN
dpc-3332	343	2	:	:	PUNCT
dpc-3332	343	3	10.1007	10.1007	NUM
dpc-3332	343	4	/	/	SYM
dpc-3332	343	5	s00281	s00281	NOUN
dpc-3332	343	6	-	-	PUNCT
dpc-3332	343	7	016	016	NUM
dpc-3332	343	8	-0594	-0594	NOUN
dpc-3332	343	9	-	-	PUNCT
dpc-3332	343	10	9	9	NUM
dpc-3332	343	11	.	.	PUNCT
dpc-3332	344	1	pmid	pmid	NOUN
dpc-3332	344	2	:	:	PUNCT
dpc-3332	344	3	27717961	27717961	NUM
dpc-3332	344	4	.	.	PUNCT
dpc-3332	345	1	pmcid	pmcid	NOUN
dpc-3332	345	2	:	:	PUNCT
dpc-3332	345	3	pmc5368200	pmc5368200	PROPN
dpc-3332	345	4	.	.	PUNCT
dpc-3332	346	1	16	16	NUM
dpc-3332	346	2	.	.	PUNCT
dpc-3332	347	1	van	van	PROPN
dpc-3332	347	2	doorn	doorn	PROPN
dpc-3332	347	3	r	r	PROPN
dpc-3332	347	4	,	,	PUNCT
dpc-3332	347	5	van	van	PROPN
dpc-3332	347	6	haselen	haselen	PROPN
dpc-3332	347	7	cw	cw	PROPN
dpc-3332	347	8	,	,	PUNCT
dpc-3332	347	9	van	van	PROPN
dpc-3332	347	10	voorst	voorst	PROPN
dpc-3332	347	11	vader	vader	NOUN
dpc-3332	347	12	pc	pc	NOUN
dpc-3332	347	13	,	,	PUNCT
dpc-3332	347	14	et	et	PROPN
dpc-3332	347	15	al	al	PROPN
dpc-3332	347	16	.	.	PROPN
dpc-3332	347	17	mycosis	mycosis	NOUN
dpc-3332	347	18	fungoides	fungoide	NOUN
dpc-3332	347	19	:	:	PUNCT
dpc-3332	347	20	disease	disease	NOUN
dpc-3332	347	21	evolution	evolution	NOUN
dpc-3332	347	22	and	and	CCONJ
dpc-3332	347	23	prognosis	prognosis	NOUN
dpc-3332	347	24	of	of	ADP
dpc-3332	347	25	309	309	NUM
dpc-3332	347	26	dutch	dutch	ADJ
dpc-3332	347	27	patients	patient	NOUN
dpc-3332	347	28	.	.	PUNCT
dpc-3332	348	1	arch	arch	ADJ
dpc-3332	348	2	dermatol	dermatol	NOUN
dpc-3332	348	3	.	.	PUNCT
dpc-3332	349	1	2000;136(4):504	2000;136(4):504	NUM
dpc-3332	349	2	-	-	SYM
dpc-3332	349	3	510	510	NUM
dpc-3332	349	4	.	.	PUNCT
dpc-3332	349	5	doi	doi	NOUN
dpc-3332	349	6	:	:	PUNCT
dpc-3332	349	7	10.1001	10.1001	NUM
dpc-3332	349	8	/archderm.136.4.504	/archderm.136.4.504	PUNCT
dpc-3332	349	9	.	.	PUNCT
dpc-3332	350	1	pmid	pmid	NOUN
dpc-3332	350	2	:	:	PUNCT
dpc-3332	350	3	10768649	10768649	NUM
dpc-3332	350	4	.	.	PUNCT
dpc-3332	351	1	17	17	NUM
dpc-3332	351	2	.	.	PUNCT
dpc-3332	352	1	kim	kim	PROPN
dpc-3332	352	2	yh	yh	PROPN
dpc-3332	352	3	,	,	PUNCT
dpc-3332	352	4	jensen	jensen	PROPN
dpc-3332	352	5	ra	ra	PROPN
dpc-3332	352	6	,	,	PUNCT
dpc-3332	352	7	watanabe	watanabe	PROPN
dpc-3332	352	8	gl	gl	PROPN
dpc-3332	352	9	,	,	PUNCT
dpc-3332	352	10	varghese	varghese	PROPN
dpc-3332	352	11	a	a	PROPN
dpc-3332	352	12	,	,	PUNCT
dpc-3332	352	13	hoppe	hoppe	PROPN
dpc-3332	352	14	rt	rt	PROPN
dpc-3332	352	15	.	.	PUNCT
dpc-3332	353	1	clinical	clinical	ADJ
dpc-3332	353	2	stage	stage	NOUN
dpc-3332	353	3	ia	ia	PROPN
dpc-3332	353	4	(	(	PUNCT
dpc-3332	353	5	limited	limited	ADJ
dpc-3332	353	6	patch	patch	NOUN
dpc-3332	353	7	and	and	CCONJ
dpc-3332	353	8	plaque	plaque	NOUN
dpc-3332	353	9	)	)	PUNCT
dpc-3332	353	10	mycosis	mycosis	NOUN
dpc-3332	353	11	fungoides	fungoide	NOUN
dpc-3332	353	12	.	.	PUNCT
dpc-3332	354	1	a	a	DET
dpc-3332	354	2	long	long	ADJ
dpc-3332	354	3	-	-	PUNCT
dpc-3332	354	4	term	term	NOUN
dpc-3332	354	5	outcome	outcome	NOUN
dpc-3332	354	6	analysis	analysis	NOUN
dpc-3332	354	7	.	.	PUNCT
dpc-3332	355	1	arch	arch	ADJ
dpc-3332	355	2	dermatol	dermatol	NOUN
dpc-3332	355	3	.	.	PUNCT
dpc-3332	356	1	1996;132(11):1309	1996;132(11):1309	NUM
dpc-3332	356	2	-	-	SYM
dpc-3332	356	3	1313	1313	NUM
dpc-3332	356	4	.	.	PUNCT
dpc-3332	357	1	pmid	pmid	NOUN
dpc-3332	357	2	:	:	PUNCT
dpc-3332	357	3	8915308	8915308	NUM
dpc-3332	357	4	.	.	PUNCT
dpc-3332	358	1	18	18	NUM
dpc-3332	358	2	.	.	PUNCT
dpc-3332	358	3	bahalı	bahalı	PROPN
dpc-3332	358	4	ag	ag	PROPN
dpc-3332	358	5	,	,	PUNCT
dpc-3332	358	6	su	su	PROPN
dpc-3332	358	7	o	o	PROPN
dpc-3332	358	8	,	,	PUNCT
dpc-3332	358	9	cengiz	cengiz	PROPN
dpc-3332	358	10	fp	fp	NOUN
dpc-3332	358	11	,	,	PUNCT
dpc-3332	358	12	emiroğlu	emiroğlu	PROPN
dpc-3332	358	13	n	n	CCONJ
dpc-3332	358	14	,	,	PUNCT
dpc-3332	358	15	ozkaya	ozkaya	PROPN
dpc-3332	358	16	db	db	PROPN
dpc-3332	358	17	,	,	PUNCT
dpc-3332	358	18	onsun	onsun	PROPN
dpc-3332	358	19	n.	n.	PROPN
dpc-3332	358	20	prognostic	prognostic	ADJ
dpc-3332	358	21	factors	factor	NOUN
dpc-3332	358	22	of	of	ADP
dpc-3332	358	23	patients	patient	NOUN
dpc-3332	358	24	with	with	ADP
dpc-3332	358	25	mycosis	mycosis	NOUN
dpc-3332	358	26	fungoides	fungoide	NOUN
dpc-3332	358	27	.	.	PUNCT
dpc-3332	359	1	postepy	postepy	ADJ
dpc-3332	359	2	dermatol	dermatol	NOUN
dpc-3332	359	3	alergol	alergol	NOUN
dpc-3332	359	4	.	.	PUNCT
dpc-3332	360	1	2020;37(5):796	2020;37(5):796	NUM
dpc-3332	360	2	-	-	SYM
dpc-3332	360	3	799	799	NUM
dpc-3332	360	4	.	.	PUNCT
dpc-3332	361	1	doi	doi	NOUN
dpc-3332	361	2	:	:	PUNCT
dpc-3332	361	3	10.5114	10.5114	NUM
dpc-3332	361	4	/	/	SYM
dpc-3332	361	5	ada.2020	ada.2020	X
dpc-3332	361	6	.100491	.100491	NOUN
dpc-3332	361	7	.	.	PUNCT
dpc-3332	362	1	pmid	pmid	NOUN
dpc-3332	362	2	:	:	PUNCT
dpc-3332	362	3	33240023	33240023	NUM
dpc-3332	362	4	.	.	PUNCT
dpc-3332	363	1	pmcid	pmcid	NOUN
dpc-3332	363	2	:	:	PUNCT
dpc-3332	363	3	pmc7675080	pmc7675080	NOUN
dpc-3332	363	4	.	.	PUNCT